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ABSTRACT
Understanding the Alternative Splicing-regulated Transcriptomic
Changes During Mouse Retinal Development and Disease Through
Global and Gene-centric Approaches
Devi Krishna Priya Karunakaran, Ph.D
University of Connecticut, 2015
Alternative splicing (AS) is an important layer of gene regulation and has been shown to
control various cellular processes including splicing, mRNA export, translation and cell
cycle. Mis-regulation in AS has been implicated in many diseases. But, the role of AS in
the retinal development and diseases remains unexplored. To this end, I employed a twopronged approach, (i.e), gene-centric approach and an en-mass transcriptome analysis
approach to address this question. For the first approach, I studied the role of an
alternative splicing factor, Sfrs10 and a kinase, Citron Kinase (CitK) and its spliced
isoforms in murine retinal development and diseases. Expression analysis of Sfrs10 in
mouse and human retinae showed that unlike mouse, it was not expressed in normal
human retina but was observed only in AMD retina, suggesting a specific role in response
to oxidative stress. In parallel, I showed that the loss of CitK affected the cell division of
a subset of retinal progenitor cells which in turn affected the late neurogenesis,
specifically that of the Islet1+ bipolar neurons. In the second approach, global analyses
were performed by employing RNA deep sequencing on cytoplasmic and nuclear
fractions of developing retinal tissue. We investigated if the nuclear transcriptome would
be ahead of that of the cytoplasm where it simultaneously executes the current molecular
program whilst preparing for the next program i.e., de novo transcription. Also, I employed
a custom bioinformatics pipeline to reverse-engineer the order in which the molecular
programs are set up as the retinal tissue develops. Further, I extended the study to Nrl
i

gene knockout to identify the perturbation of molecular pathways in the absence of the
gene. Here, our bioinformatics strategy could predict the perturbed molecular programs
well before its histological manifestation. We also compared our methodology with the
existing methods of data analysis and show that our pipeline could give information on
transcription kinetics of genes segregated into each bin. Thus, this pipeline was employed
in the temporal comparison of a triple microRNA cluster knockout and its wild type
counterpart across different stages of development.
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Chapter 1: Retinal development
“The development of an organism may be considered as the execution of a
‘developmental program’ present in the fertilized egg. A central task of developmental
biology is to discover the underlying algorithm from the course of development.”
– Aristid Lindenmeyer
As a developmental biologist, I acknowledge the words of Lindenmeyer, which has
aptly captured the essence of every developmental biologist’s goal i.e., to understand the
course of the dynamic process of development and intricate regulatory networks that
dictate various decisions taken at every step during development. Thus, the focus of my
research was to understand the role of RNA processing, specifically that of alternative
splicing and how it regulates the transcriptome in the developing mouse retina. To this
end, I employed a two-pronged approach – a gene-centric approach using i) an
alternative splicing factor called Serine-arginine rich splicing factor 10 (Sfrs10), where I
studied its role in mouse retinal development and disease and ii) a kinase called Citron
Kinase, where I studied the role of its spliced isoforms in retinal progenitor cells in the
developing rat retina and iii) en-masse approach using deep RNA sequencing.
In this chapter, I will discuss the model system used in this study, which is the mouse
retina. First, I will discuss the history of the retinal research and why retina has been a
preferred model system to many neurobiologists. This is followed by the architecture of
the vertebrate retina and how the visual information flows from the input neurons in the
retina to the brain. Then, I will explain how retina develops from the diencephalon, various
models proposed to understand the cell fate of retinal progenitor cells and birth order of
retinal cells. Lastly, I will discuss the transcription factors that are known to regulate the
production of each retinal type.
1

1.1 Retina as a model system
The eye, as an organ, has been long studied and the history dates back to fourth
century B.C. when Plato mentioned in his writings that the light from the eye captured
objects with its rays. Later, in 1604, Johannes Kepler was the first to give the ‘theory of
retinal image’ explaining that vision occurs through a picture of visible things on the white,
concave surface of the retina[1]. Since then, retina and the image formation in the eye
have always been of great interest to many neuroscientists. An important breakthrough
in the retinal field happened in 1887, when Roman y Cajal started working with the avian
retina as he considered retina to be the most suitable system to study the basic
organization of the nervous system [2]. In 1893, he published his findings on the retinal
biology and mentioned how retina is an advantageous structure for neurobiologists
because of its accessibility, its stereotypic architecture with cell bodies and synapses, and
the linear flow of visual information. The studies made on the retinal circuitry paved way
for his ‘neuron doctrine’ [2]. Thereafter, cell fate of retinal progenitor cells, ‘competence
model’ of the retinal progenitor cells were studied [3]. In 1996, birth order of the retinal
neurons was characterized by Cepko and her group, who uses retina as the model system
to explore central nervous system development as its size and location lends itself to
experiments both in vivo and in vitro [3, 4]. Recent advancements in technology along
with plethora of literature on expression kinetics of many genes playing vital role in various
key processes during its development have bettered our understanding of the retinal
development. Thus, the aforementioned advantages of retina along with exhaustive
literature in the field has made it a great system to investigate the role of RNA processing,
specifically alternative splicing during its development and in retinal diseases.

2

1.2 Structure of the vertebrate retina
The retina is a thin layer of neural tissue that lines the inner part of the eye. It converts
the electrical light signal into a chemical signal which is then relayed to the brain via the
optic nerve. The retina is comprised of three nuclear layers and two synaptic layers [3,
5](Fig 1.1). The retinal pigmented epithelium (RPE) forms a single layer of cells attached
to the choroid and outer segments of photoreceptors. This layer provides nutrients and
removes wastes from the photoreceptor cells. Closer to the RPE is the outer nuclear layer
(ONL). This layer contains the nuclei of the light-detecting photoreceptor cells rod
photoreceptors and cone photoreceptors. Rod photoreceptor cells are more numerous
than cones (Fig 1.1) and are significantly more sensitive, being able to be activated by
individual photons of light [6]. Three types of cone photoreceptors exist in the retina: red,
green, and blue, each of which are activated by red light, green light and blue light,
respectively [7]. In murines, there are only red/green and blue cone photoreceptors and
they constitute about 3% of the cells in the ONL and are much less sensitive than rods
but allow for color vision [8]. The inner nuclear layer (INL) contains the nuclei of
interneurons and one glia, namely the Muller glia. These interneurons include horizontal
cells, bipolar cells, and amacrine cells (Fig 1.1). The outer plexiform layer (OPL) is the
synaptic layer where photoreceptor cell axons synapse with bipolar cell and horizontal
cell dendrites. The layer closest to the vitreous is known as the ganglion cell layer (GCL)
(Fig 1.1), which contains the main output neurons of the retina, namely the ganglion cells
[3]. The long ganglion cell axons comprise the optic nerve, which terminates in the lateral
geniculate nucleus in the brain from which the information is relayed to the visual cortex.
The inner limiting membrane is the most proximal to the vitreous and separates the first
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layer of the retina from the vitreous humor and contains the end-feet of the Muller glia
(Fig 1.1). The inner plexiform layer (IPL) contains synapses between bipolar cells,
amacrine cells and ganglion cell dendrites [3].
During phototransduction, light interacts with the photoreceptor outer segments and
rhodopsin in rods and cone-opsins in cones undergo a conformational change and
become activated [9]. This results in the photoreceptors decreasing the release of
neurotransmitters to the interneurons of the INL. Photoreceptor interaction with bipolar
cells varies based on the type of bipolar cell but this interaction relays the information to
the ganglion cells [9] (Fig 1.1). Lateral modulation of signal by horizontal cells and
amacrine cells allows cells from one region of the retina to influence cells of another
region. Horizontal cells receive input from photoreceptors and provide a feedback
mechanism to other photoreceptor cells. This in-turn helps to regulate and coordinate the
input from multiple photoreceptor cells [9]. Amacrine cells modulate the interaction
between bipolar cells and ganglion cells. They receive input from bipolar cells and also
serve as a feedback mechanism for those cells [9]. Once light reaches the ganglion cells,
it is transmitted to the brain. Muller glia processes extend from the vitreous humor side to
the photoreceptors acting like a ‘photoptic tube’ through which light can easily pass. This
direct passage of light is facilitated by the fact that the glia contain very few organelles,
which, if present, would scatter much of the light that would pass through [10].
1.3 Development of the mouse retina
In mouse, the eye begins to develop when optic vesicles evaginate from the
diencephalic region of the neural tube around E9.5 [11]. After the evagination of the optic
vesicles from the diencephalon, each optic vesicle invaginates to form an optic cup
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around E10.5 (Fig 1.2). The inner lining of the optic cup gives rise to the neural retina
while the outer lining results in the formation of the RPE [11] (Fig 1.2).
Retina is a very good model system with a stereotypic architecture as well as the birth
order of its cell types are well characterized. Ganglion cells are born first at E11.5,
followed by cone photoreceptors, horizontal cells and amacrine cells (Fig 1.3). Amacrine
cells are produced postnatally too. Muller glia and bipolar cells are produced postnatally
while rod photoreceptor cells are produced throughout retinal development with its peak
production at birth [3] (Fig 1.3). In 1996, Cepko et al., proposed the ‘Competence model’
where it was shown that progenitor cells in early embryonic development are capable of
producing more than one neuronal cell type, which was mainly determined by intrinsic
signals rather than environmental cues [3]. While, the progenitor cells later in the
development were restricted to giving rise to only one type of neuron [3]. Thus, although
a retinal progenitor cell is considered multipotent, at any given time during development,
the given progenitor cell will be restricted in its ability to produce certain cell types [12].
For example, progenitor cells fated to produce bipolar cells do not have the
competence/ability to produce neurons born embryonically, even when placed in an
embryonic milieu [12]. The reverse of this experiment also was performed where
progenitors fated to produce embryonically born neuronal types could not produce them
when placed in the postnatal environment [12]. This substantiated the view that progenitor
cells had the ability to produce all retinal neurons, but their competence was restricted by
the developmental time period in which they were isolated. Thus, cell-fate of retinal
neurons is determined by both intrinsic factors inherent to the progenitor cells, which
determine their competence to produce subsets of neurons, as well as by extrinsic signals
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which influenced the specific type of a neuron that will eventually be produced in a given
competence state [12].
1.4 Gene regulation in the developing mouse retina
Identification of gene regulatory networks connecting various pathways during retinal
development have led to a better understanding of not only the retinal development but
also, mechanisms that regulate these processes. The role of one of the master regulatory
genes, Pax6, has been well-established in Drosophila, where ectopic expression of the
gene was shown to induce eye formation with normal morphology [13]. Pax6 has been
shown to play a crucial role in maintaining the multipotency of the retinal progenitor cells
[14]. It acts upstream of β helix-loop-helix (bHLH) family of transcription factors, many of
which are key players in retinal development. One of the members of bHLH family, Math5
has been shown to positively regulate the formation of ganglion cells while it is negatively
regulated by the Notch-Delta pathway [15]. Key transcriptional factors in photoreceptor
formation include Nrl and Trβ2, which compete to keep the rod and cone photoreceptor
cell production in balance [16]. In the absence of Nrl, all rod photoreceptors become conelike. Nrl along with its target, Nr2e3 is essential for the rod photoreceptor production [17].
Nrl and another factor Crx (Cone- rod homeobox) are together required for the
maintenance of rod and cone photoreceptors [18-20]. A few factors crucial for bipolar cell
production and maintenance include bhlhb4, and Otx2, where bhlhb4 has been shown to
be essential for rod bipolar cell maturation [21], while Otx2 has been shown to be crucial
for both photoreceptors and bipolar cells [22]. Other bHLH factors such as Mash1 and
Math3 are also needed for proper bipolar cell production [23]. While the homeobox gene,
Chx10 is primarily present in retinal progenitor cells during early retinal development, later
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it is expressed in the bipolar cells and Muller glia and is required for their production [21,
24]. Another factor, Sox2 has been shown to play a vital role in the embryonic and adult
neural progenitors and is expressed in Muller glia [25]. Thus, transcriptional regulation
controlling the production of various retinal cell types is well established. But, the
underlying layer of isoform regulation of most of these genes still remain unexplored. This
understanding of isoform-level regulation can help greatly in therapeutic strategies when
a particular isoform can either be knocked down or upregulated without altering the
expression at the gene level. To this end, in the next chapter, I discuss the importance of
Alternative splicing (AS) and how this layer of regulation has diverse roles including in
central nervous system development.
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Figures:
Figure 1.1

Fig 1.1: Stereotypic architecture of the retina: Hematoxylin and eosin stain of an
adult mouse retinal section superimposed with schematic representation of retinal cell
types. OS=outer segements of photoreceptors; IS=inner segments of photoreceptors;
ONL=outer nuclear layer; OPL=outer plexiform layer; INL=inner nuclear layer; IPL=inner
plexiform layer; GCL=ganglion cell layer; RP=rod photoreceptor; CP=cone
photoreceptor; RBP=rod bipolar; CBP=cone bipolar; AC=amacrine cell; GC=ganglion
cell; MG-Mϋller glia
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Figure 1.2

Fig 1.2. Development of the retina from neural ectoderm: Retinal development
begins around embryonic day (E) 8.5 with the evagination of the diencephalon to form the
optic vesicle followed by the formation of lens placode with signals from optic vesicle at
E9. Inductive signals between lens placode and optic vesicle results in the formation of
optic cup and les vesicle at E10. At E10.5, lens is formed and the bilayered optic cup
forms the outer non-neural retinal pigmented epithelial (RPE) layer and the neural retinal
layer. Adopted and modified from Colozza G. et al [26].
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Figure 1.3

Fig 1.3. Birth order of retinal cell types: The black arrow indicates the time-line starting
with E11.5 to postnatal day (P) 14 and P0 is the day of birth. The first cell type sto be
born is the output neuron, ganglion cells (green), followed by cone photoreceptors (red),
interneurons horizontal cells (dark blue), amacrine cells (mustard yellow), bipolar cells
(fuchsia), and Muller glia (orange). The rod photoreceptor (white) production occurs
across development with a peak at P0. Adopted and modified from Cepko et al [3].
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Chapter 2: Alternative Splicing
This chapter focuses mainly on RNA processing, specifically the alternative splicing
(AS). My research focus is to combine the retinal development and AS to understand the
role of AS in the developing mouse retina. To this end, this chapter describes the
processes of transcription and splicing followed by alternative splicing process and the
diverse roles played by AS in cell cycle, metabolism, disease, and CNS development as
well as the factors that aid this process called alternative splicing factors.
2.1 Transcription and Splicing
Development of an organism is a tightly-controlled dynamic process, which
involves the regulation of various genes at multiple levels of complexity. At the cellular
level, numerous decisions are made including proliferation, division, differentiation and
determination. For all these processes, expression of various genes at different phases
are required. Therefore, their expression should be tightly regulated at every phase. The
development of central nervous system follows the same paradigm. A neural progenitor
cell is capable of undergoing an asymmetric (a progenitor cell and a neuron) or symmetric
cell division, which could be into two neurons or two progenitor cell. For each of these
decisions to be executed, various cell cycle regulating genes and fate determining genes
are involved. Spatio – temporal expression of these genes are often regulated at the
transcriptional levels and at post-transcriptional levels. The transcriptional level of
regulation refers to the transcriptome changes that occur in a tissue-specific and timespecific manner.
Regulation of gene expression can be done at the DNA level, with the usage of an
alternative transcription start site and polyadenylation sites or total silencing of a particular
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gene or a set of genes by regulating the levels of a transcription factor. Often, the gene
expression regulation occurs at the post transcriptional level, where different isoforms for
a gene are generated, thereby allowing for diversity at the proteome level as well as in
mRNA localization, transport, and turnover. Certain sequences in mRNA such as its 3’
untranslated region (3’UTR), exon-exon junction also determine the patterns of its
turnover, transport, subcellular localization and its translation [27]. The exon-junction
complex (EJC) plays an important role in the post-transcriptional regulation of mRNA,
where it is recruited during splicing and remains associated with the mRNA and allows
the export of the transcript to the cytoplasm [28].
Although the central dogma (information from DNA flows through a temporary
messenger RNA in the nucleus, which is then exported to cytoplasm and is translated
into proteins that carry out all major structural and functional activities in a cell) has
pointed RNA to be an intermediate, there is another layer of regulation at the posttranscription level that ultimately decides the type of protein synthesized. RNA processing
or regulation of RNA gained importance in late 1970s, when “one gene one protein”
hypothesis was questioned as there was a discordance in the number of protein coding
genes to the number of protein products in the higher mammals. The first step in RNA
processing is the production of mature RNA by the process called splicing.
Splicing: Splicing is co-transcriptional and is carried out by a complex, which is made of
five small nuclear RNAs and a large number of accessory proteins, called spliceosome
[29, 30]. This splicing machinery is required for the recognition of splice sites and to
catalyze the two esterification steps. The primary RNA transcript (pre-mRNA), which is
the identical copy of DNA has the exon and intron boundary (AG/GT), marked by a
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5’Splice site (SS) (discovered in 1978 [31]) and a 3’Splice site, which is marked by AG/G
(intron-exon boundary) [32] and a branch point [33, 34] (Fig 2.1). The machinery gets
assembled at these splice sites, which begins with the recognition of the 5’SS by the
snRNP U1 and binding of the splicing factor 1 (SF1) to the branch point and of the U2
auxiliary factor (U2AF) to the polypyrimidine tract [35] (Fig 2.1). This step results in the
formation of E-complex, which then becomes energy-dependent, pre-spliceosomal ‘A’
complex after SF1 is replaced by U2 snRNP at the branch point [35] (Fig 2.1). Further,
U4/U5-U6 tri-snRNP complex gets recruited leading to the formation of ‘B’ complex (Fig
2.1), which is then converted to the catalytically active ‘C’ complex after conformation
changes [35]. This remodeling of the complex leads to the excision of intron as a ‘lariat’
structure and fusion of exons to form the mature transcript (Fig 2.1).
The decision to include or exclude an exon is decided by another level of regulation
called Alternative splicing (AS) (Fig 2.2). The process of AS is aided by certain cis- and
trans-acting factors called RNA-binding proteins, which play an important role in various
aspects of posttranscriptional regulation of both nuclear and cytoplasmic mRNA including
alternative splicing, localization, export and translational regulation, besides playing a vital
role in constitutive splicing [36].
2.2 Alternative Splicing
Alternative splicing (AS) has long been thought be occurring at the initial step of
splicing during the SS recognition and early spliceosome assembly [37]. Although that is
mostly the case, recent evidences have shown that this decision could be made during
different stages of splicing including later stages of spliceosome assembly via the
interaction between cis-acting and trans-acting factors that either promote or repress the
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recognition of SS or during either of the two esterification steps (Fig 2.2). AS is one of the
mechanisms that contribute to proteome diversity as well as to tissue-specificity of many
genes, thereby regulating gene expression in a spatio-temporal manner. Indeed, recent
high-throughput sequencing studies on various human tissues have shown that 50% or
more of alternatively spliced isoforms are differentially expressed among the examined
tissues. The concept of AS was first introduced in 1977 with the discovery of exons and
introns in the adenovirus hexon gene [38, 39]. Walter Gilbert predicted that different
combinations of exons of could be spliced together to give the diversity in the mRNA
isoforms [40]. Thus, AS can be seen as an important mechanism to create protein
diversity in response to various developmental, environmental and metabolic cues [4143].
AS gained impetus due to the realization that there are fewer human protein
coding genes (PCGs) compared to the number of proteins in humans. Due to the advent
of technologies such as splicing-sensitive microarrays and high-throughput RNA
sequencing (HTS), importance and the occurrence of AS in various tissues have gained
limelight. Datasets obtained from these technologies have facilitated the understanding
of AS regulated events in contexts of development or differentiated tissues or normal
versus diseased states. In humans, about 90% of multi-exonic genes in various tissues
employ alternative splicing [44, 45]. While, some AS events are species-specific, it is
mostly an evolutionarily conserved process, which highlights the importance of AS very
early in evolution. An example of a species-specific AS event is that of the transient
receptor potential cation channel V1 (Trpv1) gene. A trigeminal ganglion-specific isoform
of this gene is expressed in vampire bats but not in fruit-feeding bats. This isoform has a
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lower temperature threshold, thereby enabling the vampire bats to sense warm-blooded
animals [46].
2.2.1 Types of Alternative Splicing
Alternative splicing can occur in multiple ways to produce different combinations
of exons to yield various isoforms. Some of the frequently occurring types of AS events
include, i) inclusion of the alternate exon ii) exclusion of the alternate exon iii) alternative
5’ SS selection iv) alternative 3’ SS selection v) intron retention, where an entire intron or
a part of it can be retained along with exons. Alternative splice sites are often termed
‘cryptic donor’ or ‘cryptic acceptor’ [47, 48] (Fig 2.3). There are also other less-frequent
complex events such as mutually exclusive AS event, alternative transcription start site,
usage of different polyadenylation signals. The frequency of these events vary among
invertebrates and vertebrates. It has been shown that in higher vertebrates including
mouse and humans, most frequently occurring AS event is exon skipping (almost 40% of
AS events), while in drosophila, exon skipping, alternate acceptor and donor and intron
retention events are observed at equal frequency with about 20% of exon skipping event
[48].
Difference in the type of AS events are also seen in the different regions of mRNA,
i.e., coding region versus untranslated region (UTR). It has been shown that exon
skipping event is more frequent in the coding region while the intron retention event is
more frequent in the 5’UTR. Also, more cryptic acceptors are found in the coding
sequence compared to that in the UTRs. The less-frequent complex events mostly occur
in the coding region [48].
2.2.2 Factors influencing alternative splicing
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Various factors such as secondary structure, splice site selection, cis-acting
elements can influence the AS event. The secondary structure can affect AS events by
sometimes masking the splice sites or binding sites for splicing factors. For example, a
stem and loop secondary structure has been shown to sequester alternative exon 6B of
the chicken β-tropomyosin pre-mRNA, leading to its exclusion [49]. Another example is
that of the Ras gene, where the IDX exon of Ras pre-mRNA can form a secondary
structure with an ISS, preventing the binding of hnRNP H [50]. The helicase P68 exposes
this binding site resulting in the binding. Some small nucleolar RNAs (snoRNAs) have
also been implicated in AS regulation. For example, snoRNA HBII 52 has been shown to
regulate the AS of Htr2c pre-mRNA by binding to an ESS in exon V b to aid its inclusion
[51].
The selection of splice site is also partially influenced by secondary structures in
the pre-mRNA. An example is that observed in Dscam pre-mRNA in Drosophila. The exon
6 cluster of this pre-mRNA contains 48 mutually exclusive exons and various
combinations of these exons have been shown to produce 38,016 isoforms [52].
Combination of a conserved sequence downstream of exon 5 (docking site) and another
conserved sequence, a variant of which is upstream of each of exon 6 variants (selector
sequence) allows for the inclusion of only one exon 6 variant. The other variants are
excluded by the binding of hrp36, a Drosophila homolog of hnRNP A, to the selector
sequence [53].
Alternative exons are shorter than constitutive exons and are flanked by longer
introns but they are more conserved than the constitutive exons, especially the exonintron boundary and these extend to 80 – 100 nucleotides in to the intron, where cis16

regulatory elements are embedded. The nature of cis-acting elements and their target
binding proteins depend on their position relative to regulated exons. Proteins such as
Nova1, Nova2, Fox1, Fox2, hnRNP L, hnRNP F, hnRNP H have been shown to act as
either activators or repressors depending on the location of their binding site. For
example, Nova1 binds to an intron splicing enhancer (ISE) in Gabrg2 (GABA A receptor,
γ2) pre-mRNA and enhances the inclusion of exon 9, while it binds to the exon splicing
suppressor (ESS) in the exon 4 of its own pre-mRNA and prevents its inclusion [54].
hnRNP L can either activate or repress depending on the location of its binding site
relative to the regulated 5’ SS [55]. Similarly, hnRNP H can promote or repress the
spliceosomal assembly based on the location of G-rich sequences whether it is
downstream of the 5’SS or in the exon [55]. Sometimes, these factors can work in
combination to activate or inhibit the splicing process. For example, Nova1 and Nova2
can bind to an ESS and inhibit the formation of the ‘E’ complex by altering the composition
before hnRNPs bind, ultimately inhibiting the binding of U1 snRNP. On the contrary, if
Nova1 and Nova2 bind to an ISE downstream of the alternative exon, they promote the
formation of ‘A’, ‘B’ and “C’ complex during splicing [56].
2.2.3 Role in diseases
AS plays an important role in diseases as one can imagine the effects of disrupted
splicing, such as cancer, metabolic disorders such as obesity, gene mutation etc. [57-59].
A well-known example of disrupted RNA processing and AS events is observed in
a class of disorders called ‘microsatellite expansion disorders’. Microsatellites are very
short sequence (~ 1 to 10) repeats, which are variable in number between individuals and
are capable of causing a disease when the number expands beyond the threshold. This
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expansion can cause either loss of protein function or gain of aberrant protein function in
the open reading frame or gain of function of the RNA that contains this expansion [60].
A few examples of diseases that are caused by RNA gain of function is myotonic
dystrophy types 1 and 2 (DM1 & DM2) [61, 62], fragile X-associated tremor ataxia
syndrome (FXTAS) and spinocerebellar ataxia 8 (SCA8) [63]. In DM1, CUG repeat
located in the 3’UTR of Dmpk mRNA expands beyond its normal range of 5 – 38 repeats
to about 50 - > 2500 repeats [64], while DM2 is caused by expanded CCTG repeats in
intron 1 of the Znf9 gene [65] and the clinical symptoms of DM1 and DM2 are quite similar
except that DM2 is less severe and does not present in the congenital form [62, 64].
The flexibility offered by AS to offer proteome diversity is used well in various types
of cancer. Since there is a thin line of separation between normal cell cycle and cancerous
growth, most AS events that are known to occur involve reverting of some of the isoforms
expressed during cell cycle in the adult stage, thereby leading to the cancerous growth.
AS regulates several genes that play important roles in promoting invasive behavior. In
addition, a process that often plays a role in the acquisition of invasive behavior in cancer
cells,

the

epithelial-to-mesenchymal

transition

(EMT),

is

accompanied

by

a

reprogramming of AS [66]. Also, once the cells become cancerous, they suppress the
apoptotic pathway. Therefore, genes involved in apoptosis pathway, which are
alternatively spliced, express their anti-apoptotic isoforms thereby aiding the growth [67].
Some of the apoptotic genes that are alternative spliced include Bcl-x, Caspase2 and
Fas. AS events in exon 2 of Bcl-x create two isoforms – Bcl-x(L), which has anti-apoptotic
effects and Bcl-x(s), a pro-apoptotic isoform [68].
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Casp2 mRNA is alternatively spliced to produce two most important isoforms –
Caspase-2L, which is a full-length coding isoform with pro-apoptotic properties, while the
other isoform, Caspase-2s, is an isoform with additional 61-nucleotide exon. This exon
inclusion results in the frameshift leading to a premature stop codon, thus creating a shortlived nonsense-mediated decay substrate. This isoform was shown to protect against cell
death [69, 70].
Another example is Fas pre-mRNA, where the full-length protein coding isoform
(Fas-L) is pro-apoptotic. While, it also produces a shorter isoform, which excludes a 63
nucleotide-long exon 6. This event results in the deletion of transmembrane domain
leading to the soluble form of Fas, which is capable of inhibiting FasL-mediated cell death
[71].
2.2.4 Role in central nervous system development
AS plays an important role in defining tissue-specificity. This, in part, could be
explained by tissue-specific expression of the splicing factors and their target mRNA
expression. Among all human tissues, brain has been shown to employ the highest
degree of AS. Many brain-specific AS regulators have been identified, such as, nPTB,
NOVA1, NOVA2, Hu/elav proteins, to name a few. In addition, more than 300 RNA
binding proteins have been identified in proliferating and post-mitotic brain cells with a
region and cell specific expression. For example, PTB is highly expressed in progenitors
while downregulated in differentiated neurons, where another isoform, nPTB is
upregulated. Recently, it has been shown that switch from PTB to nPTB is an important
post-transcriptional regulatory step in neuronal differentiation [72].
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Another brain-specific factor, Nova proteins, are also involved in programming of
different types of neuronal cells. Nova1 and Nova2 are differentially expressed in
postnatal mouse brain, with Nova2 being highly expressed in the neocortex and
hippocampus and Nova1 being expressed in the hindbrain and spinal cord [73].
Conditional knockout analysis of Nova2 has shown that Nova2 regulates ~7% of brainspecific splicing in the neocortex and that Nova2- dependent AS regulates the expression
of mRNA transcripts that encode synaptic functions [73].
2.2.5 Role in cell cycle regulation
During normal development and differentiation, dynamic changes in the
expression and activity of the splicing machinery are coordinately regulated to modulate
the alternative splicing events in a spatio-temporal fashion and according to the
physiological needs of the cell. Cell cycle is a key process during development allowing
for the proliferation of progenitor cells and for the simultaneous execution of decisions
such as determination, differentiation into a particular lineage once cells exit the cell cycle.
Therefore, numerous intricate networks work in a well-coordinated manner to execute
these cellular processes. Perturbations caused by mutations, which alters the expression
or activity of a splicing factor can lead to an array of human diseases. Cell cycle regulation
is also a tightly- controlled process, which keeps the cell under check and prevents it from
becoming cancerous. Any deviation in the expression of genes that are ‘check points’ in
cell cycle can lead to uncontrolled growth of cells leading to cancer. Therefore, alternative
splicing plays an important role in cell cycle regulation by regulating the isoforms of
various important genes involved in cell cycle.
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There are many genes that are employed at various phases of cell cycle including
cyclin D1a, CD44, Rac1, Ras etc. Cyclin D1a, is the more common full-length isoform
containing five exons. Another variant isoform is known as cyclin D1b, which is
polyadenylated in exon 4 at a particular site [74]. Although both isoforms can associate
with CDK4 and regulate the activity of CDK similarly [75], D1a can shuttle between the
nucleus and cytoplasm in a cell-cycle dependent manner due to the presence of a
phosphorylation site present at its C-terminus, while D1b remains nuclear due to the
absence of this phosphorylation site [75, 76]. Cyclin D1b remains nuclear and is known
to be upregulated in breast and prostate cancers [77] and mutations in D1a at the
phosphorylation site can also mimic D1b and increased nuclear levels of the protein could
be more oncogenic [78].
Another key player of cell cycle that is highly regulated by AS is CD44. Gunther et al.,
has shown that CD44 contains variant exons 4 -7 and isoform containing variant exons
6-7 were expressed specifically in a metastasizing pancreatic carcinoma cell line [79].
Various combinations of ten variant exons in CD44 leads to numerous isoforms of CD44
[80]. An isoform containing variant exon 6 was seen to be expressed in B and T
lymphocytes after lymphocyte activation [81]. Normal expression of CD44 is that of the
isoform containing the variant exons 8-10, which is seen in epithelial cells [82].
A member of Ras superfamily of GTPases, Rac1 has two variant isoforms. Like Ras,
Rac1 shuttle between an active form when it is bound to GTP and an inactive GDP-bound
form. Rac1 activates transcription by NFkB and AKT kinase, members of important
pathways implicated in various cancers [83, 84]. An isoform of Rac1 called Rac1b, which
contains a 57-nucleotide exon 3b, has been shown to be expressed in colorectal cancer.
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Another important gene involved in the cytokinesis step of cell cycle regulation is
Citron Kinase (CitK). It belongs to Rho family of GTPases and is found to be expressed
in the proliferative cells of the developing brain. There are two known isoforms of this
gene – full length protein-coding isoform called citron kinase and a shorter isoform without
the kinase domain coding region. This gene was employed to study the role of alternative
splicing in retinal progenitor cells in the developing rat retina and the function of other
newly identified isoforms of CitK. Background on this gene is discussed in the next section
and the results obtained in the study is discussed in chapter 4.
2.2.6 Alternative Splicing factors
Trans-acting factors that facilitate the process of AS are called alterative splicing
factors (ASFs). These factors can either repress or promote the inclusion of an exon in
the final transcript. Accordingly, there are two large family of ASFs namely serine-arginine
rich (SR) proteins and heterogeneous nuclear ribonuclear protein (hnRNPs). While SR
proteins usually are splicing enhancers and that they promote the inclusion of the
alternative exon, members of hnRNP family suppress the inclusion of an exon. SR
proteins typically contain one or two RNA –recognition motif (RRM) and one or two RS
dipeptide containing domain. The RS domain of these proteins interact with other splicing
factors and facilitate the recruitment of the spliceosomal components such as snRNP U1
to the 5’ SS or U2AF65, the largest subunit of U2AF to the 3’SS (SR proteins are
discussed in detail in chapter 3) [85]. hnRNPs contain RRM-type and hnRNPK homology
(KH) domain-type RNA binding domains and play a key role in splicing of pre-mRNA and
mRNA metabolism. They act as repressors by affecting the formation of the E and A
complexes during the spliceosome assembly. Other repressors include Polypyrimidine-
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tract binding proteins (PTB or hnRNP I), which blocks the binding of U2AF, hnRNP A1,
which binds to intronic splicing suppressors (ISS) located upstream of exon 3 in HIV Tat
pre-mRNA and prevents the binding of U2 snRNP [86]. Also, tissue-specific factors, Fox1
and Fox2 inhibit the formation of the E’ complex by binding to intronic sequences to
prevent SF1 binding to the Calca pre-mRNA [87]. In addition to repressing, splicing
inhibitors also block the binding of activators to enhancers. Hu/ELAV family of proteins
inhibit U1 snRNP binding by competing with the binding of TIA1 to an AU-rich sequence
downstream of the 5’ SS of exon 23a of neurofibromatosis type 1 pre-mRNA [88]. Another
example is hnRNP A1 binding to an ESS upstream of the Tra2b-dependent exon splicing
enhancer in exon 7 in the SMN2 pre-mRNA, inhibiting the formation or stabilization of U2
snRNP complex [89].
Thus, the final decision of whether or not an alternative exon is included in the
transcript is determined by concentration or activity and the combination of activators and
repressors. For example, SR protein 9G8 (SFRS7) and hnRNP F and H regulate the
splicing of exon 2 of α-tropomyosin by competing for the same binding site [90]. Similar
regulation exists in β-tropomyosin exon 6B, where there is an antagonistic regulation
between hnRNP A1 and SR proteins, ASF/SF2 (SFRS1) and SC35 [91]. PTB and CELF
(CUGBP- and ETR-3 like factor) protein family and CUGBP1 act antagonistically to
regulate the inclusion of exon 5 of troponin T type 2 pre-mRNA [92].
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Figures
Figure 2.1

Fig 2.1 Steps in the splicing process. Basic splicing mechanism begins with the
recognition of 5’ splice site and branch point by U1snRNP and U2AF (‘E’ complex). This
leads to the recruitment of U2 snRNP, resulting in the formation of ‘A’ complex, which
results in first trans-esterification step. Recruitment of the tri-snRNP complex (U4-U6-
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U5) to the pre-mRNA leads to the second trans-esterification step. Finally, the intron is
excised as a ‘lariat’ and the exons are fused to form the mature RNA.
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Figure 2.2

Fig 2.2 Mechanism of alternative splicing. A. Presence of splicing enhancers, such as
SR proteins (shown in ‘blue’) on the pre-mRNA facilitates the recruitment of the splicing
machinery, leading to the inclusion of the alternate exon. B) Presence of splicing
repressors, such as hnRNPs (shown in ‘magenta’) on the pre-mRNA prevents the
recruitment of the splicing machinery, leading to the exclusion of the alternate exon.
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Figure 2.3

Fig 2.3. Types of Alternative Splicing. A – E. – Various types of alternative splicing
events include A) exon splicing B) Mutually exclusive event C) Alternative 5’ splice site
D) Alternative 3’ splice site E) intron retention.
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Chapter 3: Role of the alternative splicing factor, Sfrs10 in mouse
retinal development
This chapter approaches the question of role of alternative splicing (AS) specifically
through an alternative splicing factor, Serine-arginine rich alternative splicing factor 10
(Sfrs10) in mouse retinal development and disease. This approach to understanding the
role of AS, follows the same paradigm of understanding the process of transcription
through transcription factors. First, expression analysis of this gene, both at the mRNA
and protein level, is discussed followed by the investigation of its role as a stressresponse gene in age-related macular degenerating retinae.
3.1 SR proteins
Serine/arginine (SR) family of proteins are a highly conserved family of splicing
regulators. The discovery of SR proteins dates back to studies in Drosophila, when
genetic screening identified SWAP (suppressor-of-white-apricot), Tra and Tra2 as
splicing factors [93, 94]. Characterization of their sequences led to the identification of the
RS domain. Identification of factors ASF/SF2 and SC35 from human cell lines extended
their structural characterization to reveal the presence of atleast one RNA recognition
motif (RRM) and another region that is not an exact match to RRM but partially matched
the consensus sequences and was referred to as RRM homolog (RRMH). These proteins
are called “SR proteins” and was described by Roth and his colleagues based on five
criteria [95]: 1. All members have a phosphoepitope recognized commonly by the
antibody, mAb104 2. They co-purify in a two-step salt precipitation procedure 3. They
contain one or two RRMs at the N-terminus and an arginine-serine (RS) dipeptide
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containing domain at the C-terminus. Sizes of these proteins are conserved from
Drosophila to humans on a SDS-PAGE. These proteins can complement splicing
deficient S100b extracts [95]. SR proteins, besides, acting as exon-splicing enhancers
(ESE), have also been implicated in mRNA export, localization, nonsense-mediated
decay (NMD) and translation [85, 96-98]. When they act as ESEs, they recruit the splicing
machinery to the pre-mRNA via their RS-domain-protein interactions, to the splice site
[99-101]. Kinetic analyses have shown that the relative activity of SR proteins determines
the magnitude of splicing efficiency [85]. This activity depended on the SR protein number
and the distance between the ESE and the intron. Also, the activation of splicing was
proportional to the number of RS repeats within the RS domain [102].
Location: SR proteins are usually enriched in nuclear compartments termed
‘speckles’, which occur throughout the nucleus [85, 103]. Speckles can be of two types –
Inter-chromatin granule clusters (IGCs), which are about 20-25nm in diameter, and
perichromatin fibrils, which are about 5nm in diameter. IGCs are usually the
storage/assembly sites for pre-mRNA splicing factors while the fibrils are sites of actively
transcribing genes and splicing [104, 105]. Biochemical analyses have shown that RS
domains are responsible for bringing the SR proteins to these speckles. RS domain, RRM
and their phosphorylation status are required for the recruitment of SR proteins to
perichromatin fibrils from IGCs.
Phosphorylation and concentration of SR proteins: Phosphorylation of SR
proteins is vital for their activity in both constitutive and alternative splicing and for their
localization. Serines in the RS domain get phosphorylated and this activity determines
their activity [85]. Regulation of SR protein activity by phosphorylation has been
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implicated in cancers and other diseases. Phosphorylation is required for efficient SS
recognition. A number of SR protein kinases have been identified that specifically
phosphorylate the serine residues in the RS domain. They include SR protein kinase
(Srpk), Clk/Sty kinase, cyclin-dependent kinases (Cdk), and topoisomerases [106, 107].
Also, SR proteins function in a concentration-dependent manner. SRp38 has been shown
to facilitate inclusion of the Flip exon of the Gria2 (Glutamate receptor, ionotropic,
AMPA2) pre-mRNA, whereas the mutually exclusive Flop exon is included in its absence.
Interestingly, both of these exons contain SRp38-binding sites and it was shown that
intracellular concentrations of SRp38 and differential binding to exons influenced whether
Flip or Flop exon was included [108].
SR proteins as repressors: There is a balance between activation and repression,
which regulates the inclusion/exclusion of an exon in the primary transcript [86, 109].
Although, there are several members in the SR protein family, some of the members have
distinct binding sites endogenously, for example, SRSF3 and SRSF4 do not have any
overlap in the binding sites of their targets [110, 111]. There are a few SR proteins which
cooperatively operate with overlap in their binding sites, such as SRSF1 and SRSF2,
which can compensate for one another in exon inclusion/exclusion [112]. Sometimes, SR
proteins bind to intronic regions and function as negative regulators. An example is that
of SF2/ASF, which during adenovirus infection, binds to an intronic repressor element
located upstream of the 3’ SS at the branch point sequence in the adenovirus pre-mRNA
[113]. The binding prevents the recruitment of U2AF and so the splicing process.
Role of SR proteins in mRNA export: SR proteins are known to shuttle between
cytoplasm and nucleus depending on their phosphorylation status. SF2/ASF, SRp20 and
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9G8 have been shown to shuttle between the two compartments. It has been shown that
SR proteins, 9G8 and SRp20 promote nuclear export of the intronless histone H2A mRNA
by binding to 22-nucleotide sequence within H2A mRNA in mammals and frog. These SR
proteins have also been shown to handover mRNA to the nuclear export factor, Tipassociated protein (Tap) [114, 115]. Another SR protein, Npl3p, a yeast protein has been
shown to assist mRNA export in yeast, where the phosphorylation of its RS domain
regulates the efficiency of its export function [116].
Role of SR proteins in translation: SR proteins have been shown to play diverse roles
in RNA processing including translation of mRNA. They can either directly or indirectly
influence translation. For example, SF2/ASF influences the AS of the kinase that
regulates translation initiation, Mnk2 pre-mRNA [58]. Directly, SF2/ASF has been shown
to influence translation by associating with polyribosomes and mediating the recruitment
of components of mammalian target of rapamycin (mTOR) pathway, which releases the
inhibitor of the cap-dependent translation, thereby promoting translation [117]. Also,
SRp20 has been shown to promote translation of a viral RNA initiated at the internal
ribosome entry site [118].
3.2 Serine-Arginine rich alternative splicing factor 10 (Sfrs10)
SFRS10 (Tra2beta) belongs to SR-protein family. Sfrs10 is a mammalian homolog
of Drosophila Tra2beta, which regulates the AS of genes involved in sex determination of
the fly [119, 120] and causes sex reversal in Drosophila due to the altered splicing of
doublesex (dsx) transcripts [121]. Sfrs10 contains a RRM and two RS domain, one at the
N-terminus and the other at the C-terminus. Sfrs10 has been shown to activate splicing
of some targets via (A)GAA binding motifs in its RRM [122], while for some targets, it can
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activate through its N-terminal RS domain (RS1), which has been shown to be vital and
highly conserved between vertebrates and non-vertebrates. Sfrs10 protein lacking RS1
domain has been shown to play the role of a splicing repressor suggesting a dual role of
an enhancer and repressor during splicing [123].
3.2.1 Role in development and metabolism
In higher vertebrates, loss of Sfrs10 results in mouse embryonic lethality around
embryonic day (E) 7.5-8.5 [124]. Brain specific knockout of Sfrs10 has shown to result in
perinatal death where pups die by P1 and show malformed brain [122]. The role of Sfrs10
in various tissues such as testis, intestinal and vascular smooth muscle has been studied.
SFRS10 has been shown to be involved in the regulation of splicing of the clathrin light
chain B (Cltb) at the vesicles, which is involved in receptor-mediated endocytosis [125,
126], and in splicing of Mypt, which is involved in vascular smooth muscle diversification
(splicing of MYPT) [127]. SFRS10 has been shown to alter splicing of lpin1 [128], which
is a key regulator of lipid metabolism, thereby leading to increased lipogenesis and VLDL
secretion in mice [129-131]. It has been shown that Sfrs10 plays a crucial role in neuronal
development and survival through its targets such as Sgol2 and Tubd1 [125]. Additionally,
knockdown of Tra2b has been shown to perturb p21-mediated cell cycle inhibition,
thereby resulting in apoptosis [125].
3.2.2 Role in diseases and in stress-response
Sfrs10 was originally identified as a stress response gene called RA301 that was
strongly induced in cultured astrocytes during reoxygenation following hypoxia and in
ischemic rat brain [132]. The same group showed that knockdown of Sfrs10 in astrocyte
subjected to hypoxia/reoxygenation stress had 3-fold reduction in the release of a
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neuroprotective interleukin-6 (IL6). This was the first report of an ASF linked to active
stress-response mechanism. Other evidence of stress induced upregulation of Sfrs10
was shown by Tsukamoto et al [133] where it was observed that middle carotid artery
occlusion caused upregulation of Sfrs10 in vascular smooth cells. In gastric cell lines
exposed to arsenite led to changes in splice patterns of Sfrs10 itself and it was
translocated to the cytoplasm in part due to the change in its phosphorylation status [134].
In the same study, knockdown of Sfrs10 altered inclusion of exons responsible for the
central variable region of CD44, which led to suppression of cell growth. Also, carotid
artery occlusion induced ischemia in the brain showed hyperphosphorylation and
translocation of Sfrs10 into the cytoplasm of the affected neurons [70]. This shift in Sfrs10
was concomitant with changes in the splice site usage in the known initiator caspase,
ICH-1/caspase2 gene. Over expression of Sfrs10 has been shown to upregulate p53
levels [135]. Reduced levels of Tra2b have been observed in various diseases including
stroke, breast cancer [136] and neurodegenerative diseases like spinal muscular atrophy
(splicing of SMN) [137-139] and in tauopathies like Alzheimer’s disease and frontotemporal dementia with Parkinsonism (FTDP) [136, 140]. The gene, microtubule
associated protein tau (MAPT) undergoes AS to produce six brain-specific protein-coding
isoforms. The ratio of these isoforms is perturbed due to mutations in the splicing
elements in the gene, which leads to the production of irregular ratios of Mapt transcripts
observed in patients affected with FTDP. It was also shown that mutations in Mapt
produced abnormal Tau proteins causing neurodegeneration. Sfrs10 regulates the
splicing event of exon 10 inclusion in Tau pre-mRNA. Inclusion or exclusion of exon 10
leads to the generation of three- or four- microtubule repeats and the ratio under normal
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conditions equals one and is essential for proper neuronal function. Imbalance created in
the ratio leads to neurodegenerative diseases such as Alzheimer’s disease [141, 142].
3.3 Rationale
The alternative splicing factor, Sfrs10, has been shown to play an
important role in brain development. I wanted to explore the function of Sfrs10 in the
developing mouse retina. To this end, I first characterized the gene and its protein
across mouse retinal development. The expression of alternative splicing factor, Sfrs10
was examined across various species as the Sfrs10 protein is 100% conserved
between all mammals including mouse and humans. This led to the analysis of Sfrs10
protein by immunohistochemistry on sections of retinae obtained from normal humans.
Surprisingly, Sfrs10 protein was not expressed in normal humans, unlike in mouse,
where it had an ubiquitous expression by adulthood. Since Sfrs10 is a well-known
stress- response gene, I investigated retinal sections obtained from patients with agerelated macular degeneration (AMD). Further, I also tried to explore the function of this
gene under hypoxic stress in cell culture system, which was eventually shown by
Kuwano et al [143] that Sfrs10 plays a protective role by promoting the formation of antiapoptotic isoform of Bcl2 (Bcl2α) under stress.
Following sections include contents of two my publications [144, 145] titled “The
expression analysis of Sfrs10 and Celf4 during mouse retinal development” and
“Expression Analysis of an Evolutionarily Conserved Alternative Splicing Factor,
Sfrs10, in Age-related Macular Degeneration”.
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3.4 Background
Age-related Macular degeneration (AMD) is the leading cause of blindness in the
aging population in the developed world. According to National Eye Institute, in 2010,
approximately 2 million people were affected with AMD in the US and the number is
estimated to go up to 3.6 million by 2030 (http://www.nei.nih.gov/eyedata/amd.asp). AMD
affects the macula, the region in the retina that is responsible for sharp, central vision.
AMD can be of two distinct forms: dry AMD (non-exudative or atrophic) or wet AMD
(exudative or neo-vascular) of which dry AMD is the most common. AMD is a multifactorial
disease that includes genetic, environmental and physiological components. The
underlying cause of AMD is thought to be the hypoxic condition experienced by the
photoreceptors leading to their degeneration [146-152].
Rod photoreceptors consume more O2 per gram of tissue weight than any other
cell in the body [6]. This constant high energy demand makes the photoreceptors more
susceptible to hypoxic stress. Factors such as oxidative stress, accumulation of
autoxidative lipofuscin in the lysosomes of retinal pigmented epithelial (RPE) cells [153158] and accumulation of drusen in between Bruch’s membrane [159, 160] and the
epithelial layer affect the RPE which results in the senescence of these cells. RPE not
only plays a vital role in supplying nutrients and oxygen from choroidal vasculature to the
photoreceptor cells, but also in removing the metabolic wastes from the photoreceptors.
Since the outer segments of the photoreceptors interact with RPE, senescence of the
latter affects the normal functioning of the former [161, 162].
Genome wide association studies have shown SNPs in genes including VegfA,
VegfR2, Arms2, Htra1, and CFH to have significant association with AMD [163-169].
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However, the role of alternative splicing in the pathogenesis of AMD is not well
understood. Members of SR protein family such as SFRS1 have been shown to play a
role in the pathogenesis of AMD. Phosphorylated SFRS1 was shown to promote proximal
site selection in exon 8 of VEGF to generate the angiogenic isoform, VEGF (165) in AMD
[170, 171]. We investigated the role of SFRS10 in AMD.
3.5 Results
3.5.1 Sfrs10 is expressed across mouse retinal development
To determine whether Sfrs10 was expressed during mouse retinal development, RT-PCR
was performed across retinal development. The position of the primers used to amplify
the coding sequence of Sfrs10 is shown in Fig 3.1A. Expression was observed across
retinal development with two distinct isoforms at postnatal day (P)4, P10 and P14 (Fig
3.1B). Sequence analysis of both these isoforms revealed that the isoform at 1234 bp
was the canonical isoform encoding a full-length Sfrs10 protein. The higher MW isoform
at 1511 bp was similar to the previously reported exon 2a containing isoform. Inclusion
of exon 2a introduces a premature stop codon, which results in non-sense mediated
decay of this transcript. Gapdh was used as a control (Fig 3.1B’). 5’ rapid amplification
of cDNA ends (5’RACE) was performed to investigate whether alternate transcription start
sites were being employed for Sfrs10 across retinal development. For this, PCR was
employed on 5’-RACE ready cDNA library from retinae at different developmental time
points. While the forward nested primers were in the 5’ linker sequence, the reverse
primer was in exon 4 of Sfrs10. The PCR product was then purified and subjected to
restriction digestion with EcoNI, which yielded two bands as predicted to be of 380 bp
and 130 bp, respectively (Fig 3.1C). There was no change in the transcription start site
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across retinal development. Similar investigation across different developmental time
points was carried out to check the alternate polyA signal usage in Sfrs10 (NM_009186.4)
as it contains three putative polyA signals (1672 bp, 1762 bp, 2247 bp). 3’ rapid
amplification of cDNA ends (3’RACE) was employed with forward primers designed
upstream of each polyA signal and a reverse primer in the linker sequence followed by
restriction digestion with BsrI, which yielded two bands as predicted 407 bp and 230 bp.
Again, the second PolyA signal at 1762 bp was utilized for Sfrs10 transcript across retinal
development (Fig 3.1D).
3.5.2 Sfrs10 is expressed in differentiating retinal cells
Next, we employed IHC with AB#1 on mouse retinal section across postnatal
development to ascertain the cell types expressing Sfrs10. At P0, Sfrs10 was observed
in the nuclei in the ganglion cell layer (GCL) (Fig 3.2A). At P4, it was observed at the
bottom of the outer neuroblastic layer (ONBL), besides the GCL (Fig 3.2B). Sporadic
Sfrs10+ cells were also observed in the middle of the ONBL of the P4 retina. Next, Sfrs10
was costained with syntaxin, which was localized to the cytoplasm of the Sfrs10+ nuclei.
At P8, Sfrs10 was observed in all of the cell types in the INL including, Müller glia,
horizontal cells, bipolar cells, and amacrine cells and the GCL (Fig 3.2D). In addition, in
the newly formed ONL at P8, a few Sfrs10+ cells were observed. Similar pattern was
observed in the ONL of P10 and P14 retinal sections (Fig 3.2E, F).
3.5.3 Sfrs10 marks red/green cone photoreceptors between P8-P14
The sporadic Sfrs10+ cells in the ONL at P8, P10 and P14 could either be rod
photoreceptors or cone photoreceptors. To distinguish between these two possibilities,
P8 and P10 retinal sections were stained for expression of Sfrs10 and red/green opsin.
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Three independent antibodies for Sfrs10 (AB#1, AB#2, and AB#3) were employed to
confirm the specificity of the antibody (Fig 3.3A). Since the primary antibodies to detect
both Sfrs10 and red/green opsin were raised in rabbit, they could not be detected
simultaneously. Instead, serial IHC was performed, first with Sfrs10 followed by red/green
opsin.

Since Sfrs10 and red/green opsin are segregated into separate cellular

compartments, i.e. nucleus and cytoplasm, respectively, we were able to employ serial
IHC. Here, it was observed that Sfrs10+ nuclei were enveloped by red/green opsin
staining thereby confirming the identity of these cells to be red/green opsin cone
photoreceptors (Fig 3.3B-D”). All three Sfrs10 antibodies showed similar pattern, thereby
confirming the specific enrichment of Sfrs10 in red/green cone photoreceptors. Further,
we performed immunoblot analysis on P0 retinal extracts with the two antibodies (AB#1
& AB#2), which again showed a single immunoreactive band at the expected molecular
weight of Sfrs10 (Fig 3.3G, H).
3.5.4 Sfrs10 is peri-nuclear in mouse rod photoreceptors
Analysis of Sfrs10 expression across postnatal development ending at P14 showed that
the rod photoreceptors did not express Sfrs10.

However, it is known that rod

photoreceptors undergo rapid outer segment genesis between P13 and P17 and terminal
differentiation including synapse formation is thought to be complete by P21 [161, 172].
To test whether Sfrs10 is expressed in rod photoreceptors during their terminal
differentiation, IHC was performed for Sfrs10 on P22 retinal sections, which showed
Sfrs10 expression in rod photoreceptors, albeit in a different pattern (Fig 3.4A). Unlike
cone photoreceptors, where Sfrs10 was found in a diffused nuclear pattern, in rod
photoreceptors it was localized in a peri-nuclear ring-like structure. Since photoreceptors
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do not have a large cytoplasmic space around the nucleus, it was not clear if Sfrs10 was
in the cytoplasm or the nucleus. To further delineate the localization of Sfrs10, 6 μm
retinal sections were costained with Sfrs10 and LaminB2 antibody, which marks the inner
membrane of the nuclear envelope [173]. Here Sfrs10 was found on the DAPI stained
region, but did not overlap completely with LaminB2 thereby confirming its localization on
the nuclear side of the nuclear envelope (Fig 3.4A-A’’).
To investigate the role of Sfrs10 in mouse retinal development, we wanted to use
a retina-specific conditional knockout of Sfrs10. While I waited for the chimeras to arrive
from the KOMP facility at the University of California, Davis, I simultaneously started
addressing the question through en-masse transcriptomic analysis using RNA
sequencing, which I will discuss in Chapter 5.
3.5.5 Sfrs10 is 100% conserved in mammals
Sfrs10 has three functional domains namely, N-terminal RS1 domain (31-113
amino acids (AA)), C-terminal RS2 domain (231-287 AA) and RNA recognition motif (118196 AA) (Fig 3.5A). AA sequences corresponding to these functional domains were
compared across different vertebrate species to assess the percentage of conservation
of Sfrs10. The selected species were Danio rerio (zebrafish), Xenopus tropicalis (frog),
Gallus gallus (chicken), Pan tronglodytes (chimp), Bos taurus (cow), Canis lupus
familiaris (dog), Homo sapiens (humans), Sus scrofa (pig), Mus musculus (mouse),
Rattus rattus (rat) and Delphis delphis (dolphin). The selection was based on the
availability of the entire AA sequence in each class.
The entire RS1 domain was conserved 100% between chicken and all the
mammalian species (yellow background, Fig 3.5B) while only the RS dipeptide region
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showed 100% conservation in all species (Fig 3.5B). RS2 domain was similar to RS1
domain in that there was 100% conservation in the RS dipeptide region among all the
species (yellow background, Fig 3.5B’’) with the entire domain conserved 100% among
the mammals (Fig 3.5B’’). Within the RRM of SR proteins there are two motifs called
ribonucleoprotein 1 (RNP1), an octamer, and ribonucleoprotein 2 (RNP2), a hexamer,
which are highly conserved [174-177]. In Sfrs10, RNP1 sequence is RGFAFVYF (159166 AA) and RNP2 sequence is LGVFGL (125-130 AA). Comparison of RNP1 motif
across the species showed 100% conservation except for zebrafish and frog, which had
one AA change (phenylalanine to leucine in zebrafish, alanine to serine in frog) (red box,
Fig 3.5B’). Similarly, comparison of RNP2 motif showed 100% conservation across all the
species (blue box, Fig 3.5B’). Interestingly, the entire Sfrs10 AA sequence showed 100%
conservation in mammals including the linker regions between the functional domains.
3.5.6 Sfrs10 expression is conserved in mouse, rat and chicken retinae
Given that Sfrs10 is highly conserved at the protein level across different species,
we wanted to investigate whether its conservation was reflected in its expression. We
chose mouse, rat, chicken, and zebrafish as these are widely used model organisms for
retinal research. We employed immunoblot analysis using an antibody that recognizes
the conserved N-terminal of the protein (black box, Fig 3.6A). A single band at the
predicted (39 kDa) size was observed in mouse, rat, and chicken retinal extract (Fig 3.6B).
This band was at the same molecular weight (MW) as the positive control, which was the
protein extract prepared from HEK-293t cells transfected with a construct expressing full
length Sfrs10 protein. Notably, no immunoreactivity was observed in the lane with
zebrafish retinal extract (Fig 3.6B).
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3.5.7 Sfrs10 expression is pan-retinal in mouse, rat and chicken
To ascertain the cell type specific expression of Sfrs10, retinal sections from adult mouse,
rat and chicken retina were subjected to IHC with the same antibody used for immunoblot
analysis (black box, Fig 3.6A). In mouse, Sfrs10 was robustly expressed in all the cell
types of the retina including, ganglion cells, amacrine cells, Müller glia, bipolar cells,
horizontal cells and in both cone and rod photoreceptors. The expression pattern in
photoreceptors was different with Sfrs10 expressed diffusely across the nucleus in cone
photoreceptors, while the expression was peri-nuclear in rod photoreceptors (Fig 3.7A).
In rat, Sfrs10 expression was similar to that of mouse and was observed in all cell types
of the retina (Fig 3.7B). Similarly, in chicken, Sfrs10 was expressed in both the ganglion
cell layer and in the inner nuclear layer, but in the photoreceptor layer there was a minor
difference in the expression pattern. Sfrs10 expression was not observed in a subset of
cells, which by the staining pattern was deduced to be rod photoreceptors (Fig 3.7C).
3.5.8 SFRS10 is not expressed in normal human retinae but is upregulated in AMD
retinae
Given that Sfrs10 is a known stress response gene that is 100% conserved
between mouse and human, we sought to investigate its expression in normal and AMD
human retinae. For this, three independent normal retinal sections were subjected to IHC
with anti-Sfrs10 antibody (Table 3.1).
Sample #1 showed no Sfrs10 expression in any of the retinal layers (Fig 3.8A).
Similarly, sample #2 showed no SFRS10 expression (Fig 3.8B). Again, sample #3
showed no SFRS10 expression, except for low levels in a few cells in the ganglion cell
layer (Fig 3.8C).
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Table 3.1: Case history of specimens analyzed

Sourc
e

Sampl
e No.

Ag
e

Se
x

Categor
y

hours
post
morte
m fix

Abca
m
NDRI

1
2

50
74

M
F

Normal
Normal

unknow
n
4

unknown
COPD

NDRI

3

74

F

Normal

5

Cancer

Cause of
Death

Medical History
unknown

NDRI

4

88

F

AMD

7.8

Respiratory
failure

NDRI

5

86

F

AMD

7.4

Abcess

NDRI

6

89

M

AMD

6.5

no history available
Lung cancer,
Pneumonia,
Congestive heart
failure
Endometro cancer,
osteoporosis,
hypertension,
glaucoma, macular
degeneration,
Hemangioma,
aortic stenosis,
insomnia
Macular
degeneration,
Diabetes, Cataract
surgery,
hemicholoectomy,
hypertension,
hypercholesterole
mia
Macular
Degeneration,
pneumonia,
hypoxic respiratory
failure, dementia

CVA
Acute
unknow
4.0 cardiac
UCHC
7
76
F
n
5.0
arrest
Unknown
Abbreviations: CVA – Cerebro Vascular Accident (Stroke); COPD – Chronic Obstructive
Pulmonary Disease; NDRI – National Disease Research Interchange; UCHC – University
of Connecticut Health Center.
Next, we wanted to investigate the expression in AMD, so we obtained three
independent AMD samples from NDRI (Table 1). Here, the level of degeneration in the
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three samples was determined by the localization of L/M opsins in the cone
photoreceptors by IHC. Under normal conditions, opsins are restricted to the membrane
of the outer segments (OS) [178] as shown in normal sample #3 (Fig 3.9A). However, in
case of the AMD retinae, L/M opsins were observed in the entire cone photoreceptor
membrane (Fig 3.9B-D). This is in agreement with previous reports indicating that opsins
in a degenerating retina relocalize to the entire photoreceptor membrane due to aberrant
opsin trafficking [178]. Notably in Sample #4, vertical alignment of OS was lost and the
thickness of the outer nuclear layer (ONL) was reduced compared to other two AMD
retinae,

indicating that this retina had a higher degree of degeneration (Fig 3.9B).

Subsequently, all of these retinal sections were subjected to IHC with anti-Sfrs10
antibody. Sample #4 showed a distinct upregulation of SFRS10 in a speckled pattern (Fig
3.10A). Similar upregulation was seen in a few cells in all three nuclear layers in sample
#5, where the layers were comparable to that in a normal retina (Fig 3.10B). The
expression in sample #6 was similar to previous two samples with upregulation seen as
distinct speckles in ganglion cells as well as in some cells in the INL and the ONL (Fig
3.10C). In addition, we analyzed the foveal/parafoveal regions from sample #7 by serial
IHC. Again, the staining for red/green opsin showed that the opsin is redistributed
throughout the membrane of the photoreceptor, indicating that the sample was
undergoing degeneration (Fig 3.10D). In case of SFRS10, the staining in red and green
cone photoreceptors (encapsulated by red/green opsin) was diffused throughout the
nucleus (solid white arrows in the inset, Fig 3.10D), while, a speckled expression was
observed in rod photoreceptors (open white arrow in the inset, Fig 3.10D).
3.5.9 Human Sfrs10 promoter is different from that of rodents
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The lack of expression in normal human retina could be due to the difference in
the transcriptional regulation of mouse and human Sfrs10. To investigate the Sfrs10
promoter region, multiple sequence alignment was performed on the 400 bp region
upstream of transcription start site in human, mouse and rat (Fig 3.12A). The homology
between mouse and rat was 80% (Fig 3.12A), but the homology between mouse and
human promoter was 34% (Fig 3.12A’), and between rat and human promoter was 32%
(Fig 3.12A”). Moreover, promoter in all three organisms did not have a conventional TATA
sequence (Fig 3.12A). Since the mouse and rat promoters were highly similar and they
both showed pan-retinal expression, we sought to investigate whether their promoters
contained hallmarks of promoters associated with ubiquitously expressed genes. For
this, the presence of GC-rich regions or CpG islands was investigated, as they are usually
associated with “active” chromatin structures like those of house-keeping genes [179,
180]. Using CpG island detection tools such as CpG Island Searcher and CpGPlot, it
was found that mouse and rat Sfrs10 promoter region had CpG islands (Fig 3.11A, B).
These CpG islands had average GC content of 60-70% and observed/expected CpG ratio
>60%. However, the human Sfrs10 promoter did not have CpG islands (Fig 3.11C).
3.5.10 Sfrs10 forms stress-related speckles
Besides the upregulation of Sfrs10 in AMD retinae, it also showed a speckled pattern of
expression. This pattern has been described for other SR proteins such as SC35 [181,
182].

In addition, Sfrs10 has been shown to colocalize with SC35 in human

neuroblastoma cell lines [183]. Thus, human retinal sections were co-stained with Sfrs10
and SC-35, which showed that SFRS10+ speckles did not overlap with SC35+ speckles
(Fig 3.13A-B’’). This led us to investigate whether SFRS10+ speckles were indeed stress
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granules. HSF1 is known to form stress granules under various kinds of stress [184]. Also,
HSF1 was shown to colocalize with SFRS10 in human colon cancer cell lines [185].
Therefore, AMD retinal sections were co-stained with Sfrs10 and HSF1, which showed
that SFRS10+ speckles did not overlap with HSF1+ stress granules. Nonetheless, the
presence of HSF1+ granules confirmed that this retina is under stress and that SFRS10+
speckles are distinct and stress induced (Fig 3.13C-D’’).
3.5.11 Sfrs10 role in hypoxic stress
To test the role of Sfrs10 under hypoxic stress, whether it plays a pro-apoptotic or
anti-apoptotic role, I employed cell culture system to mimic human AMD conditions. I used
three different cell lines, namely human embryonic kidney (HEK) cells, HeLa cells and
retinal cells derived from retinae by Dr. Kamla Dutt. I had planned to induce hypoxic stress
by administering1) cobalt chloride 2) Arsenite and 3) hypoxic chamber in these cells.
While my preliminary tests to check if Sfrs10 was expressed in these cell lines showed
that it was expressed under normal conditions in these cells, another group published the
finding on the same question, and showed that Sfrs10 acts as an anti-apoptotic gene by
competing with miR-204 and promoting the expression of Bcl2α isoform, which is a
protective isoform of Bcl2 [143].
3.6 Discussion
Sfrs10 as a nuclear marker for red/green cone photoreceptors
ASFs are known to auto-regulate their levels. Indeed, Sfrs10 is one of the
seven RNA-splicing associated genes that contain “exonic” class of “ultraconserved
elements” [186]. This class of RNA-binding proteins is shown to auto-regulate their levels
by the inclusion of a stop codon containing exon, which is highly conserved in the
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vertebrate genome. This auto regulation is thought to be critical for the maintenance of
cellular homeostasis of various classes of RNA-binding proteins. This is concordant with
the expression pattern of Sfrs10 observed across the retinal development. The higher
MW isoform contains exon 2a, which introduces premature stop codon, rendering the
transcript to NMD pathway and regulating the levels of the lower MW canonical isoform.
Sfrs10 expression in postnatal retinal development follows the order of terminal
differentiation of retinal neurons. Ganglion cells are the first cells to differentiate, followed
by amacrine and horizontal cells at P4. The costaining of syntaxin and Sfrs10 in the
ONBL of P4 retina suggests that they are mostly likely differentiating amacrine and
horizontal cells. This observation is in agreement with the previous report where it was
shown that syntaxin marks both differentiating amacrine and horizontal cells in the
postnatal developing retina [187].

At P8, bipolar cells, amacrine cells, and cone

photoreceptors differentiate followed by rod photoreceptors by P21. This suggests that
Sfrs10-mediated AS is involved in genes that regulate the terminal differentiation of the
retinal cells. Further, Sfrs10 expression specifically in red/green cone photoreceptors
suggests that Sfrs10-mediated AS is specifically required by this subset of cone
photoreceptors during development and for their maintenance. This observation would
make Sfrs10 one of the first alternative splicing factors to mark red/green cone
photoreceptors at P8.

Additionally, it would be a valuable nuclear marker of cone

photoreceptors at this stage in retinal development as well as in retinal diseases.
Sfrs10 is not detected in the zebrafish retina
Sfrs10 is a widely studied alternative splicing factor that is 100% conserved at the
AA levels in most mammals. At the nucleotide level, Sfrs10 is one of the seven RNA-
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splicing associated genes that contain “exonic” class of “ultraconserved elements” [186].
This class of RNA-binding proteins is shown to auto-regulate their levels by the inclusion
of a stop codon containing exon which is highly conserved in the vertebrate genome. This
auto regulation is thought to be critical for the maintenance of cellular homeostasis of
various classes of RNA-binding proteins. As Sfrs10 is one of the very few highly
conserved genes, we investigated the expression of Sfrs10 in the retina of widely studied
model organisms including, mouse, rat, chicken and zebrafish. Immunoblot analysis
showed expression in mouse, rat and chicken, which suggests that its transcription is
conserved along with its AA sequence. As predicted, no immunoreactivity was observed
in the lane containing zebrafish retinal extract (Fig 3.6B). The antibody employed here
was directed toward the N-terminus of Sfrs10, which is not conserved in zebrafish (black
box, Fig 3.6A). Thus, the absence of the immunoreactivity could be failure of the antibody
to recognize Sfrs10 and that it might still be expressed in the zebrafish retina.
Sfrs10 is upregulated only in response to stress in human retinae
Interestingly, SFRS10 is 100% conserved at the AA level between mouse and
human, yet it is not expressed normally in the human retina. This was surprising, but in
agreement with its role as a stress response gene that would be normally suppressed.
At the level of transcription regulation, CpG islands are shown to be associated with
promoters of house-keeping genes and active genes by a comprehensive analysis of
CpG islands in the European Molecular biology laboratory (EMBL) database [180, 188].
In all, the constitutive expression of Sfrs10 in mouse and rat retinae (Fig 3.7A, B) along
with the presence of CpG islands (Fig 3.11A, B) suggests that it might regulate the AS of
constitutively expressed genes in these organisms. In contrast, SFRS10 is not expressed
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in the normal human retinae (Fig 3.8A, B, C), and its promoter lacks CpG islands (Fig
3.11C), which suggests that SFRS10 might not be required for general maintenance. In
contrast, it was upregulated in AMD retinae (Fig 3.10A, B, C), which is consistent with its
role as a stress response gene.

Interestingly, sample #7, for which there was no

diagnosis of AMD, showed upregulation of SFRS10 suggesting that it was experiencing
stress (Fig 3.10D). Since SFRS10 upregulation is often linked to hypoxic stress, one can
extrapolate that retinal sample #7 was most likely undergoing hypoxic stress. In addition,
the redistribution of red/green opsin staining throughout the membrane of photoreceptor
(Fig 3.10D) indicates retinal degeneration [178].
In all, the upregulation of SFRS10 in AMD retinae suggests that it might be required
for AS of a subset of genes involved in hypoxic stress response. For instance, a gene
might normally be expressed but under stress conditions, it might undergo AS shift and
the isoform responding to stress is regulated by SFRS10. Some of the known targets of
Sfrs10 like Creb1, Pank2 are known to play a key role in metabolism [122, 189]. It could
be that there is an increased demand for the isoform regulated by Sfrs10 under hypoxic
stress. It is to be noted that both the aforementioned targets have isoforms in the retina.
Future investigation involves testing of the splice pattern shifts in these targets under
hypoxic stress.
Sfrs10 does not co-localize with SC35 domain and is not part of stress-granules in
human AMD retinae
Most SR proteins have been shown to be a part of the SC35 “nuclear speckle”
under normal conditions. Presence of Sfrs10+ speckles independent of SC35 domain in
AMD retinae (Fig 3.13A-B”) suggests that Sfrs10 and SC35 might not interact in the retina
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under hypoxic stress. It could be that SC35 regulates the splicing of genes that are
normally required by the cell whereas Sfrs10 independently regulates a specific subset
of genes that are required only under stress conditions. This partitioning of the SR
proteins might provide efficient response to stresses such as hypoxia.
Non-overlapping Sfrs10 speckles with HSF1 stress granules in AMD retina (Fig
3.13C-D”) suggest that Sfrs10 does not interact with HSF1. It could also be that HSF1
regulates the transcription of genes that are required early in the stress response while
Sfrs10 regulates the AS of the subset of genes that might be required later in the stress
response. Overall, our data suggest that Sfrs10 might not be required for normal
maintenance or functioning of neurons in human retina but is predominantly active under
hypoxic stress, which is thought to be the underlying cause of AMD.
3.7 Materials and Methods
Animal Procedures
All procedures with mice were performed in accordance with the animal protocol
approved by Institutional Animal Care and Use Committee at the University of
Connecticut. The CD1 or the ICR mice from Charles River Laboratory, MA, were
employed for all experiments. Chicken eyes were also obtained from Charles River
Laboratory, Storrs, CT. The rat strain used was Wistar and was purchased from Charles
River Laboratory. Zebrafish were obtained from Dr. Sylvain De Guise’s laboratory at the
University of Connecticut, Storrs, CT.
Human samples
Slides with human retinal sections were obtained from Abcam, MA
(http://www.abcam.com/) and from the National Disease Research Interchange (NDRI)
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(http://ndriresource.org/). In both cases, the authors were not involved in the
procurement of the samples. Preprocessed de-identified retinal sections with the
associated diagnosis were obtained for IHC analysis. Therefore, in this case the
authors were issued a waiver from the University of Connecticut Institutional Review
Board for human subject research. Briefly, the case history for all the samples was
provided by NDRI. Also, to classify the AMD samples from the normal, pathological
diagnosis was performed by Dr. Federico Gonzalez-Fernandez, MD, PhD, who
collaborates with NDRI for the ophthalmologic pathology project. The parameters used
in the diagnosis of AMD include accumulation of soft drusen beneath the retinal
pigmented epithelium, disciform scar formation indicated by the fragmentation of
Bruch’s membrane and geographic atrophy.
In regards to the one sample (sample #7) obtained from the University of Connecticut
Health Center (UCHC), consent from the next of kin, where applicable was obtained
prior to post-mortem retinal tissue procurement. This protocol was approved by the
University of Connecticut institutional review board for human subject research. The
sample was de-identified before it was further processed in Dr. Kanadia’s laboratory for
IHC analysis and was conducted in compliance with the Health Insurance Portability
and Accountability Act.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
Retinae from different developmental time points in CD1 mice (E12, E14, E16, E18, P0,
P4, P10, and P14) were harvested and total RNA prepared in Trizol following the
manufacturer’s protocol (Invitrogen). For cDNA synthesis, 1μg of total RNA from retinae
harvested at various time points was used [190].
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Table 3.2: List of Primers used in Sfrs10 RT-PCR analysis
Primer
name

Primer Sequence (5' - 3')

F1

AGCTTGACAGCTTCAGGAAAGGCC

R1

ATCCCAGCTCTATGGCAGGTTTCAG

Gapdh Fwd ACAGTCAAGGCCGAGAATGGGAA
Gapdh Rev

TCAGATGCCTGCTTCACCACCTTCT

PCR to detect Sfrs10 isoforms was performed for 30 cycles (95°C for 30 seconds; 58°C
for 30 seconds; 72°C for 1.5 minutes) with primers listed in Table 3.2. Gapdh was used
as the control. PCR used to detect Gapdh was performed with the same temperature
profile as described above. All PCR products were resolved on a 2.5% agarose gel.
RLM-RACE
Retinae from different developmental time points in CD1 mice (E15.5, E17.5, P0, P5, and
P14) were harvested and total RNA was prepared as described above. 5′ RNA ligasemediated rapid amplification of cDNA ends (5′ RLM-RACE) (First Choice RLM-RACE kit
from Invitrogen) was employed to determine the transcription initiation site(s) of
Sfrs10 mRNA. This method amplifies cDNA only from full-length, capped mRNA,
therefore allowing identification of the actual 5′ ends of mRNAs. Total RNA from different
time points were first treated with Calf Intestine Alkaline Phosphatase (CIP) to remove
the 5′ phosphate from degraded mRNA, rRNA, and tRNA. Samples were then treated
with Tobacco Acid Pyrophosphatase (TAP) to remove the cap structure of intact mRNAs,
leaving a 5′ phosphate group on this mRNA subset only, followed by ligation of an RNA
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adapter to the decapped mRNAs. Reverse transcription and subsequent PCR
amplification using adapter-specific outer and inner primers (provided in the kit) and genespecific reverse primer were performed to allow the 5′ ends of mRNA transcripts to be
mapped.

The

gene

specific

reverse

primer

of

Sfrs10

is

5′-

CCAAACACGCCAAGACAACAGTTG-3′. Instead of cloning, the PCR products were
purified and then subjected to restriction digestion with EcoNI to check if the same product
is obtained throughout development. Uncut and cut products were resolved on 2%
agarose gels.
3’RACE
Retinae from different developmental time points in CD1 mice (E15.5, E17.5, P0, P5, and
P14) were harvested and total RNA was prepared as described above. Reverse
transcription was performed using Moloney Murine Leukemia Virus Reverse
Transcriptase (M-MLV RT) with the addition of 3’RACE adapter to the RNA mix. cDNAs
obtained were used for PCR amplification with gene-specific forward primer and adapterspecific outer and inner primers. The sequence of gene-specific primer is 5’CTTTCTAAATATCAATGCTTAACCAGAACCATTC-3’. Next, the PCR products were
purified and then subjected to restriction digestion with BsrI to check if the same product
is obtained throughout development. Uncut and cut products were resolved on 2%
agarose gels.
Immunohistochemistry (IHC)
All of the experiments were performed on 10-16 μm cryosections obtained from different
time points in CD1 mice except for the 6 month retina which was obtained from C57/BL6
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mice. The cryosections were first hydrated in phosphate-buffered saline (PBS, pH 7.4)
and washed three times (5 minutes each at room temperature (RT)), followed by
incubation with PBTS buffer (1X PBS with 0.1% triton-X 100, 0.2% BSA and 0.02% SDS)
for an hour at RT. Primary antibody (AB#1-rabbit anti-Sfrs10, 1:750, Fitzgerald inc.,
Product #70R-1420; AB#2-rabbit anti-Sfrs10, 1:500, Sigma-Aldrich, Product # AV40528;
AB#3 – rabbit anti-Sfrs10, 1:500, Cemines, Product # AB/SF100; mouse anti-syntaxin -1
(HPC-1), 1:300, Santacruz biotechnologies Inc., Product # sc12736; mouse anti-islet1,
1:300, Developmental Studies Hybridoma Bank, Product# 40.2D6; mouse anti-Pkc-α,
1:300, Calbiochem, Product # OP74; mouse anti-glutamine synthase, 1:300, Chemicon
International, Product # MAB302; mouse anti-SC35, 1:300, Abcam, Product # ab11826;
rat anti-HSF1, 1:100, Abcam, Product # ab61382) was incubated in PBTS buffer
overnight at 4ºC. Sections were washed with PBTS buffer containing 4’, 6-diamidino2phenylindole (DAPI) (Roche diagnostics) 10 times (15 minutes each at RT). Following
the washes, secondary antibody (anti-rabbit antibody conjugated with Alexa488, 1:750,
Product # 21206, anti-mouse conjugated with Alexa 568, 1:750, Product # A10037,
Invitrogen) was incubated in PBTS buffer overnight at 4ºC. Sections were washed with
PBTS buffer 7 times (15 minutes each at RT), rinsed with PBS and covered with Prolong
gold anti-fade reagent (Invitrogen) and coverslip glass.
Serial IHC
Here the aforementioned IHC protocol was employed with one modification. Upon
completion of the nuclear antigen detection by the first antibody, (primary – rabbit antiSfrs10, 1:750 and secondary – Alexa488, 1:750), a 10’/RT incubation with 4%
paraformaldehyde was conducted. Subsequently, the cytoplasmic antigen detection by
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the second antibody (primary – rabbit anti - red/green opsin, 1:300, Millipore, Product #
AB5405 and secondary – Alexa568, Invitrogen, 1:750, Product # 11011) was performed.
Immunoblot
Retinal tissue extracts from mouse, rat, chicken and zebrafish were prepared in RIPA
(50mM Tris (pH 8.0), 150mM Sodium chloride, 1% Igepal, 0.5% SDS) buffer containing
1X protease inhibitor cocktail (cOmplete mini, EDTA-free, Roche Diagnostics). Following
the protein estimation of the extracts, 50μg of protein was resolved on 4-20% Tris-glycine
gradient gel (Invitrogen). The gel was transferred to a positively charged nylon membrane
(Invitrogen), which was then subjected to immunoblot analysis as described previously
[191]. Rabbit anti-Sfrs10 (1:1000; Fitzgerald Inc., Product # 70R-1420) was used to detect
Sfrs10 in the extract. Mouse anti-Gapdh (1:500; Sigma Aldrich, Product # G8795) was
used as the loading control.
Bioinformatics tools and databases
Alignment

analysis

was

carried

out

using

ClustalW

tool

(http://www.ebi.ac.uk/Tools/msa/clustalw2/). Promoter regions were characterized using
tools such as CpGPlot (http://emboss.bioinformatics.nl/cgi-bin/emboss/cpgplot) and CpG
Island searcher (http://cpgislands.usc.edu/).
Image Acquisition and 3D reconstruction
Confocal fluorescence microscopy was performed using Leica SP2. Images were
subsequently processed using IMARIS (Bitplane Inc., CA) and Adobe Photoshop CS4
(Adobe Systems Inc., CA).
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Figures:
Figure 3.1

Fig 3.1. Expression analysis of Sfrs10 during mouse retinal development. A:
Schematic representation of Sfrs10 gene showing exons (orange arrows, E1-E9), intron
(black line) and the primers (green arrows, F1 &R1) used for RT-PCR analysis. B: Gel
image showing two RT-PCR products of Sfrs10, top band (+ exon 2a), bottom band (55

exon 2a). B’: Gel image showing Gapdh expression. C: 5’RACE analysis across retinal
development. Shown here is the position of the primers and the restriction site for EcoNI.
D: 3’RACE analysis across retinal development. Shown here is the position of the primers
and the restriction site for BsrI. E: Schematic representation of the gene after the RACE
analysis [144].
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Figure 3.2

Fig 3.2. SFRS10 expression across postnatal retinal development. A, B, D, E, F:
Immunohistochemistry across postnatal retinal development with rabbit anti-Sfrs10
(green). Nuclei are marked with DAPI (blue). Scale bar: 30μm. GCL, Ganglion cell layer;
INL, Inner Nuclear layer; ONL, Outer nuclear layer; ONBL, Outer neuroblastic layer. C:
Immunohistochemistry for Sfrs10 (green) co-stained for Syntaxin (red) which marks
differentiating amacrine cells. Nuclei are marked with DAPI (blue) [144].
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Figure 3.3
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Fig 3.3. Specific enrichment of SFRS10 in red/green cone photoreceptors. A:
Schematic of Sfrs10 protein with RRM (RNA recognition motif) flanked by two RS (SerineArginine dipeptide rich) domains. Above and below the schematic are boxes representing
the epitope positions for antibody (AB) #1 (blue box, amino acids 1-51), AB#2 (purple
box, amino acids 2-51) and AB#3 (yellow box, amino acids 84-97). B- D”: Serial IHC with
rabbit anti-Sfrs10 AB#1 (green) and rabbit anti-red/green opsin (red) and the merged
image at P8 (B-B”), P10 (C-C”) and P14 (D-D”). E- E”: Serial IHC with rabbit anti-Sfrs10,
AB#2 (green) and rabbit anti-red/green opsin (red) and the merged image (E”). F - F”:
Serial Immunohistochemistry with rabbit anti-Sfrs10, AB#3 (green) and rabbit antired/green opsin (red) and the merged image (F”). Scale bars 30 μm. G, H: Immunoblot
analysis for Sfrs10 (AB#1 (G), AB#2 (H)) on retinal protein extracts from P0 mouse [144].
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Figure 3.4

Fig 3.4. Differential expression of SFRS10 in rod photoreceptors versus cone
photoreceptors. A: IHC on P22 retinal section for SFRS10 (green), laminB2 (red).
Nuclei are marked with DAPI (blue). Shown here is the outer nuclear layer. Scale bar
5μm A’: Magnified image of the boxed region in (B) showing perinuclear localization of
SFRS10 in laminB2 positive cells. Scale bar 3 μm. A”: Schematic representation of
SFRS10 localization observed in A [144].
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Figure 3.5

Fig 3.5. Sfrs10 is 100% conserved in mammals. A: Schematic of Sfrs10 protein with
RRM (RNA recognition motif) flanked by two RS (Serine-Arginine dipeptide rich) domains.
B - B’’: Amino acid alignment of RS1 domain (B), RRM domain (B’), RS2 domain (B”) of
Sfrs10 protein from different species [145].
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Figure 3.6

Fig 3.6. Expression of Sfrs10 is conserved in mouse, rat and chicken retina. A:
Alignment of Sfrs10 amino acid (1-100) sequences from mouse, rat, chicken and
zebrafish. The black box marks the region used as antigen to raise Sfrs10 antibodies. B:
Immunoblot analysis for Sfrs10 (green) on retinal protein extracts from mouse, rat,
chicken and zebrafish. The last lane has extract from HEK-293t cells that were expressing
exogenous Sfrs10. Gapdh (red) serves as the loading control [145].
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Figure 3.7

Fig 3.7. Sfrs10 expression is pan-retinal in mouse, rat and chicken. A-C”: IHC with
rabbit anti-Sfrs10 (green) on retinal sections of adult mouse (A), adult rat (B) and adult
chicken (C). DAPI (blue) marks all nuclei (A’, B’, C’). Scale Bar represents 50µm [145].
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Figure 3.8

Fig 3.8. SFRS10 is not expressed in normal human retinae. A-C: IHC with rabbit antiSfrs10 (green) on sections obtained from individuals with normal retinae. DAPI (blue)
marks all nuclei. Scale Bar represents 50µm [145].
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Figure 3.9

Fig 3.9. Red/green opsin is dispersed throughout the photoreceptor membrane in
AMD. A-D: IHC with rabbit anti-red/green opsin (red) on sections obtained from
individuals with normal (A) and AMD (B-D) retinae. DAPI (blue) marks all nuclei [145].
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Figure 3.10

Fig 3.10. SFRS10 is upregulated in degenerating retina. A–C: IHC with rabbit antiSfrs10 (green) on sections obtained from individuals with AMD retinae. DAPI (blue) marks
all nuclei. D: Serial IHC with rabbit anti-Sfrs10 (green) and rabbit anti-red/green opsin
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(red) on parafoveal section obtained from sample #7. DAPI (blue) marks all nuclei. Inset
shows the expression of SFRS10 in the red and green cone photoreceptors indicated by
solid white arrow and rod photoreceptors indicated by open white arrow. Scale Bar
represents 50µm [145].
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Figure 3.11
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Fig 3.11. CpGPLOT analysis of Sfrs10 promoter region in mouse, rat and human
Sfrs10. A-C: CPGPLOT generated by CpGPlot tool used for CpG island prediction. A,
B – Mouse and rat Sfrs10 promoter region showed CpG islands; C – No CpG islands
were seen in human Sfrs10 promoter region [145].
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Figure 3.12

Fig 3.12. Comparative analysis of mSfrs10 and hSfrs10 promoter region. A-A”:
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Comparison of Sfrs10 promoter in mouse vs. rat (A), mouse vs. human (A’), and rat vs.
human (A’’) [145].
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Figure 3.13

Fig 3.13. SFRS10 forms independent stress-related speckles. A - A”: IHC on
human retinal section with anti-Sfrs10 (green), anti-SC35 (red). Nuclei are marked with
DAPI (blue). B - B”: Magnified image of the boxed region in A - A” showing nonoverlapping Sfrs10+ speckles and SC35+ speckles. C - C”: IHC with anti-Sfrs10
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(green), anti-HSF1 (red). Nuclei are marked with DAPI (blue). D - D”: Magnified image
of the boxed region of C - C” showing non-overlapping Sfrs10+ speckles and HSF+
stress granules [145].
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Chapter 4: Role of the cell cycle regulator, Citron Kinase in rat retinal
development
This chapter addresses the role of AS in development through a cell cycle regulating
gene, Citron kinase in retinal progenitor cells in the developing rat retinae. Since this gene
knockout has a severe phenotype, we were able to characterize the phenotype and
dissect the cell types affected due to the absence of this gene. We also characterized a
novel isoforms of this gene, which could be implicated in various roles played by this
gene.
4.1 Cell cycle and its regulation:
The cell cycle is a key process by which the single-celled zygote matures
into a multicellular organism. It includes a series of events which leads to the division of
a cell into daughter cells. It includes three main phases namely Interphase – preparatory
phase where cell grows and accumulates nutrients needed for cell division, mitotic phase
– cell contents are split between two daughter cells and cytokinesis – final stage of
division which leads to two separate daughter cells. There are checkpoints at each phase
to ensure proper cell division.
Interphase is further divided into first growth phase (G1), synthesis phase (S) and
second growth phase (G2). The first phase of interphase is the First Growth phase, G1,
during which time the cell grows in size and replicates all of its organelles in preparation
for division. In addition, mRNA and protein are synthesized, which will be used during the
S phase [192]. The importance of the G1 phase is that this is when the cell decides
whether it will commit to division or whether it will leave cell cycle [193]. This second
phase is called the S or synthesis phase. As the two daughter DNA strands are produced
74

during replication, they recruit histones and to form sister chromatids. Eventually, these
identical strands of DNA become attached at a central point by a protein named cohesin
[192]. Cohesin is a member of the structural maintenance of chromosomes (SMC) family
of proteins, which affect chromosome architectures. At the end of S phase, DNA check
for successful replication is done using a set of checkpoint controls. If cells have
successfully replicated their chromosomes, they pass to the third stage of interphase, G2.
During G2, a second stage of growth occurs in the cell. This stage has an important
checkpoint known as the G2/M checkpoint that must be passed for the cell to be able to
enter mitosis [192, 194].
Mitosis begins with prophase, during which chromosome condensation occurs
through condensin recruitment. In addition, cohesin, which until this point encircles the
entire chromosome is removed from the ends of the chromosome and concentrates at
the center. This allows for the individual “arms” of the chromosomes to become visible.
This is also the stage during which the mitotic spindle forms and when in eukaryotes, the
centrioles migrate to opposite poles of the cells and begin to radiate their microtubules.
Prometaphase begins with the dissolution of the nuclear envelope into membrane
vesicles that will evenly distribute to the daughter cells and is vital for spindle attachment.
Additionally, kinetochores form around the centromere. It is a dynamic phase with
constant polymerization and de-polymerization of microtubules that are attached to the
kinetochores resulting in chromosomes moving in each direction by microtubules from
both poles of cell [194]. At the end of prometaphase, each chromosome has microtubules
attached from each pole of the spindle to the kinetochores of the centromere, which is
described as “chromosome biorientation”. Metaphase is an immobile phase where
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chromosomes line up at the equator of the cell known as the metaphase plate. Anaphase
is marked by the separation of sister chromatids due to activation of the anaphase
promoting complex (APC/C) [194]. Once all the kinetochores are attached, APC/C
becomes active and complexes with Cdc20, which then targets securin for degradation,
freeing a cysteine protease separase [194]. Separase hydrolyzes the cohesin holding the
two sister chromatids together, thereby facilitating chromatid separation. Telophase is the
last stage of mitosis during which the nuclear envelope reforms, and the chromosomes
de-condense [194].
Cytokinesis can begin as early as anaphase, which brings the cell cycle to a
completion. This is the time when the cytoplasm of the two daughter cells divides equally
[194]. It begins with the formation of a cleavage furrow assembly once the site of
separation is chosen. The furrow contains actin, myosin, and other cytoskeletal proteins
that are organized into a contractile ring known as the actomyosin ring [195]. Thereafter,
the ring contracts, generating a membrane barrier between the contents of each daughter
cells in addition to constricting the components of the spindle midzone into a structure
called the midbody [195]. This is followed by the process, called abscission, where the
furrow seals itself, finally generating two completely separate cells [195]. The end-product
of mitosis is two identical daughter cells, each with a complete set of 46 chromosomes
[194].
Regulation of cell cycle is crucial to cell survival as dis-regulation could lead to
aberrant cell division and to the eventual formation of tumors [194, 196]. On the other
hand, mutations in genes required for completion of stages of cell cycle could result in
aberrant cells which would then undergo apoptosis. Therefore, a balance between cell
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division and cell death has to be maintained during development for the proper growth of
an organism.
4.2 Citron Kinase
Rho GTPases are a family of GTPases found in all eukaryotic cells. When in their
active GTP-bound state, these GTPases perform regulatory functions through specific
interactions with target/effector proteins that include serine/threonine kinases, tyrosine
kinases, lipid kinases, lipases, scaffold proteins, and oxidases. Through their interactions
with effectors, these GTPases control some of the most fundamental eukaryotic
processes: cell movement, polarity, morphogenesis, and cell division. In cell division, Rho
GTPases influence the activity of CDK molecules during G 1, microfilament and
microtubule organization during M phase and play a vital role in the contractile ring
formation at the cleavage furrow during the cytokinesis [197].
4.2.1 Discovery of Citron Kinase
Citron Kinase was discovered in 1998 by Di Cunto et al during the screening of
new kinases that were specifically expressed in mouse primary keratinocytes [198]. It was
originally called KK-1 and 5’ rapid amplification of cDNA ends (RACE) -PCR of KK-1
transcripts did not show any significant extension of the coding sequence. However,
sequencing results from the 3’ RACE-PCR showed that the part of the coding sequence
was identical to that of Citron [198]. There were two major isoforms of Citron Kinase
identified where the first isoform was called ‘Citron Kinase (CitK)’, which is a full-length
protein sequence that coded for the following domains: kinase domain, coiled-coil domain
with a leucine zipper, Rho/Rac binding domain, zinc finger region, pleckstrin homology
domain (PH), and a proline-rich, SH3 binding domain [198]. The second shorter isoform
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of Citron Kinase had all domain coding regions except for the kinase domain and was
called Citron N (Neuron/Non-Kinase) (CitN). Maudaule et al. showed that the latter
isoform is expressed specifically in the nervous system [199]. It was shown that CitN is
associated with the Golgi apparatus of hippocampal neurons in culture. While the
overexpression of CitN has been shown to accumulate filamentous actin and protect the
Golgi apparatus from rupture, its knockdown has been shown to result in a dis-organized
golgi apparatus [200]. On the other hand, CitK has been shown to play a crucial role
during cytokinesis, specifically during the contractile process at the cleavage furrow that
eventually led to the separation of the two daughter cells [197, 199]. Later, it was shown
that CitK exhibits its role in cytokinesis through the di-phosphorylation of the regulatory
light chain of Myosin II, which is important for creating contractile forces at the cleavage
furrow and for assembly of stress fiber [199].
4.2.2 Expression of CitK in the developing brain
To understand the expression patterns of CitK and CitN in the developing mouse,
RNA in situ hybridization experiments were performed on both embryos and postnatal
brains using two probes, one that was specific for the kinase domain that would only
hybridize with the CitK transcript, and the other that was specific to the coiled-coil region,
which was present on both CitK and CitN mRNA transcripts [201]. Analysis revealed that
signal for both probes was highly robust as early as embryonic day (E) 10.5 to E16.5, with
the highest expression in the developing CNS including retina with further localization to
the proliferating areas of the neural tube [201].
Protein analysis of CitK and CitN during various developmental time-points using
specific antibodies revealed that only CitK was present during embryonic time-points prior
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to E16.5. While, CitN expression dominated after E16.5 into the postnatal developmental
time-points. Thus, it was shown that in the developing CNS, CitK was specifically
expressed by proliferating cells namely progenitor cells, whereas CitN was expressed by
post-mitotic, differentiated neurons [201]. The presence of a second transcription start
site for CitN was shown when CitN protein levels were not decreased in a null mutant for
CitK.
4.2.3 Flathead mutant
A spontaneous autosomal recessive mutation was identified in 1998 by Cogswell et al.,
in an inbred colony of Wistar rats and was termed ‘flathead’ (fh/fh) since the mutants
showed diminished brain growth beginning early in the embryonic development [202].
Perinatally, these mutants could be identified due to their flattened skulls. Flathead
mutation is a frame-shift mutation caused by the deletion of G-C base pair in exon 1 of
the kinase domain in the CitK gene on chromosome 12 [203]. This results in a premature
stop codon, and the transcript is subjected to non-sense mediated decay pathway, and
therefore no protein product would be produced. Physiologically, the fh/fh rats displayed
tremors, ataxia, seizures, and abnormal growth in the retina, cerebellum and
hippocampus during postnatal development [202]. Nissl staining of coronal section of P21
wildtype and fh/fh rats revealed that the fh/fh brain was approximately one-half the size
of the wildtype [Figure 4B]. In addition, immunofluorescence analysis revealed
binucleated neurons present in the thalamus, midbrain, hindbrain, spinal cord and
cerebellum [203]. Pulse-chase experiments with BrdU injections at E15 and harvest at
P12 showed individual cells containing two BrdU+ nuclei within the same cell suggesting
that the progenitor cells did not undergo cytokinesis in the fh/fh mutant [203]. Thus, the
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defect in cytokinesis in these mutants resulted in increased cell death within the
proliferative zones of the brain, thereby wiping out the progenitor pool which would then
result in fewer neurons being born and thus a decreased brain size in the rat [203].
4.3 Rationale
Cell cycle is one of the key processes in a developing tissue. The regulation of
cell cycle is very crucial for the normal development of an organism. Mutation or missplicing of any of the genes involved in the cell cycle can greatly affect the development
sometimes leading to the death of that organism. To understand the role of alternative
splicing in cell cycle regulation and how it informs normal retinal development, we
employed Citron Kinase gene. It has been shown to play a key role in cytokinesis and is
known to contain many isoforms. CitK mutant rat model called ‘flathead’ was used to
study the role of CitK in progenitor cells of the developing rat retina.
Following sections contain the contents of the publication, Karunakaran et al., [204] titled
“Loss of Citron kinase affects a subset of progenitor cells that alters late but not
early neurogenesis in the developing rat retina”
4.4 Background
During retinal development, the balance between self-renewal of RPCs vs
neurogenesis allows for simultaneous RPC amplification and neurogenesis [205, 206].
This produces a functional adult retina with six neuronal subtypes including rod
photoreceptors, cone photoreceptors, bipolar cells, horizontal cells, amacrine cells and
retinal ganglion cells and one glial cell type, Muller glia [3, 5]. Early RPCs are multipotent
cells that are known to shift in their competence to produce different neurons over time
[14, 207, 208]. Recently, it was shown that there are RPCs that have temporal bias in
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producing a subset of neurons [209]. Together, this suggests a dynamic regulation of
RPC cell division that interprets intrinsic and extrinsic cues to regulate neurogenesis. Cell
division in the retina occurs such that the S-phase of the cell cycle occurs at the basal
end of the outer neuroblastic layer (ONBL) followed by the inter-kinetic movement of the
nucleus towards the apical end where the M-phase of the cell cycle occurs [210, 211].
Furthermore, the plane of cell division at the apical end has been reported to regulate
whether an RPC undergoes symmetric vs. asymmetric cell division [212]. This process is
what regulates RPC amplification vs. neurogenesis. It is here that the regulators of
cytokinesis can influence symmetric vs. asymmetric cell division and in turn regulate
retinal development. One such gene that regulates cytokinesis is citron kinase. Here, I
have analyzed the role of Citron Kinase and how its spliced isoforms inform cell cycle
division of retinal progenitor cells and in turn retinal development.
4.5 Results
4.5.1 Citron kinase is enriched during embryonic retinal development
CitK has 47 exons with exons 1 through 12 encoding the kinase domain. Upstream of
exon 12, there is an alternative transcription start site that is utilized to produce a
truncated protein called Citron N, lacking the kinase domain [201]. PCR amplification of
the region coding for the kinase domain with primers F1-R3 and F3-R8 (shown as green
arrows in Fig 4.1A) showed a trend with robust expression starting at embryonic day (E)12
followed by a steady decline leading to absence by postnatal (P)8 (Fig.1B.i, ii). However,
primer pairs (F12-R17) showed that the alternative transcription start site upstream of
exon 12 was being utilized at P10 and P14 (Fig 4.1B.iv). This was further confirmed by
F16-R30 and F29-R41 primer pairs that showed a robust PCR product at P14 and lower
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levels at P8 and P10 (Fig 4.1B.v, vi). Interestingly, this was not the case for F35-R46
primer pairs where the levels were not similar (Fig 4.1B.vii). The identity of the upper band
observed in E12 with F35-R46 primers was not interrogated (Fig 4.1B.vii). Moreover, PCR
with the primer pair F8-R12 (positions shown in Fig 4.1A) showed two bands at 594bp
and 410bp (Fig 4.1B.iii). Sequence analysis of both these isoforms revealed that the
isoform at 594 bp was the canonical isoform including all exons in between. The lower
MW isoform at 410 bp lacked exon 9 (schematic representation below Fig 4.1B.iii). For
the primers (F12-R17) amplifying the region between exon 12 and exon 17, there were
two bands at 843bp and 552 bp (Fig 4.1B.iv). Again, sequence analysis of both these
isoforms revealed that the isoform at 552 bp was the canonical isoform including all
exons, while the higher MW isoform at 843 bp was produced by (schematic
representation below Fig 4.1B.iv) the usage of the cryptic splice donor at 42306705 NT
position (NCBI ref - AC_000080.1) (AGT/GTAG) in intron 13. Since our analysis
interrogated short stretches of CitK mRNA, we could not determine the specific
combinations in which the two alternative splicing events were utilized. For this, we
designed a new set of primers (Fig 4.1C, Schematic representation) in cryptic donor
region in exon 13 and junction of exon 8 and 9. RT-PCR analysis with F8-RC13 showed
that there were two bands obtained at E12 and E14. The higher MW band at 895 bp
corresponds to isoform containing a part of retained intron 13 along with exon 9 included
while the lower MW isoform at 711 bp excludes exon 9 (Fig 4.1C, left). From E16 onwards,
only the higher MW isoform was observed. Analysis was not carried out beyond P0, as
CitK expression shuts down postnatally. To find whether exon 9 is expressed with the
isoform containing canonical exon 13, RT-PCR analysis with F8/9 - R14 was performed.

82

Analysis showed that there were two bands obtained across development with a robust
expression observed at E12. The higher MW band at 869 bp corresponds to isoform
containing exon 9 with a part of intron 13 retained and the lower MW at 782 bp
corresponds to the isoform with exon 9 and canonical exon 13 (Fig 4.1C, right).
Next, we interrogated the expression of CitK protein by section IHC in E12 and E16
retinae. This analysis showed CitK to be localized in discrete puncta at the apical tip,
where RPCs undergo M-phase of the cell cycle (Fig 4.1D, 4.1E, Insets). This observation
is in agreement with the report by Di Cunto et al., who reported expression of CitK in the
developing retina by whole mount in situ hybridization at E11.5 when there are only RPCs,
which suggests expression of CitK in RPCs [201]. Moreover, in the developing brain, CitK
expression was found at the cytokinesis furrow in progenitor cells [203]. Thus, expression
of CitK was considered to be in RPCs. Absence of signal in the KO-retina confirmed
specificity of the CitK antibody (Fig 4.1D’, E’). Finally, to confirm whether the punctuate
staining of CitK corresponds to RPCs, E12 sections were costained with anti-PH3
antibody (Fig 4.1F’), which marks M-phase progenitor cells, which showed overlap in
signal for PH3 and CitK (Fig. 4.1F-F”, Inset).
4.5.2 Number of progenitor cells in the KO retina is comparable to that in the WT
retina at E12 and E13
Given the robust expression of CitK in early RPCs, we wanted to interrogate its
role in retinal development. For this, we pulsed pregnant female rats at E12 with EdU one
hour prior to harvest. E12 WT and KO retinal sections were then subjected to IHC with
anti-Ki67, PH3 along with EdU detection (Fig 4.2A - F). Here, we quantified EdU+ (in Sphase) RPCs as a percentage of total Ki67+ RPCs, which showed no difference in S83

phase RPCs in CitK KO compared to WT (Fig 4.2G). Similarly, PH3+ (M-phase) RPCs
as a percentage of total Ki67+ RPCs did not show any difference between KO and WT
(Fig 4.2H).
Next, we wanted to interrogate the effect of loss of CitK on RPCs over time. So,
we performed EdU pulse-chase experiment. For this, we pulsed pregnant females at E12
followed by harvest at E13. Again, WT and KO retinal sections were subjected to Ki67,
PH3 along with EdU detection (Fig 4.3A - F). EdU+ RPCs (S-phase) as a percentage of
total Ki67+ RPCs did not change in KO compared to WT (Fig 4.3I). This was also true for
PH3+ (M-phase) RPCs (Fig 4.3J). Since RPCs did not show an observable phenotype in
CitK KO retina, we wanted to interrogate if neurogenesis was affected. Since retinal
ganglion cells (RGCs) were the only cell type produced at this point, we employed Islet1
antibody to mark the RGCs. Specifically, we looked for Islet1+ cells that were also EdU
+, so as to interrogate RGCs produced after the EdU pulse (Fig 4.3G- H”). Again, we did
not see significant difference in RGC production in KO compared to WT (Fig 4.3K).
4.5.3 Cell death of a subset of progenitor cell population is observed in the KO
retina by E14
Next, we pulsed E12 pregnant females with EdU followed by embryo harvest at
E14. Retinal sections from KO and WT embryos were subjected to IHC with Ki67, PH3
along with EdU detection (Fig 4.4A -F). Quantification of EdU+ (S-phase) RPCs as a
percentage of total Ki67+ RPCs showed statistically significant decrease in RPCs in the
CitK KO compared to WT (Fig 4.4I). This suggested that there was a loss of RPCs in the
CitK KO retina, which suggests that either the RPCs died or there was an increase in
RGC production at the expense of these RPCs. To distinguish between these two
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possibilities, we performed IHC with Islet1 along with EdU detection (Fig 4.4G – H”).
Quantification was restricted to the ganglion cell layer (GCL) to take in to account only
the differentiated ganglion cells and not include newly born Islet1+ RGCs or amacrine
cells (ACs) in the outer neuroblastic layer (ONBL). Quantification of Islet1+ cells that were
also EdU+ as a percentage of total Islet1+ cells in the GCL did not show a statistically
significant difference in KO compared to WT (Fig 4.4J). This led us to interrogate the
possibility that RPCs were undergoing cell death in CitK KO retinae. Indeed, TUNEL
analysis showed increased cell death in CitK KO compared to WT (Fig 4.5A, A’, B).
Similar analysis was extended to E16 retinae that were harvested from embryos where
the mother had been pulsed with EdU at E12. Here, a significant decrease in the size of
the ONBL and a concomitant increase in TUNEL+ cells in KO retina was observed (Fig.
4.5C, C’ D). To confirm that the TUNEL+ cells were RPCs, sections that were subjected
to TUNEL assay were stained for Ki67. Here, we observed many TUNEL+ cells were
Ki67+ as well (Fig. 4.5E – F”’). The overlap was confirmed using section tool in IMARIS
7.3 software, where the cross hairs mark the cell under interrogation with the panel on
the right showing the longitudinal axis whereas one at the bottom showing the horizontal
axis. In both cases, overlap was observed for TUNEL and Ki67 positivity (Fig. 4.5E’, F’ –
F”’). However, there were some cells that were TUNEL+ but Ki67- in the ONBL. These
cells had increased intensity of TUNEL signal which correlates with the extent of cell death
and lack of Ki67 positivity might be due to protein degradation.
4.5.4 Absence of Islet1+ bipolar cell production in the KO retina
The increase in cell death of RPCs after E14 led us to extend our analysis to the
postnatal development. At P0, the KO retinal tissue was visibly smaller than the WT retina.
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IHC analysis with different markers such as anti-PH3, anti-islet1, anti-Ki67 and anti-Pax6
antibodies showed that GCL remained uncompromised (Fig 4.6A - D’). However, the
ONBL was half the size of the WT counterpart and showed signs of rosette formation.
However, PH3 and Ki67+ RPCs, were observed in the P0 CitK KO retina (Fig.4.6A’, C’).
Similarly Islet1+ and Pax6+ RGCs and ACs were observed in the KO retina (Fig. 4.6B’,
D’). Interestingly, at P2, Islet1+ RGCs and ACs were observed in the WT and KO retinae
(Fig. 4.6F, F’). However, Islet1+ bipolar cells (BPCs) [213] were not observed in the KO
retinae (Fig. 4.6F’). Overall, the KO retinae showed rosette formation but some Ki67+
RPCs were still observed (Fig. 4.6G’). At P4, the KO retina was structurally compromised
with large rosettes in the ONBL. Again, Islet1 marked a subset of BPCs in the WT retina
but these cells were not observed in the KO retina (Fig.4.7A, B). To distinguish between
BPCs and ACs in the ONBL, Pax6 was used to mark amacrine cells (Fig. 4.7A’, A”, B’,
B”). Thus, cells positive for both Islet1 and Pax6 revealed amacrine cells in the ONBL,
while those positive for Islet1 alone marked BPCs (Fig. 4.7A, A”, boxed region). To
interrogate whether KO retina failed to produce BPCs, we pulsed P0 pups with EdU
followed by retinal harvest at P4 and IHC with Islet1 and EdU (Fig.4.7C – D””). This
analysis showed Islet1+ EdU+ BPCs were indeed produced in the WT retina (Fig.4.7C”,
inset) but were not observed in the KO retina. However, EdU+ cells were observed in the
ONBL of the KO retina (Fig.4.7D”).
4.5.5 CitK KO retina undergoes severe degeneration by P14
IHC analysis at P7 with rhodopsin showed that in the KO retina, there were
rhodopsin+ cells except it lacked lamination or canonical morphological characteristics
(Fig. 4.8A’). At P14, the KO retina had deteriorated such that the ONL and INL collapsed
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to a thin layer of cells that showed positivity for markers such as red/green opsin and
rhodopsin (Fig. 4.8C – D’). However, the RGC layer was still present and positive for
Islet1 and Pax6 (Fig. 4.8E – F’).
4.6 Discussion
Role of alternative splicing in Citron kinase expression
Here we discovered an alternatively spliced isoform of CitK that is developmentally
regulated such that exon 9 is excluded at E12 and E14. The amino acids encoded by
exon 9 are 370-431 amino acids and are part of the kinase domain. Thus, the isoform
lacking exon 9 would most likely lack the kinase function. In addition, we discovered
another alternatively spliced isoform where cryptic donor in intron 13 such that it adds 29
amino acids. These amino acids are added to the structural maintenance of chromosome
(SMC) domain, which could alter the nuclear function of CitK, which has been reported in
drosophila where its homolog is called sticky, which is required for heterochromatinmediated gene silencing through HP1 localization and H3-K9 methylation [214].
RPC death does not begin until E14
At E12, RT-PCR analysis showed highest levels of expression of CitK, but its loss
did not affect RPCs at E12 or E13. This suggests that RPCs at E12 and E13 retina may
have a compensatory mechanism that allows RPCs to undergo cytokinesis in the
absence of CitK. By E14, we begin to see reduction in RPCs which is coincident with
TUNEL+ cells suggesting CitK requirement for RPCs. Interestingly, RGC production was
not aberrant in CitK KO retinae, which is in agreement with the observation that RPCs at
E12 and E13 remain uncompromised. Indeed, it is at E12, when RGC production begins
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and the resistance of E12 RPCs to loss of CitK allows for normal RGC production. The
observation of cell death beginning at E14 raises the issue as to why it happens at E14
and not earlier (Fig. 4.9). One possibility is that there exists a compensatory gene(s)
(factor(s) X) that allowed RPCs to survive at E12 and E13 and these genes were
downregulated by E14 (Fig. 4.9). There are other Rho-dependent kinases such as Rhoassociated protein kinase (ROCK) and Cdc42 that have been shown to play a regulatory
role in the contractility of the cleavage furrow during cytokinesis [197-199, 215]. Aurora,
another member of serine/threonine kinase family and Aurora and Ipl1-like midbodyassociated protein (AIM-1) have also been shown to play a critical role in cell division
especially at the midbody furrow [216, 217]. Nir1, a mammalian homolog of retinal
degeneration B in drosophila, has been shown to have a very similar function to that of
CitK [218]. Therefore, it is possible that one or all of these genes could compensate for
loss of CitK function.
Late embryonic and postnatal neurogenesis is affected in the KO retina
The depletion of RPCs that began at E14 reached their peak at E16 resulting in a
severely compromised retina at birth. Notably, pulse-chase experiments with EdU
showed that RPCs that were in S-phase at E12 (time of EdU pulse) had survived cell
cycle and had re-entered cell cycle at E16 as shown by EdU+ cells that were Ki67+.
These cells survived because they most likely did not express CitK or if they did express
CitK, they also had the aforementioned compensatory factor. This agrees with the
observation in the brain where it was shown only ~50% of neurogenic cytokineses were
affected [219]. Thus it is possible that RPCs can be grouped into two categories of
neurogenic cytokinesis. One that is dependent on CitK and susceptible to cell death in
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the KO retina and the other that is independent of CitK which results in RPCs that remain
at P0 (Fig. 4.9). Moreover, the RPCs in the P0 KO retina fail to produce bipolar cells as
shown by the pulse chase experiments where RPCs that took up EdU at P0 (time of
pulse) did not show EdU+ Islet1+ BPCs at P4. It is also possible that RPCs in the KO
retina failed to undergo cell division as a secondary effect of the severely compromised
retina. This possibility is unlikely given that there are distinct EdU+ nuclei in the ONBL of
P4 retina which suggests that the progeny of the progenitor cells that took up EdU were
still alive (Fig.4.7B1”). In all, our data showed that loss of CitK did not affect early
embryonic RPCs resulting in normal neurogenesis while altering late embryonic RPCs
affecting subsequent neurogenesis.
Here we present a model where a subset of RPCs require CitK function and these
subsets of progenitor cells go on to produce Islet1+ BPCs (Fig. 4.9, Top). In the absence
of CitK, expression of factor(s) X allows RPCs to survive uptil E14, when the levels of
these factor(s) drops making CitK function crucial for RPC survival. This in turn results in
the death of these RPCs such that there are none left at birth to produce the Islet1+ BPCs
in the CitK KO retina (Fig. 4.9, bottom).
4.7 Materials and methods
Animal Procedures
All procedures with rats were performed in accordance with the animal protocol approved
by Institutional Animal Care and Use Committee at the University of Connecticut and in
compliance with the regulations of ‘The Association for Research in Vision and
Ophthalmology’ for the use of animals in research. Wistar rats from Charles River
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Laboratory,

MA,

were

employed

for

RT-PCR

analysis.

All

CitK

mutants

(Citkfh/fh, flathead rats), heterozygous and wildtype littermates were generated from a
breeding colony maintained at the University of Connecticut.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
Retinae from different developmental time points in Wistar rats (Embryonic day (E) 12,
E14, E16, E18, postnatal day (P)0, P4, P10, and P14) were harvested and total RNA
prepared in Trizol following the manufacturer’s protocol (Invitrogen). For cDNA synthesis,
1μg of total RNA from retinae harvested at various time points was used [190]. PCR to
examine the expression of Citron Kinase gene was performed with the primers across the
gene mentioned in table 1. RT-PCR thermocycler conditions were for 33 cycles (95°C for
30 seconds; 58°C for 30 seconds; 72°C for 50 seconds). Gapdh was used as control.
Primers used to amplify Gapdh are mentioned in table 1. RT-PCR thermocycler
conditions were for 30 cycles (95°C for 30 seconds; 58°C for 30 seconds; 72°C for 50
seconds). All PCR products were resolved on a 2.5% agarose gel. The products were
then excised and cloned into pGEMT vector (Promega, catalog # A1360) and sequenced
with T7 primer to confirm their identities.
Table 4.1: List of primers used in the CitK RT-PCR analysis
Primer
name (#
represents
exon)

Primer Sequence (5' - 3')

F1

CGGTAGCGGAGAGATGTTGAAGTTCAAGT

R3

TAACCACCTGCACTTCGGCGAAGT

F3

ACTTCGCCGAAGTGCAGGTGGTTA
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R8

GCAACAGAGACCCTCGAACTTCAGTCTCT

F8

AGAGACTGAAGTTCGAGGGTCTCTGTTGC

F8/9

AATAACATCCGGAACTCTCCTCCCC

R12

GCTCTCTGATGTCGTGGAGAAGCTGAAGA

F12

TCTTCAGCTTCTCCACGACATCAGAGAGC

RC13

AGGTCCTTAGCACTCGCTAAGCCA

R14

CTGGAACATTCTCCCACTTCAGGCT

R17

TCCTTCAGTCTGTTCTCTCTACGCTCCATG

F16

TGCAGAACATCCGGCAGGCAAA

R30

AGGGCGAGCTTCAGCTCATTGTACTG

F29

CACGAGAAGGTGAAAATGGAAGGCA

R41

CCGATGAGGATACTGTAATTGGTGAAGTGG

F35

GGTGGAAGAATTTGAGCTGTGCCTTC

R46

TCTGTCCGGCCCTCTCTGTCTCGGTA

GAPDH
Fwd

ACAGTCAAGGCCGAGAATGGGAA

GAPDH
Rev

TCAGATGCCTGCTTCACCACCTTCT

EdU pulse experiments
Pregnant heterozygous females at E12 were first weighed and injected with 1ml of 25mM
EdU in PBS/100mg of body weight and embryos were either harvested one hour after at
E12 or at E13, E14 or E16. P0 pups were first weighed and injected with 0.4ml of 25mM
EdU in PBS/100mg of body weight and retinae were harvested at P4.
Immuno histochemistry (IHC)
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All of the experiments were performed on 10-16 μm cryosections obtained from different
time points in CitK KO, heterozygous and WT littermates. For embryonic analysis,
cryosections were subjected to antigen retrieval as described by the manufacturer (Vector
laboratories, Catalog # H-3300) followed by IHC. The sections were then hydrated in
phosphate-buffered saline (PBS, pH 7.4) and washed three times (5 minutes each at
room

temperature

(RT)),

followed

by

incubation

with

PBTS

buffer

(blocking/permeabilization buffer) (1X PBS with 0.1% triton-X 100, 0.2% BSA and 0.02%
SDS) for an hour at RT. Primary antibody (mouse anti-islet1, 1:300, Developmental
Studies Hybridoma Bank, Product # 40.2D6; mouse anti-Ki67, BD Biosciences, Product
# 556003;

rabbit anti–Phospho Histone H3 (PH3), 1:300, Bethyl laboratories, inc.,

Product # IHC-00061; rabbit anti-Pax6, 1:300, Covance, Product # PRB-278P; mouse
anti-rhodopsin, clone 4D2, 1:300, Millipore, Product # MABN15; rabbit anti-red/green
opsin, 1:300, Millipore, Product # AB5405) was incubated in PBTS buffer overnight at
4ºC. Sections were washed with PBTS buffer containing 4’, 6-diamidino-2phenylindole
(DAPI) (Roche diagnostics) 10 times (15 minutes each at RT). Following the washes,
secondary antibody (anti-rabbit antibody conjugated with Alexa488, 1:750, Product #
21206, anti-mouse conjugated with Alexa 568, 1:750, Product # A10037, Invitrogen) was
incubated in PBTS buffer overnight at 4ºC. Sections were washed with PBTS buffer 7
times (15 minutes each at RT), rinsed with PBS and mounted in Prolong gold anti-fade
reagent (Invitrogen) and coverslip glass.
For the detection with mouse anti-CRIK/CitK antibody (1:50, BD Biosciences, Product #
611376), IHC protocol as described above was employed except that the blocking buffer
consisted of 1X PBS with 0.5% triton-X, 5% normal goat serum (NGS) containing DAPI
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followed by the incubation of the primary antibody in permeabilization buffer (1X PBS with
0.25% triton-X and 2.5% NGS) overnight at 4ºC. Sections were washed 3 times with the
permeabilization buffer followed by the incubation with secondary antibody in
permeabilization buffer for 2hours at RT. Sections were washed with permeabilization
buffer 5 times (10 minutes each at RT), rinsed with PBS and covered with Prolong gold
anti-fade reagent (Invitrogen) and coverslip glass.
For EdU detection, Click-iT EdU Alexa fluor 647 imaging kit (Molecular probes, catalog #
C10340) was used. The steps were followed as per instructions in the user manual.
TUNEL assay
In situ Cell death detection kit, TMR red (Roche diagnostics, catalog # 12156792910) and
TUNEL Apo-green detection kit (Biotool, Catalog # B31112) was used to assay the cell
death in the embryonic retinal tissue at E14 and E16 as per instructions in the user
manual. For determining whether the dying cells were retinal progenitor cells, E16 retinal
sections were first stained with mouse anti-Ki67 and IHC was followed as described
earlier. The sections were then fixed and TUNEL assay was carried out.
Image Acquisition and 3D reconstruction
Confocal fluorescence microscopy was performed using Leica SP2. Images were
subsequently processed using IMARIS 7.3 (Bitplane Inc., CA) and Adobe Photoshop CS4
(Adobe Systems Inc., CA). For counting, spot tool in IMARIS software was employed. For
confirming the overlap between Ki67 and TUNEL signal, section tool was employed. The
placement of the cross hairs shows the signal in the longitudinal (shown on right) and
horizontal axis (shown at the bottom) at the given position.
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Statistical analysis
Data were analyzed in Microsoft Excel 2007. Statistical significance was determined
using the Student’s t test (p ≤ 0.05). Data are presented as mean ± SEM.
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Figures
Figure 4.1
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Fig 4.1. Expression analysis of Citron Kinase during rat retinal development. A:
Schematic representation of CitK mRNA showing exons (orange boxes) and the primers
(green arrows) used for RT-PCR analysis. B: Gel images showing the expression of CitK
at retinal timepoints indicated on top along with the forward and reverse primers used.
Primers in (i) exons 1 and 3; (ii) exons 3 and 8; (iii) exons 8 and 12; (iv) exons 12 and 17
, with schematic representation of isoforms detected in (iii) and (iv); (v) exons 16 and 30;
(vi) exons 29 and 41; (vii) exons 35 and 46 ; (viii) Gapdh. (vi) & (vii) Gel images at the
bottom show a low exposure image. C: Schematic representation of combination of
isoforms identified in CitK and the primers used for RT-PCR analysis (green arrows, F8RC13 and F8/9 – R14). (Left) Gel image showing the expression of isoform containing
cryptic donor in exon 13 along with or without exon 9 included across embryonic day
(E)12, E14, E16, E18 and postnatal (P)0. (Right) Gel image showing the expression of
isoform containing exon 9 with or without cryptic donor in exon 13 across E12, E14, E16,
E18 and P0. D-E’: IHC with mouse-CitK antibody (green) on E12 WT (D) and KO (D’)
retinae and E16 WT (E) and KO (E’) retinae. Insets show the localization of CitK (arrow
heads). F-F”: IHC with mouse anti- CitK antibody (green) along with rabbit anti-PH3
antibody (red) on E12 retinal sections. DAPI (blue) marks all the nuclei. ONBL – Outer
neuroblastic layer; GCL – Ganglion cell layer [204].
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Figure 4.2

Figure 4.2. Number of Progenitor cells in WT and KO retinae are comparable at E12.
IHC on retinal sections obtained from embryonic day (E)12 embryos where the mother
was pulsed with EdU one hour prior to harvest. A, D: Retinal progenitor cells (RPCs)
positive for Ki67 (green) and PH3 (red) in WT (A) and KO (D). B, E: RPCs positive for
EdU (magenta) in WT (B) and KO (E). DAPI (blue) marks all nuclei. C, F: Merged image
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showing RPCs positive for Ki67 (green) and EdU (magenta) in WT (C) and KO (F). DAPI
(blue) marks all nuclei. Inset shows the higher magnification image of the boxed region
in the apical end of the ONBL where the solid arrow points to a RPC that is EdU+ and
Ki67+. G: Quantification of S-phase RPCs (EdU+ cells) as a percentage of all RPCs
(Ki67+ cells) in WT (blue, n=6) and KO (red, n=9). H: Quantification of M-phase RPCs
(PH3+ cells) as a percentage of all RPCs (Ki67+ cells) in WT (blue, n=6) and KO (red,
n=9). ONBL – Outer neuroblastic layer; GCL – Ganglion cell layer [204].
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Figure 4.3
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Fig 4.3: Number of RPCs and retinal ganglion cells in WT and KO retinae are
comparable at E13. IHC on retinal sections obtained from embryonic (E)13 embryos
where the mother was pulsed with EdU at E12. A, D: Retinal progenitor cells (RPCs)
positive for Ki67 (green) and PH3 (red) in WT (A) and KO (D). B, E: RPCs positive for
EdU (magenta) in WT (B) and KO (E). C, F: Merged image showing RPCs positive for
Ki67 (green) and EdU (magenta) in WT (C) and KO (F). DAPI (blue) marks all nuclei.
Inset shows the higher magnification image of the boxed region in the apical end of the
ONBL where the solid arrow points to a RPC that is EdU+ and Ki67+. G-H”: Retinal
sections showing EdU+ cells (magenta) in WT (G) and KO (H) along with IHC for Islet1
(green) in WT (G’) and KO (H’). Shown in G” and H” are the merged images of G & G’
and H & H’, respectively. Inset shows the higher magnification image of the boxed region
in the GCL where the solid arrow points to a RGC that is EdU+ and Islet1+. DAPI (blue)
marks all nuclei. I: Quantification of S-phase RPCs (EdU+ cells) as a percentage of all
RPCs (Ki67+ cells) in WT (blue, n=7) and KO (red, n=10). J: Quantification of M-phase
RPCs (PH3+ cells) as a percentage of all RPCs (Ki67+ cells) in WT (blue, n=7) and KO
(red, n=10). K. Quantification of retinal ganglion cells (RGCs) born at/after E12 by
determining Islet1+ and EdU+ cells as a percentage of all Islet1+ cells within the GCL in
WT (blue, n=3) and KO (red, n=7). ONBL – Outer neuroblastic layer; GCL – Ganglion cell
layer [204].
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Figure 4.4
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Fig 4.4: Number of RGCs in WT and KO retinae are comparable at E14 but the
number of RPCs in S-phase are fewer in the KO retina. IHC on retinal sections
obtained from embryonic (E)14 embryos where the mother was pulsed with EdU at E12.
A, D: Retinal progenitor cells in (RPCs) positive for Ki67 (green) and PH3 (red) in WT
(A) and KO (D). B, E: RPCs positive for EdU (magenta) in WT (B) and KO (E). C, F:
Merged image showing RPCs positive for Ki67 (green) and EdU (magenta) in WT (C)
and KO (F). DAPI (blue) marks all nuclei. Inset shows the higher magnification image of
the boxed region in the apical end of the ONBL where the solid arrow points to a RPC
that is EdU+ and Ki67+. G-H”: Retinal sections showing EdU+ cells (magenta) in WT
(G) and KO (H) along with IHC for Islet1 (green) in WT (G’) and KO (H’). Shown in G”
and H” are the merged images of G & G’ and H & H’, respectively. Inset shows the
higher magnification image of the boxed region in the GCL where the solid arrow points
to a RGC that is EdU+ and Islet1+. DAPI (blue) marks all nuclei. I: Quantification of Sphase RPCs (EdU+ cells) as a percentage of all RPCs (Ki67+ cells) in WT (blue, n=3)
and KO (red, n=9). Student’s t-test, p=0.01. J: Quantification of retinal ganglion cells
(RGCs) born after E12 by determining Islet1+ and EdU+ cells as a percentage of all
Islet1+ cells within the GCL in WT (blue, n=6) and KO (red, n=7). ONBL – Outer
neuroblastic layer; GCL – Ganglion cell layer [204].
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Figure 4.5
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Fig 4.5. Reduction in RPCs without change in RGCs between WT and KO retinae
at E16. A, A’: TUNEL assay (red) on embryonic (E14) WT (A) and KO (A’) retinae.
DAPI (blue) marks all the nuclei. B: Quantification showing cell death (TUNEL+ in A &
A’) in E14 WT (blue, n=6) and KO (red, n=8) retinal sections. Student’s t-test, p=0.005.
C, C’: TUNEL assay (red) on E16 WT (C) and KO (C’) retinae. DAPI (blue) marks all the
nuclei. D: Quantification showing cell death (TUNEL+ in C & C’) in E16 WT (blue, n=3)
and KO (red, n=6) retinal sections. Student’s t-test, p=0.05. E-F”’: Identity of TUNEL+
cells by IHC for Ki67 (red) and TUNEL (green) in E16 WT (E) and KO (F) retinal
sections. The boxed region in E is shown as a high magnification image in E’ with
section function in IMARIS showing the overlap of cells positive for both Ki67 and
TUNEL (Details in materials and methods). Boxed regions in F are shown as high
magnification images in F’-F”’ with section function in IMARIS showing the overlap of
cells positive for both Ki67 and TUNEL.ONBL – Outer neuroblastic layer; GCL –
Ganglion cell layer [204].
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Figure 4.6

Fig 4.6. Reduction in the ONBL in the CitK KO retina along with absence of
bipolar cells at P2. A - D’: IHC on postnatal (P0) retinal section showing PH3 (green)
in WT (A) and KO (A’); Islet1 (green) in WT (B) and KO (B’); Ki67 (green) in WT (C) and
KO (C’); Pax6 (green) in WT (D) and KO (D’). E - H’: IHC on P2 retinal section showing
PH3 (red) in WT (E) and KO (E’); Islet1 (green) in WT (F) and KO (F’); Ki67 (green) in
WT (G) and KO (G’); Pax6 (green) in WT (H) and KO (H’). DAPI (blue) marks all the
nuclei. ONBL – Outer neuroblastic layer; GCL – Ganglion cell layer [204].
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Figure 4.7

Fig 4.7. Bipolar cells are not produced in the KO retina at P4. A – B”: IHC on postnatal
(P4) retinal sections for -Islet1 (green) in WT (A) and KO (B) and for Pax6 (red) in WT (A’)
and KO (B’). Merged images of A & A’ and B & B’ are shown in A” and B”, respectively.
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In A and A’, the dashed box marks the Islet1+ & Pax6 –ve BPCs. The arrow heads point
to cells with expression of both Pax6 and Islet1.C – D”’: IHC on sections of P4 retinae
harvested from rats pulsed with EdU at P0. Expression of Islet1 (green) in WT (C) and
KO (D) and EdU detection in WT (C’) and KO (D’). Merged images of C & C’ and D & D’
are shown in C” and D”, respectively. Inset in C” shows a higher magnification image of
the boxed region highlighting bipolar cells born at/after P0. DAPI marks all the nuclei.
ONBL – Outer neuroblastic layer; GCL – Ganglion cell layer [204].
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Figure 4.8
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Fig 4.8. KO retina is severely compromised by P14. A – B’: IHC on postnatal (P7)
retinal sections showing rhodopsin (green) and Pax6 (red) in WT (A) and KO (A’); Islet1
(green) in WT (B) and KO (B’). C – F’: IHC on P14 retinal sections showing red/green
opsin (red) in WT (C) and KO (C’); rhodopsin (green) in WT (D) and KO (D’); Pax6 (red)
in WT (E) and KO (E’); Islet1 (green) in WT (F) and KO (F’). DAPI marks all the nuclei.
ONL – Outer nuclear layer; INL – Inner nuclear layer; GCL – Ganglion cell layer [204].
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Figure 4.9

Fig 4.9. Model of the effect of loss of Citron Kinase on RPCs. Shown here is a
developmental time line starting with E12 and P4. Top panel reflects the scenario in WT
retinae and the bottom reflects the scenario in KO retinae. The orange triangle shows
the expression levels of CitK as it decreases over time. The brown triangle shows the
expression kinetics of a potential compensatory factor (Factor X), which decreases by
E14. The circles represent RPCs, where open circles represent CitK -ve RPCs while
solid circles (orange) represent CitK+ RPCs. The loss of CitK does not affect RPCs at
E12 but is required for the survival of RPCs beginning at E14 shown as reduction in the
number of solid circles in the KO scenario. This reduction in CitK+ RPCs results in
drastic loss by P0 such that Islet1+ Bipolar cells are not produced in the KO retinae
[204].
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Chapter 5: Global analyses to understand the regulation of
transcriptome by alternative splicing
This chapter discusses the global approach to understand the role of AS in retinal
development. To this end, we employed RNAseq and custom microarray to address the
question. We also devised a custom bioinformatics pipeline to extract biological meaning
from the large dataset obtained from RNAseq. This method was compared to other
methods routinely employed by other biologists and we showed that the former method
has more inference values. Therefore, this strategy was extended to another RNAseq
data obtained from various developmental time points from wild type and a triple
microRNA cluster knockout retinae.
5.1 Technologies employed to understand alternative splicing at the global level
Alternative splicing (AS) has been shown to be a key regulatory step in the gene
expression and is of the mechanisms to generate cellular and functional complexity in
higher eukaryotes. Gene-targeted approaches highlighted the importance of AS in
various tissues but those analyses could only go so far. Therefore, en-masse approach
of transcriptome analysis was taken to understand the global picture of various regulatory
networks that governed the expression of genes on the whole in a tissue -specific manner.
Global analyses of gene expression mostly relied on Microarray profiling and expressed
sequence tagged – cDNA sequence (EST approach), which have shown that about twothirds of human genes contain one or more alternatively spliced exon. Due to the limitation
in the depth coverage and sensitivity at the time offered by microarray and conventional
sequencing technologies, the extent of AS events in humans was not known. Wholegenome tiling arrays were also employed to capture the transcriptome complexity but this
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technology could not capture splice-junction information. Other method such as eventspecific arrays have been used but they have been hampered by the specificity, high
costs and difficulty in the data analyses. The other technology, EST approach provided
partial sequences of individual cDNA clones but is sensitive to cloning biases.

Other

technologies that were employed include serial analysis of gene expression (SAGE) [220]
and parallel signature sequencing, which also could not provide specific splicing event
information. In 2007, the potential of RNA sequencing (RNA seq) was first demonstrated
by the polony multiplex analysis of gene expression (PMAGE), which allowed for the
detection of as low as 0.3 RNA copies per cells [221]. RNAseq offers increased depth
coverage and sensitivity. Thus, Illumina based RNAseq technology has become the new
way of thinking for most biologists that are interested to understand the transcriptome at
single-nucleotide resolution.
5.1.1 Microarray
Microarray is a multiplex array on a solid substrate, which is used a highthroughput screening technique to measure the expression levels of large number of
genes simultaneously. The concept was first introduced by Tse Change in 1983, when
he illustrated “antibody microarrays” [222]. While DNA microarray technology is the most
widely used type of microarray, other types of microarray including protein, peptide,
cellular, glycoarray are routinely performed. The two platforms that are currently available
for DNA microarrays include glass microarrays, which involves spotting on a glass slide
and high-density oligonucleotide arrays, also called “chip”, which involves insitu
oligonucleotide synthesis.

5.1.1.1 Principle
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The principle behind DNA microarrays include three main steps:
1. Array preparation – using chip or glass slide via surface engineering, DNA fragments
are usually synthesized and then covalently linked to the solid surface such as silicon
chip or glass via surface engineering. The spot size is usually less than 200µ in diameter.
Each spot contains a few picomoles of a specific sequence called probes.
2. Sample preparation – Isolation of DNA or mRNA and cDNA preparation, known as
targets.

3. Hybridization and acquisition - These immobilized probes are used to hybridize to
the target. The probe-target hybridization is detected quantitatively either using a
fluorophore or chemiluminescence labeled targets. The signal strength measure gives
the relative measure of gene expression in the sample.

Post data-acquisition, data is analyzed using appropriate software followed by
quantification and interpretation of data.

5.1.1.2 Advantages and Disadvantages

Some of the advantages of microarray include:


Simultaneous detection of multiple probes



Initial and faster screening in disease diagnosis



Gene level and protein level detection makes the gene to protein to disease
correlation easier.



Cost-effective – glass type DNA microarrays are affordable.
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No additional equipment is required – hybridization step does not require any other
equipment.



Increased detection sensitivity – glass microarrays have longer target sequences
about 2kb, which makes it more sensitive in probe- target hybridization.

While there are advantages to this method and is widely used, it has a few disadvantages
including


labor involved in synthesis, purification, storage of probes



probe bias where some probes might have a stronger covalent linking to its targets
while some might have variations at the single nucleotide level, which in turn might
affect the hybridization



cross hybridization, where homology in closely related gene family members might
cause the target to hybridize to a different probe.



Upregulation or downregulation might not necessarily be reflected by the probe –
target hybridization.



Difficulty in detecting alternative splicing event – although splicing arrays are
employed, unambiguous identification of novel isoforms are harder with small
fragments of probes.

5.1.1.3 Applications

Microarray is used for different kinds of analysis such as expression analysis of
genes in normal versus diseased condition, mutation analysis to find single nucleotide
polymorphisms (SNPs), genomic analysis to find new genes, disease prognosis,
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especially, in cancer to find the markers that are up regulated compared to the normal
conditions, drug discovery to identify the protein products of the diseased gene, which in
turn is used in the synthesis of drugs to target these products and toxicology to find the
effects of toxins at the cellular level and changes caused by in the genetic profile due to
their exposure.
Recent advancements in the field of deep sequencing, especially in RNA
sequencing technology, has over ridden microarray technology to a greater extent. The
latter method provides the depth and nuanced information that is not available in the
former technology. Also, the bias introduced due to the probe binding in microarray is
avoided in RNAseq technology. Additionally, RNAseq can be used to build the whole
genome for a new model organism, which is not possible by microarray.
5.1.2 Deep sequencing and RNA sequencing
The advent of high-throughput sequencing based methods has changed the way
in which transcriptomes are studied. RNA sequencing (RNAseq) is widely used in the
analysis of transcriptome to accurately measure gene expression levels, isoform
expression levels and to find novel isoforms. RNA sequencing (RNA-Seq) involves direct
sequencing of complementary DNAs (cDNAs) using high-throughput DNA sequencing
technologies followed by the mapping of the sequencing reads to the genome. It provides
a more comprehensive understanding of the complexity of eukaryotic transcriptomes in
that it allows for the identification of novel exons, exon-intron boundaries, transcription
start sites [223], and new splicing variants. It also allows for the precise estimation of
isoform expression [224-233]. RNA seq’s ability to construct a novel full length isoform
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sequences as well give their expression levels make this technology to be widely used in
the study of en-masse transcription regulation.
One of the earliest technology to obtain a comprehensive profile of the
transcriptome, including lowly expressed transcripts, polony multiplex analysis of gene
expression (PMAGE) was developed by George M. Church [221]. It has been shown to
provide accuracy in the mRNA expression assessment since individual cDNA molecules
are subjected to sequencing without any prior library amplification or sub-cloning. The
principle of PMAGE is that individual cDNA template molecules are clonally amplified onto
each polony bead in millions of parallel, compartmentalized droplets formed in a waterin-oil emulsion. Polony sequence-by-ligation (SBL) provides an accurate, cost-effective
and multiplexed platform for high throughput DNA sequencing. SBl works on the premise
of the high fidelity of DNA ligase, which iteratively label each bead with a fluorophore
encoding the identity of a base within the template. Microscopy-based detection of
fluorescence ligation allows for the assessment of about 5 million cDNA molecules per
run and digital quantification allows for the analysis of broad range of mRNA expression.
Another form next-generation sequencing was that 454 pyrosequencing, which
works on the principle of pyrosequencing. This technology was developed by 454 Life
Sciences. It is quite similar to PMAGE, in that DNA is amplified in an emulsion. This
method uses luciferase to generate light for detection of individual nucleotides added to
the nascent DNA, data from which is used to generate nucleotide read-out of the
sequences. This provides longer reads compared to Illumina but does not have depth
coverage. While there are many different platforms for sequencing, the most commonly
used platform is that Illumina.

116

5.1.2.1

Illumina (Solexa) sequencing

Illumina sequencing, was jointly founded by Shankar Balasubramanian and David
Klenerman in 1988 [234]. This sequencing is based on the reversible dye-terminator
technology. The principle of this method involves formation of DNA clusters, which is the
clonal amplification of DNA. This method gnerates shorter reads but the depth coverage
is much greater compared to other methods.
Sample preparation: Samples are prepared to using a two-step process: (1)
Tagmentation and (2) Cycle-amplification. Tagmentation is the process where DNA is first
fragmented and by transposomes, and specific adaptor sequences are ligated to the 3’
and 5’ ends of the resulting fragments. Subsequently, additional motifs replace the
adaptor sequences in the process called reduced cycle amplification. These motifs
include sequencing primer binding sites, indexes, and oligo sequences for hybridization
in the flow cell [235].
Cluster generation: This step employs a cluster station. It comprises of a flow cell, which
can hold up to eight samples (each can go on a lane in that flow cell). Next, the denatured
DNA template is loaded to the flow cell, which anneals to the oligo that are already bound
to the flow cell. Once bound, a second strand is synthesized using these oligos, creating
a double-stranded template, which is covalently attached to the flow cell surface. This
process is repeated after denaturing and washing away original DNA template. The
strand that is left over, then bends over to hybridize with the lawn oligo. This is called
bridge amplification, which is continued for many cycles to create an exponential
amplification of these strands [236].
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Sequencing: For sequencing, the reverse strands are cleaved and washed away. 3’ ends
of the forward strands are also blocked. Read-1 primer is added, which binds to the
respective binding site on the read-1 strand. Fluorescently-labeled dNTPs, with a
temporarily blocked 3’hydroxyl groups are added. With the incorporation of each
nulcleotide, fluorescence is emitted following a light source application, wavelength of
which will indicate which nucleotide has been added to the read. Following this, the
temporary inactivation is removed at the 3’ hydroxyl group allowing for binding of another
nucleotide and the process is repeated. After the read length is reached, it is denatured
and washed away. Then, an index-1 primer is added to the flow cell and the first index
read is generated the same way the read-1 was generated. Incase of paired end reads,
once forward strand is sequenced, the reverse strands are sequenced by uncapping the
3’ ends using index-2 reads. Once it is generated, the excess is washed away.
Polymerase generates a complementary strand and the double-strand generated is
denatured. This time, forward strands are cleaved and washed away and 3’ ends of the
reverse strand are blocked to inhibit hybridization. Then, read-2 primer is added following
the addition of fluorescently labelled dNTPs and the above-mentioned process is
repeated for this strand [231, 237].
Reads generated from pooled samples are sorted based on the unique indexing
sequences with which they were labeled during sample preparation. Using paired-end
reads increase the alignment depth, thereby reducing ambiguity within the alignment.
Data analysis: During the analysis of the large dataset, the reads obtained are mapped
to the reference genome. Once the alignment is done, subsequently the data can be
interrogated for novel isoforms, splicing events, single nucleotide polymorphisms,
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insertion-deletion identification, microRNA and long non-coding RNA identification etc
[231].
5.2 Customized bioinformatics pipeline and microarray to understand the
biological processes underpinning normal and aberrant retinal development
5.2.1 Rationale:
One of the long standing goals in the retinal field has been to get a complete
repertoire of transcriptome underpinning various biological processes and to understand
how the transcriptome shifts either during developmental progression or in a pathological
condition. To this end, we employed RNA sequencing technology on a fractionated
developing mouse retina and devised a custom bioinformatics strategy to extract the
biological meaning from the large data-set. The fractionation facilitated the interrogation
of the cytoplasmic transcriptome separately from that of the nucleus, thereby allowing us
to check if the nuclear transcriptome was preparing for the next molecular event while
transcribing genes for the current step, while cytoplasmic transcriptome would mainly
reflect that which will be translated into proteins. Also, to understand the degree of
alternative splicing usage by genes expressed in the developing retina, we estimated
expression levels of the constituent isoforms of genes to leverage the gene expression.
Also, in parallel, we devised a customized unique splice junction microarray, which
contained the unique splice junctions for isoforms of genes expressed in RNAseq data.
The pipeline was extended to Nrl wildtype and knockout mouse retinae (Courtesy: Dr.
Anand Swaroop, National Eye Institute) and compared to another methodology, which is
generally used by other biologists, to find the best way of analyzing large datasets.
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5.2.2 Background
The retina has been the most accessible part of the developing central nervous system
with a wealth of information on detailed birth order of its cell types and on many genes
involved in executing specific programs such as cell cycle regulation, cell fate
determination, and neuronal differentiation. However, a comprehensive gene regulatory
network is still not achieved as gene-centric approach can only go so far. To address this
issue, transcriptome capture to identify co-transcriptionally regulated genes across retinal
development has previously been attempted and was of great value [238]. However,
these efforts were hampered by the lack of depth of the captured transcriptome and lack
of fractionation to gain higher resolution. Another concern was that at any given time the
retina consists of different cell types with varied transcriptomes, which renders finding
meaning from co-transcriptionally regulated genes difficult. We wanted to investigate
whether higher depth of the captured transcriptome through RNA-Seq with minimal crosscompartment (nucleus-cytoplasm) normalization could resolve this issue.
Here we report analysis of RNA-Seq data from cytoplasmic and nuclear
transcriptome of the developing retina. We show that combinatorial use of RNA-Seq with
our custom bioinformatics strategy revealed the precise order of gene activation and
transitions in processes during retinal development. Transition in gene expression was
validated and resolved at the isoform level through our custom microarray. Importantly,
we show proof of principle by extending our methodology to analyze RNA-Seq data from
P21-Nrl-WT and KO retinae. Our approach which focuses on understanding the temporal
progression in gene expression during normal/aberrant development can be extended to
development and disease progression of other tissues.
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5.2.3 Results
5.2.3.1 RNA-Seq of fractionated retina
RNA for deep sequencing was obtained from retinae from E16 as it is the midpoint in
embryonic development and P0 as it is a major transition in development. RNA-Seq was
performed on rRNA depleted RNA captured from the cytoplasmic extract (CE) of E16 and
P0 along with nuclear extract (NE) of P0. The rationale was that by comparing the CE
across development, we would capture mRNA that were most likely translated into
proteins, which in turn would reveal transitions in biological processes during the retinal
development.

Also,

comparing

the

cytoplasmic

transcriptome

minimizes

the

contamination of unspliced transcripts contributed by the nuclear fraction, which might
spike the FPKM units of isoforms and in turn the gene expression. On the other hand,
comparison of P0CE to P0NE would reveal transcriptome dynamics within a time point.
The two-way comparison (time and fraction) would capture change in transcription
kinetics with three distinct sets of transcripts: transcripts in both fractions; transcripts
exclusively in the CE; and transcripts exclusively in the NE. Overall, the transcriptome
captured by RNA deep sequencing was obtained as 99.28, 117.38, and 127.46 million
paired-end reads from E16CE, P0CE, and P0NE, respectively. An important decision for
RNA-Seq analysis is setting the threshold for gene expression, which in the field ranges
from 0.3–1.0 FPKM [239]. This range suggests that the threshold for any dataset must be
vetted through empirical evidence. Thus, we interrogated a range of FPKM values to set
the threshold for gene expression in the retina. We found that 1 FPKM was the
appropriate value, as genes with known retinal expression were above this threshold,
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hence considered expressed. In contrast, skeletal muscle-specific genes were below 1
FPKM, and were considered not expressed in the retina (Table 5.1).
Table 5.1: Skeletal muscle-specific genes expression. The table shows FPKM
values of skeletal muscle-specific genes in E16CE, P0CE and P0NE samples.
Skeletal-muscle

E16CE

P0CE

P0NE

genes

FPKM

FPKM

FPKM

Tnnt3

0.10

0.11

0.00

Tnnt1

0.94

0.50

0.50

Tnni3k

0.00

0.02

0.10

Tnni2

0.30

0.21

0.20

Tnni1

0.10

0.90

0.44

Tnnc2

0.00

0.00

0.10

Tnnc1

0.63

0.95

0.91

Tnn

0.00

0.00

0.10

While the low-level expression (<1 FPKM) of skeletal muscle-specific genes might have
a yet-to-be-identified biological function in the retina, we reasoned that in the absence of
any literature support it would be safe to consider them as not expressed, to ensure high
specificity of our analysis, at the cost of possible slight loss in sensitivity. Once the
threshold was set, the reads were then subjected to our custom bioinformatics pipeline
as described in materials and methods. The output of mapping and gene expression
quantification was reported in Fragment per Kilobase per million mapped reads (FPKM)
units.
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5.2.3.2 Validation of RNA-Seq data
A detailed explanation of how to run the scripts in the customized bioinformatics pipeline
and how to perform the downstream analysis are given in Appendix 1. We used genes
with established expression kinetics to objectively assess the sensitivity of RNA
sequencing [240]. For example, Fgf15, Sfrp2, Atoh7 and Irx4 are known to have higher
expression levels at E16 than at P0, which was reflected in E16CE compared to P0CE
data (Fig. 5.2A) [238, 241-245]. Likewise, expression of Fabp7, Gngt2, Nr2e3, Nrl, and
Rho was as predicted in that it was higher in P0CE compared to E16CE (Fig. 2B) [238,
246-252]. Finally, Pax6 showed little variation between E16CE and P0CE (Fig. 5.2B),
which was also as expected [253, 254]. The transcriptional kinetics of some of these
genes was independently validated by qPCR analysis across retinal development (E14,
E16, E18, P0, P2, P4, P10, P25), thereby confirming the robustness of both RNA-Seq
data and the bioinformatics approach used to assign expression and binning [255].
We also used the same paradigm of genes with established expression kinetics to
determine the level of cross-contamination between P0CE and P0NE RNA. To determine
the level of nuclear RNA contaminating the cytoplasmic extract, we checked the
expression of genes whose transcripts are predominantly nuclear, such as Xist, Malat1,
Tsix and Neat1 [255-258]. Indeed, for all four genes, the FPKM values were significantly
higher in the NE compared to the CE (Fig. 5.2C). Determining the level of cytoplasmic
RNA contamination in the nuclear extract presented a unique challenge as the majority
of the RNA in the CE would be expected to be in the NE. For this, we examined expression
of replication-dependent histone genes, as they are intronless and are known to be
efficiently exported to the cytoplasm [259]. Indeed, histone genes have higher FPKM in
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the CE than the NE (Fig. 5.2D). Furthermore, replication-dependent histone genes also
serve to account for genomic DNA contamination. These genes lack introns and do not
require splicing, so histone genomic DNA would be read as histone mRNA and inflate
FPKM values in the NE, which was not the case (Fig. 5.2D), thus confirming minimal
genomic contamination. Finally, genomic DNA contamination would result in FPKM value
>0 for all genes; however, we observed 0 FPKM in the NE for a large number (804) of
genes. In all, these controls suggest that there was minimal genomic DNA contamination
in our fractionated NE RNA-Seq data.
5.2.3.3 RNA-seq revealed high-resolution transcription kinetics
We wanted to test the fidelity of our approach in capturing in vivo kinetics and the
identification of co-transcriptionally regulated genes. Inherent to our binning strategy is
identification of co-transcriptionally regulated genes. Therefore, the aforementioned
binning strategy (Fig. 5.1) was employed for the E16CE vs. P0CE comparison and the
P0CE vs. P0NE comparison to extract the transcription kinetics. For example, genes in
the E16CE_Only bin had FPKM below threshold in P0CE. This suggests that transcription
of these genes was initiated at/before E16 and was downregulated after E16 or just before
P0. Genes in the P0CE_Only bin were transcribed after E16, but before P0. Genes in the
OR_E16CE bin suggest that their transcription was initiated at/before E16 and
downregulated after E16, but before P0 such that their FPKM was not below threshold in
P0CE. Overall, 12,041 gene were expressed (Additional file 1: Figure S2) of which 10,369
were non-differentially represented (Non_DR) between E16CE and P0CE (Additional file
2: Table S1.1, S1.2, Additional file 1: Figure S2). Further analysis of alternative splicing
status showed that genes in Non_DR bin were alternatively spliced at a higher level (42%)
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compared to those undergoing transcriptional change (37%, Additional file 1: Figure S2).
Likewise, the binning strategy was employed with the P0CE-P0NE comparison, which
showed an increase in the number of expressed genes, which was mostly accounted for
by the 2007 genes in the P0NE_Only bin (Additional file 1: Figure S2). Investigation of
the alternative splicing status showed that genes over represented in P0NE (OR_P0NE)
employed the highest degree of alternative splicing (68%) compared to other bins
including OR_P0CE (36%) and Non-DR (52%) (Additional file 1: Figure S2). Next we
combined E16CE-P0CE transcription kinetics with those observed in P0CE-P0NE
transcription kinetics. Briefly, we took genes in a bin from the E16CE-P0CE comparison
and interrogated their distribution in the different bins in the P0CE-P0NE analysis, which
yielded high-resolution transcription kinetics. The term “high-resolution transcription
kinetics” encapsulates both temporal and detection sensitivity. For example, amongst the
genes in the not expressed (No_Ex, 22,331) and E16CE_Only (632) bins, 1628 and 379
were detected above threshold in the P0NE_Only bin, respectively (Fig. 5.2E and 5.2J).
Similarly, 86 genes from the 384 genes in the OR_E16CE bin and 1710 genes from the
10,369 genes in the Non_DR bin were upregulated in the P0NE compared to the P0CE
(Fig. 5.2F and G). In contrast, 35 genes of the 255 genes in the OR_P0CE bin were
downregulated in P0NE compared to P0CE, while FPKM for 13 genes was below
threshold (Fig. 5.2H). Likewise, 11 genes of 401 genes found in P0CE_Only in the
E16CE-P0CE comparison were downregulated in P0NE compared to CE and 94 genes
had FPKM below threshold (Fig. 5.2I). Overall, there were 2007 genes with transcripts
exclusively in P0NE, of which 1084 were protein coding genes, 582 were Gm clones, 214
were Riken clones, and the rest were non-coding RNA genes (Table 5.2).
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Table 5.2: Distribution of 2007 transcripts in P0NE_Only sample
Type of RNA

#
genes

Protein coding genes

1084

Gm clones

582

Riken clones

214

Miscellaneous/Anti-

35

sense/non-coding/rRNA
Pseudogenes

33

snoRNA

21

microRNA

27

lincRNA

5

snRNA

6

5.2.3.4 Transcriptionally coupled genes revealed molecular programs in the
developing retina
Our objective here was to employ RNA-Seq to find transcriptionally coupled genes so that
we could leverage them to discover molecular programs being employed during retinal
development. For this, genes were subjected to DAVID analysis (Fig. 5.3A-I).
Interestingly, our first submission of genes (632; Fig. 5.2E) in the E16CE_Only bin to
DAVID did not enrich for any statistically significant (Benjamini <0.05) functions (Fig.
5.3B). But, other bins with fewer or more genes than in E16CE_only, yielded many
functions (Fig. 5.6, Additional file 3: Table S2.1). For example, genes in the OR_P0CE
bin enriched for 7 functions of which the top hit was “visual perception” (Fig. 5.3B,
Additional file 3: Table S2.1), showing that this function was initiated just before birth. This
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showed that transcriptionally coupled genes could inform biological processes that were
executed at that developmental timepoint.
One caveat to our binning strategy was that while it grouped genes based on transcription
kinetics, it separated genes participating in a common biological process (identified by
DAVID) into different bins. This in turn would prevent extraction of the expression kinetics
of genes known to participate in executing a biological process of interest. To address
this issue, we devised a subtractive iterative approach using GeneMANIA (Fig. 5.3C-II)
to identify genes participating in a common biological process from the different bins. For
example, 17 genes in OR_P0CE genes (E16CE-P0CE) that enriched for visual
perception by DAVID were used as bait in GeneMANIA, followed by the aforementioned
subtractive iterations (Fig. 5.3C; 1x-3x) to generate a final list of 36 genes (Fig. 5.3C,
Right). Subsequently, each gene was assigned to its respective bin in both E16CE-P0CE
and P0CE-P0NE comparisons (Fig.

5.3D-III). Redistribution of the genes into their

respective bins is shown in Fig. 5.3E. For visual perception, the transcription of Rdh5,
which converts all-trans retinal to 11-cis retinal [260] was initiated at/before E16, shut
down just before birth and was initiated again at birth as we find it in P0NE_Only bin in
P0CE-P0NE (Fig. 5.3E). In contrast, Crb1, Cngb3, Pcdh15 and Rgs9, which play a role
in photo transduction [261, 262] and structural support/maintenance of photoreceptors
[263, 264], were transcribed at/before E16 and upregulated at P0 as they were overrepresented in P0NE in P0CE-P0NE (Fig. 5.3E). Rp1, which is a photoreceptor-specific
microtubule-associated protein [265], was the only gene that was transcribed at P0
(P0CE_Only in E16CE-P0CE) that continued to be upregulated as it was overrepresented in P0NE in P0CE-P0NE (Fig. 5.3E). Transcription of Guca1a was initiated
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between E16 and P0 (P0CE_Only in E16CE-P0CE), except it was turned off before P0
(P0CE_Only in P0CE-P0NE) (Fig.

5.3E). Through this method we were able to

deconstruct the precise activation of genes involved in many aspects of vision
acquisition/phototransduction during embryonic development.
The same analysis was performed on all the bins in P0CE-P0NE comparison.
Specifically, genes in the OR_P0NE bin showed enrichment for 120 GOterms of which
one of them was “synapse” (Additional file 3: Table S2.2). This functional enrichment
agrees with studies showing that synaptogenesis occurs postnatally in the rodent retina
[266]. Further analysis of genes underlying the GOterm “synapse” showed transcription
initiation of the AMPA receptor subunit genes including, Gria1, Gria2 and Gria4 before/at
E16 (Non_DR in E16CE-P0CE) (Additional file 1: Figure S3). Similarly Grik2, which
encodes for a subunit of the ionotropic kainate receptor, was also initiated before/at E16
(Additional file 1: Figure S3). Gad2, which is necessary for the production of the inhibitory
neurotransmitter GABA, was transcribed before E16, while Gad1 transcription was
initiated after E16 prior to birth (Additional file 1: Figure S3). Overall, genes involved in
formation of the presynaptic activity were activated mostly during embryonic development
(Additional file 1: Figure S3). In contrast, genes involved in postsynaptic activity had
overlapping transcriptional activation with a subset of genes (Grid2, Grid1, Grik5, Grin3a,
Ryr2 and Shank2) that were specifically activated in P0NE (Additional file 1: Figure S3).
Finally, employing the same analysis for genes in P0NE_Only, which reflected de novo
transcription, enriched for 14 GOterms, where voltage-gated calcium ion channel activity
was one of the top hits (Additional file 3: Table S2.2). Again, this enrichment did agree
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with previous studies where it has been shown that calcium channel activity is crucial for
the construction of functional synapses that occurs postnatally [266].
5.2.3.5 Extending the analysis to other time points through the custom microarray
To confirm our RNA-Seq findings and extend our analysis across retinal development,
we leveraged our RNA-Seq data to design a custom microarray. The array was designed
to en masse validate isoform kinetics by assaying for unique exon-exon junctions of a
subset of genes across retinal development. The junctions were selected based on the
following criteria: 1) gene must have more than one isoform expressed in the RNA-Seq
data; and 2) An exon-exon junction must be unique such that it is not found more than
once in all of the isoforms for that gene in the Ensembl database. In all, the microarray
had 28,575 probes for 5581 genes and was employed to interrogate expression of these
isoforms in the cytoplasmic transcriptomes of E12, E16, E18, P0, P4, P10 and P25
retinae. Data obtained were subjected to K-means clustering with the Genesis software,
which was set to generate 10 clusters (Additional file 4: Table S3). Based on the overall
patterns across time, the clusters were organized into three groups: embryonic,
embryonic + postnatal and postnatal clusters (Fig. 5.4A-C), subsequently referred to as
clusters 1, 2, and 3, respectively.
Next, we applied DAVID analysis to each cluster and found that embryonic clusters
(Clusters 1 and 2) enriched for functions such as cell cycle regulation and cell projection
organization (Fig. 5.4D). For the embryonic + postnatal clusters (Clusters 3 - 9), the
functional GOterms that were enriched were those required for cell cycle regulation and
terminal differentiation of neurons, such as vesicle-mediated transport, synapse
formation, negative regulation of apoptosis, and axon guidance (Fig. 5.4E). Finally, the
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sole postnatal cluster (Cluster 10) was the only one that enriched for functions such as
visual perception, photoreceptor cell differentiation and sensory perception of light (Fig.
5.4F). In all, the isoform-specific microarray confirmed RNA-Seq findings and further
revealed the complexity of alternative splicing employed by the developing retina.
Thus, binning of the RNA-Seq data was crucial for the identification of cotranscriptionally regulated genes, which in turn gave us the temporal transitions in
biological programs enriched by the transcriptionally coupled genes (Fig. 5.6).
5.2.3.6 Comparison with other analysis methods
Our analysis pipeline is characterized by two main features, namely the temporal nature
of the analysis and the binning strategy that allow us to do the functional analysis on
genes with very specific expression kinetics. The current norm for next generation
sequencing based functional analysis in the literature is done based on simple differential
expression (DE) analysis, where the whole list of DE genes is fed into DAVID, or a similar
functional annotation analysis platform.. The list of DE genes can sometime be too large,
exceeding the input size limit of the functional analysis tool. To overcome this problem, a
sub-list is sometimes selected based on prior knowledge of the gene functions [267]. Most
analysis are also done in a static manner, where samples represent two conditions at the
same time point [268]. In this section, we study the effect of binning and the temporal
analysis on the result, by varying the analysis strategy. We first apply our analysis strategy
to RNA-Seq data from P21-Nrl-WT and P21-Nrl-KO (Courtesy Dr. Anand Swaroop; NEI)
[268].Then we apply three variants of the analysis pipeline, listed in Table 5.3, to the same
data, and we compare the results.
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Table 5.3: The table shows our analysis strategy, highlighted in grey and the
three other analysis variants we compared with.
Temporal analysis coupled

Static analysis coupled with

with binning strategy

binning strategy

Temporal analysis coupled

Static analysis coupled with

with simple DE analysis

simple DE analysis

5.2.3.7 Temporal analysis combined with static analysis of Nrl WT and KO RNASeq is more informative
The loss of Nrl results in cell-fate switch from rod to cone photoreceptors [269]. This
made Nrl-KO an ideal system to test our hypothesis that temporal comparison would yield
more information than the static analysis. First we performed static comparison between
P21-Nrl-WT and P21-Nrl-KO data (Additional file 1: Figure S4, Additional file 5: Table
S4.1), similar to the one previously reported [269]. The objective of transcriptomics
analysis of wild-type and knockout tissue is to find genes undergoing change to reveal
the resulting biological change in the absence of that gene. Surprisingly, DAVID analysis
of genes undergoing dynamic changes in gene expression in static comparison of P21Nrl-WT and KO enriched for a couple of generic functions that did not could not give any
meaning in terms of the knockout phenotype (Additional file 3: Table S2.5).
Our RNA-Seq analysis of data from E16CE to P0CE and P0CE to P0NE
comparisons showed that comparison across time (∆/time) was crucial in revealing
biologically relevant meaning from co-transcriptionally regulated genes. Therefore, we
introduced the variable of time by comparing P21-Nrl-WT and P21-Nrl-KO data separately
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to our P0 data (P0CE + P0NE) (Additional file 1: Figure S4, Additional file 5: Table S4.2,
S4.3). The rationale was that ∆/time would reveal unique sets of gene in P0 vs. P21-NrlKO comparison, which in turn would reveal changes in the biological processes. In both
comparisons, there were several bins with co-transcriptionally regulated genes
(Additional file 1: Figure S4), which is not surprising, considering the major developmental
shift from newly born developing retinae at P0 to fully functional P21 retinae. Also, DAVID
analysis yielded significant GOterms for all the bins in the temporal analysis (Additional
file 3: Table S2.3, S2.4). Moreover, there were many common functions in P21_Only bin
(P21WT_Only and P21KO_Only) in both analyses. The most relevant issue was to
ascertain the overlap in the identity of genes for the same process in the P21_Only bin in
both sets of comparisons. For example, one of the common function in P21_Only bin was
“visual perception”. Interrogating the genes underlying the GO term “visual perception”
in these bins, there were 21 genes common to both P0-P21WT and P0-P21KO analysis.
However, 3 genes (Gnat1, Gucy2f, Rpgr) were only found in the P0-P21WT comparison,
and one gene (Glra1) was specific to the P0-P21-KO comparison (Fig. 5.5, Left). The
three genes unique to WT comparison are known to operate specifically in rod
photoreceptors, which were of course absent in the Nrl-KO retina [270-272]. On the other
hand, Glra1 is an important gene for cone-bipolar cells, which might be undergoing
adaptive changes in the Nrl-KO retina [273]. The GO terms enriched by genes in
P21_Only bin in the P0 vs. P21-Nrl-KO comparison were also informative. One of the
functions enriched in DAVID was “regulation of blood pressure” (Fig. 5.5, right). Analysis
of function of the genes underlying this enrichment revealed that most of them were
engaged in vasodilation, suggesting that the Nrl-KO retina was undergoing vasculature
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restructuring/dilation as a secondary effect of the cell-fate switch. Moreover, a recent
report showed that the Nrl-KO retina develops dilated retinal blood vessels and leakage
at P60 [274]. This showed that our gene expression/binning strategy captured the
molecular signature at P21 for a phenotype that manifests histologically at P60.
5.2.3.8 Binning vs. DE based analysis of Nrl WT and KO data
Here we have introduced a new strategy for RNAseq data analysis. To understand the
advantages afforded by this approach we compared our binning method to the more
commonly used DE method. First we analysed the static comparison between Nrl-WT vs.
Nrl-KO data by the binning method and the DE-based method. Here we found that the
DE-based method showed large number (1116) of genes with differential expression
(Additional file 6: Table S5.1). Similar data was obtained by the binning method except
that the DE genes were now in bins labelled OR and Only, which reduced the large list of
DE genes into manageable quanta. Moreover, the inherent value of the bins is inferred
transcriptional kinetics. However, the binning method has a cost, which is reflected in the
few statistically significant biological functions enriched by DAVID analysis. In contrast,
the DE-based method generates a large list, which requires the investigator to decide the
fold-change that might be relevant for his/her study. The one advantage of the DE method
is that it produces a wide range of functional enrichments (12 GOterms) for DE gene-list
for DAVID analysis(Additional file 7: Table S6.3).
Next, we analyzed temporal comparison between P0 vs. P21 Nrl-WT and P0
vs.P21 Nrl-KO by both the binning method and the DE-based method (Additional file 6:
Table S5.2, S5.3). Here the binning method revealed gene transcription kinetics across
time, which inherently is valuable for deciphering developmental changes in normal and
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aberrant situations. The DE-based method produced a large DE gene-list, but it did not
yield any change in gene transcription over time (Additional file 7: Table S6.1, S6.2). Thus,
it would require further deconstruction of the list, which is not necessary by the binning
strategy. Also, DAVID analysis of the binned data provided enrichment of biological
functions tethered to the specific gene expression profile. This is of great value as it is
one of the central goals of performing RNAseq to capture transcriptome change over time
(Additional file 3: Table S2.3, S2.4). In all, the two approaches of RNAseq analysis have
merits that can be leveraged to effectively analyze RNAseq data.
5.2.4 Discussion
Amongst the co-transcriptionally regulated genes identified by our binning strategy, genes
that remained transcriptionally unaltered employed a higher degree of alternative splicing
than those undergoing dynamic regulation. This suggests that during development the
major transcription initiations and terminations might lay down the foundation, while the
proteome diversity generated through alternative splicing might be engaged in resolving
the finer details, such as neuronal subtype specification and terminal differentiation.
Another advantage of the binning strategy was that the large transcriptome data was
quantized, allowing us to interrogate the dataset for genes with established expression
kinetics. The purpose of this was to challenge the binned data generated based on the 1
FPKM threshold for known gene expression patterns (Fig. 5.2A&B).
Once the dataset was validated, the status of genes in various bins in the E16CEP0CE comparison in the P0CE-P0NE comparison was interrogated, which revealed
dynamic transitions in the transcription kinetics in the same developmental stage. For
example, the 632 genes in E16CE_only bin in the E16CE-P0CE comparison bifurcate
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into No_Ex and P0NE-Only bins in the P0CE-P0NE comparison (Fig. 5.2E). This
suggests that while some genes will remain off, some are re-initiated and predicts that
these transcripts will appear in the CE of the next developmental stage. This was
confirmed by our quantitative PCR analysis for Nr2e3, Nrl and Rho across postnatal
retinal development [255]. The presence of transcripts for 1084 protein coding genes in
the P0NE_Only bin suggested that we had captured de novo transcription of genes that
might be required for the next developmental program. For example, Ces5a is a ~36 kb
gene that has FPKM below threshold in E16CE and P0CE, but has FPKM of 161 in P0NE.
This value is much higher than FPKM of genes such as Nr2e3 (35.4 FPKM), Nrl (6.1
FPKM) and Gngt2 (22 FPKM) (Table 5.4).
Table 5.4: An example of a “P0NE_Only” gene, Ces5a, whose FPKM unit in P0NE
is comparable to those of other genes with known established expression
kinetics (Nrl, Nr2e3, Gngt2)
Genes

E16CE FPKM P0CE FPKM

P0NE FPKM

Ces5a

0.073539

0.420057

161.0296

Nrl

0.558403

15.88869

6.104338

Nr2e3

0.008781

28.08

35.45415

Gngt2

10.06518

91.92727

22.08052

This indicates that expression of Ces5a is more than physiologically equivalent, yet it is
not observed in P0CE where it could be translated. One possibility is that there is an
active regulation of its export, although this warrants further investigation.
The intrinsic value of identifying co-transcriptionally regulated genes is the
expectation that they might reveal the biological processes being executed by the
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developing retina. Our bioinformatics pipeline can deconstruct the order of activation of
specific genes engaged in executing a specific biological process so that one can begin
to generate gene regulatory networks underlying retinal development. A key feature of
our pipeline is the use of GeneMANIA to find potential partners of the core set of genes
from a specific bin that enrich for a function in our DAVID analysis (Fig. 5.3C). A priori,
one would predict a progressive increase in the number of genes with sequential
application of the GeneMANIA part of the pipeline (Fig. 5.3C). However, we observed that
there was reduction in the number of genes (Fig. 5.3C, Right). This suggests that
leveraging RNA-Seq data to remove genes that were not expressed in the retina enriched
for those genes relevant to retinal development and function at the timepoint under
investigation.
Next we applied our analysis pipeline to find co-transcriptionally regulated genes
in the P0 and P21-Nrl-WT comparison and the P0 and P21-Nrl-KO comparison
(Additional File 1: Figure S4, Additional file 5: Table S4). One of the salient features of
this analysis was that temporal analysis was more informative than static comparison.
One explanation is that temporal analysis created bins that were developmentally
regulated, which through DAVID analysis revealed changes in biological processes. For
example, there is no cell cycle occurring at P21 so the majority of the cell cycle genes
should be inactivated. Indeed, we observe cell cycle in the P0_Only bin in both P0 vs
P21-Nrl-WT and P0 vs. P21-Nrl-KO analysis (Additional file 3: Table S2.3, S2.4). These
genes in static analysis would show up as not expressed. Similarly, genes in P21_Only
bin enriched for functions such as ion channel activity, ion transport, visual perception,
synapse, voltage-gated ion channel activity, neurotransmission and others (Additional file
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3: Table S2.3, S2.4). This was as expected as the retina is fully functional at P21
compared to P0. The advantage of our strategy is that it allowed us to understand the
progression in gene expression kinetics in normal development and leverage that to
understand how this progression deviates in the knockout retina. When P21_Only bin
(either P21WT_Only or P21KO_Only) was analyzed through DAVID, we found many
functions that were common to both sets of comparison, except examination of the
number of genes underlying these functions revealed that there were subtle differences
between the two bins (P21WT_only and P21KO_Only) (Additional file 3: Table S2.3,
S2.4). This suggested that while many of the functions remain unaltered in the KO, there
are subtle changes in the manner in which they might be executed. For example, “visual
perception” showed up in the P0 vs. P21-Nrl-WT and P0 vs. P21-Nrl-KO comparisons in
the P21_Only bins (Fig. 5.5). There were 24 genes underlying enrichment of this function
in the WT comparison (Fig. 5.5), while there were 22 genes in KO comparison (Fig. 5.5).
Upon comparing the gene identities from both sets, subtle differences emerged that
allowed us to find the biological meaning from change in a single gene such as the rod
photoreceptor-specific gene, Gnat1, that was absent in the Nrl-KO retina, which lack rod
photoreceptors [270]. Finding Gnat1 through temporal analysis raises the question
whether it would have been found in static analysis. While Gnat1 was present in the
P21WT_Only bin in static analysis, the rest of the genes that would normally be part of
the GO term “visual perception” were in the Non_DR bin. Thus, without a priori knowledge
one would not find this specific gene out of the entire list of genes in the P21WT_Only.
Temporal analysis combined with our gene expression and binning strategy followed by
our custom bioinformatics pipeline was able to find these subtle changes, which in case
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of static analysis was not possible (Additional file 1: Figure S4). While one could find these
subtle changes in the static analysis by looking at specific genes, but that requires a priori
knowledge. The advantage of doing whole transcriptome analysis is that one could find
patterns computationally, which can be leveraged to obtain new insights without the need
for a priori knowledge. For example, GOterms such as potassium channel complex,
sodium channel activity, synaptic vesicle, calcium ion transport and regulation of blood
pressure regulation (Additional file 3: Table S2.4) were enriched by genes in the
P21_Only bin in P0 vs. P21-Nrl-KO comparison, but were absent in the WT comparison.
This finding suggests that there are specific anomalies in the Nrl-KO retina. Given that in
the Nrl-KO retina, the majority of the rod photoreceptors have converted to cone
photoreceptors, changes in ion transport and synaptogenesis are to be expected [17,
275]. However, regulation of blood pressure seemed out of place for the Nrl-KO retina.
Indeed, closer examination of the genes underlying this function revealed the need to
examine vasodilation in the Nrl-KO retina. Notably, previous reports showed that the NrlKO retina develops dilated retinal blood vessels and leakage at P60 [274]. Thus, this
confirming the prediction made through shifts in the molecular signatures identified by our
temporal analysis. Importantly, our analysis predicted an outcome based on gene
expression pattern changes occurring between P0 to P21 that manifests at P60.
5.2.5 Materials and Methods
Animal Procedures
All experiments used CD1 mice from Charles River Laboratory, MA. All mice procedures
were compliant with the protocols approved by the University of Connecticut’s Institutional
Animal Care and Use Committee (IACUC).
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RNA fractionation
Retinae were dissected from E16 embryos and P0 pups followed by fractionation protocol
as described previously [255]. Once the fractions were obtained, Trizol (Invitrogen, CA,
cat # 15596-026) was used as per the manufacturer’s instruction.
Library preparation for deep sequencing
After the total RNA was prepared from the two fractions, ribosomal RNA (rRNA) was
removed using Ribozero Ribosomal RNA removal kit (Epicenter, WI, cat # RZH1046) by
following the manufacturer’s instruction. The removal of rRNA was confirmed by gel
electrophoresis and was used for RNA-Seq library preparation. RNA-Seq library was
prepared using Script-seq mRNA seq library preparation kit (Cambio, UK, cat #
SS10906). The library was deep sequenced in multiple runs using Illumina Hi-Seq 2000
platform at the University of Connecticut Health Center Deep sequencing core facility.
P21 WT and Nrl-KO RNA-Seq data was shared with us by Dr. Anand Swaroop; National
Eye Institute [268].
RNA-Seq analysis
CD1 reference creation
The transcriptome captured by deep sequencing was obtained as short paired-end reads.
We analyzed the RNA-Seq data from each sample through riboPicker [276], an algorithm
to identify reads derived from rRNA, which showed minimal (0.02 – 0.34%) rRNA
transcripts (Table 5.5).
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Table 5.5: Read mapping statistics and rRNA levels in the E16CE, P0CE, and
P0NE samples
Sample

Percentage of transcriptome

Percentage of

# mapped bases

mapped read pairs

rRNA reads

in Gb

E16CE

61.26%

0.34%

7.54

P0CE

52.85%

0.19%

7.69

P0NE

25.42%

0.03%

4.02

Next, reads were mapped to the mouse genome and the transcriptome to create a
reference. The mouse genome sequence (mm10, NCBI build 38) was downloaded from
UCSC database [277, 278] together with the GTF for the Ensembl transcript library
(release 68) (http://genome.ucsc.edu).

The paired-end reads from E16 cytoplasmic

extract (CE), P0CE and P0 nuclear extract (NE) were mapped separately to the mm10
genome and the transcript sequences extracted according to the Ensembl transcript
library coordinates. Mapping was done using bowtie [279] and allowed for three
mismatches in seed-length of 30 bases. For each sample, the two sets of read alignments
(genome and transcriptome) were merged together using the HardMerge tool from the
NGSTools suite [280]. HardMerge keeps alignments of read that align uniquely to the
transcriptome, uniquely to the genome only or uniquely to each reference, where both
alignments agree. Other alignments are discarded. This initial mapping was used to
perform mismatch analysis with another tool in the NGSTools suite (Additional file 1:
Figure S1). Accordingly, the first 6 and last 32 bases from each read were trimmed. The
trimmed reads (62 bp) were remapped using the aforementioned mapping parameters to
the genome and transcriptome, and were once again merged using the HardMerge rules.
Since the RNA-Seq was performed on retinal RNA extracted from CD1 strain mice, the
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resulting alignments from all three samples were pooled together and used to call Single
Nucleotide Variations (SNVs) using SNVQ [280]. The CD1 reference genome was
created by modifying the mm10 reference to reflect the inferred SNVs. Transcript
sequences were extracted from the modified genome.
Gene Expression Analysis
E16CE, P0CE and P0NE reads were mapped against the created CD1 transcriptome
reference. The P21 WT and KO single end reads were mapped against the C57BL6
reference transcriptome (version 68). Mapping was done using bowtie and allowed for
one mismatches in seed-length of 30 bases. Gene expression were estimated using,
IsoEM, a novel expectation-maximization algorithm that estimates isoform frequency from
single and paired RNA-Seq reads. IsoEM exploits read disambiguation information
provided by the distribution of insert sizes generated during sequencing library
preparation, and takes advantage of base quality scores, strand, and read pairing
information. Isoform expression is reported as Fragment per Kilobase per million mapped
reads (FPKM) units and gene expression is the sum of FPKM of its constituent isoforms
[281]. For gene differential expression, two methods were run, GFOLD [282] and Fisher’s
exact test with house-keeping gene normalization as suggested by Bullard et al. [283].
Gapdh was used as the housekeeping gene for this analysis. Genes were called
differentially expressed if they showed ≥2 fold expression in one sample by both methods.
GFOLD was run on the CD1 transcriptome aligned reads, with default parameters and a
p-value of 0.01. Fisher’s exact test was run on estimated number of reads mapped per
kilobase of gene length (calculated from IsoEM estimated FPKM values). Similar to
GFOLD, a p-value of 0.01 was used for Fisher’s exact test.
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Binning strategy
Samples were analyzed in pairs, and genes were classified based on their expression
levels (expressed vs. not expressed), differential gene expression calls, and the number
of expressed isoforms for the gene. 1 FPKM was set as threshold for expression. Genes
were then classified into one of the following bins (Fig. 1) based on yes/no calls. Firstly,
genes with expression level less than 1 FPKM are placed in the not expressed (not_Ex)
bin (Fig. 1i). Rest of the genes, which were expressed were further categorized into the
following bins (Fig. 1ii). Genes expressed exclusively in one sample were placed in one
of the ONLY bins (Fig. 1iii). Differential expression calls were made to genes expressed
in both samples (Fig. 1iv). If a gene passed GFOLD and Fisher’s test, then it was placed
in the over represented (OR) bin. Genes, which did not pass both or either of these tests,
were placed in the non-differentially represented (non_DR) bin. Bins of expressed genes
were subcategorized based on the alternative splicing status of the genes. This
categorization included single and multiple isoform bins (SI, MI). There were genes with
multiple isoforms that were individually below threshold, but the sum of FPKM values of
these isoforms is above threshold. These were placed in the multiple isoforms below
threshold (MIBT) bin. Similarly, genes expressed with multiple isoforms where only one
isoform was above threshold were placed in the multiple isoforms one above threshold
(MOAT) bin.
Functional annotation analysis
Genes belonging to each bin were analyzed for enrichment of individual GOterms to find
whether co-transcriptionally regulated genes had overlapping functions using the
Database for Annotation, Visualization and Integrated Discovery, DAVID (Fig. 3A-I) [284,
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285]. Default parameters (≤0.05 Benjamini score) were used for all analyses. The gene
lists enriching for GOterms were run through GeneMANIA to identify potential partners
[286]. First, we took the gene list underlying a biological process identified by DAVID and
used it as bait in another online tool called GeneMANIA (Fig. 3C-II), which identified
potential partners for genes from the primary list. The potential partners identified by
GeneMANIA are based on all published literature and databases, which could introduce
a partner that is relevant in another tissue, but might not be expressed in the retina. To
eliminate such genes, we selected only those genes that were expressed in our RNASeq data. Subsequently, this short list of genes was added to the primary list to generate
a secondary list, which was used again as bait in GeneMANIA. This process was repeated
until convergence, which was reached after three iterations (Fig. 3C-II).
Microarray design
We designed a custom microarray with Affymetrix to en masse interrogate the
presence/absence of unique exon/exon junctions in isoforms expressed in the RNA-Seq
data. After mapping the RNA-Seq reads from the three samples (E16-CE, P0-CE and
P0-NE) to the Ensembl 68 transcripts and running IsoEM to estimate the FPKM values
for each of the three samples, genes expressed in any of the three samples were
selected. Exon-exon junctions that are unique among expressed transcripts in genes that
have more than one expressed transcript were selected (Junctions with flanking
sequences of length ≤ 12 bases were eliminated). As a result, we included probes for
28,574 unique junctions from 11,923 transcripts on the custom Affymetrix microarray chip.
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Custom Affymetrix data analysis
Cytoplasmic RNA (1µg) was prepared from retinae harvested from E12, E16, E18
embryos and P0, P4, P10 and P25 and processed at Yale Center for Genome Analysis.
Expression levels of probe targets were computed from the raw intensity values using the
Robust Multichip Average (RMA) algorithm [287, 288], which was performed with the affy
R package [289]. Subsequently, the data were processed through Gene Expression
Similarity Investigation Suite (Genesis) (v1.7.6) for k-means clustering [290]. Here, we
ran 500 iterations to generate a total of 10 clusters that fell into three categories based
on expression kinetics. These trends were defined as embryonic, postnatal, and
embryonic + postnatal. The gene lists belonging to each cluster were separately analyzed
for functional enrichment using DAVID.
5.3 Extension of the pipeline to understand the effect of triple microRNA knockout
in mouse retinal development
5.3.1 Rationale
We devised a custom bioinformatics pipeline which we leveraged to extract
biological processes underpinning retinal development and extended the analysis to a
wildtype and knockout paradigm. Once we established, the workability of our pipeline, we
wanted to extend it to study the temporal progression of wildtype and knockout and use
the information to extract the pathway affected in the knockout during the course of the
aberrant development. Here, we used RNAseq data obtained from a normal and triple
microRNA (miR 183/96/182) knockout retinae (Courtesy: Dr. Lijin Dong, National Eye
institute) to identify molecular signatures that are changing in the knockout compared to
the wildtype developing retina. This data was leveraged to the expression of one of the
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key targets of the microRNA cluster named Mak. Quantitative PCR results from Dr. Dong
has shown that this gene is shown to be upregulated in the knockout compared to the
wildtype and this result was used to leverage the output of our pipeline.
5.3.2 Background
microRNAs are class of small non coding RNAs, which are about 22 nucleotides
in length. These evolutionarily conserved class of RNA play an important role in post
transcriptional regulation by binding to the 3’UTR of mRNA target via RNA interference
mechanism. Since their discovery in C. elegans, about 2000 microRNAs have been
identified and have been shown to play a key role in various cellular processes such as
cell proliferation, regeneration, hematopoiesis, neuronal differentiation etc. Also, they
are known to regulate cellular pathways as multiple microRNAs can target one mRNA
and one microRNA can have multiple mRNA targets. microRNAs have diverse temporal
and tissue-specific expression patterns across different species. Previous studies on
various microRNAs in primary cell culture have shown that they play a vital role in the
regulation of angiogenesis of choriocapillaries, oxidative damage prevention and proper
maintenance of cultured RPEs. They are also strongly linked to the ER stress,
implicating their role in various diseases such as AMD. Approximately 78 microRNAs
have been shown to be expressed only in the retina, implying the importance of
microRNAs in the regulation of gene expression in the retina [291, 292]. In Drosophila,
microRNAs have been suggested to play a role in photoreceptor differentiation, while in
murines, they have been linked to lens differentiation [292]. In mice, inactivation of
Dicer, which is required for microRNA maturation, has been shown to cause
progressive degeneration of retina [293].
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More than 30% of animal microRNAs are organized into clusters (miRBase),
which are group of microRNA precursors with an inter-microRNA distance of less than
10kb on the same genomic strand [294]. One of the highly conserved cluster of miRNAs
is miR-183/96/182, which is located on an intergenic region of human chromosome 7q.
In mouse, the sequences coding for these miRNA are located within 4 kb of each other
on chromosome 6qA3 and transcribed in the same orientation. They have been shown
to give very similar expression patterns in zebrafish whole-mount experiments [295].
miR-96/182/183 cluster play an important role in both development and disease and are
considered as a specific cluster for sensory organ development, particularly in retina
[296] and in hair cells of the inner ear [297]; their expression has also been documented
in several cancers including breast, ovarian, endometrial, bladder, prostate, lung,
hepatocellular and thyroid [298-300]. Inhibition of the miRNA cluster has been shown to
induce p53/apoptosis signaling pathway [301]. The temporal and spatial expression of
miR-96/-182/-183 cluster has been shown to correlate with functional maturation of the
inner ear [297]. Expression analysis of miR-96/182/183 across retinal development
have been shown to be minimal at embryonic time points with a steady increase
postnatally and reaching the peak in the adult retina [302]. Insitu hybridization of retina
has shown miR-183/96/182 cluster to be highly expressed in photoreceptors and
interneurons of the inner nuclear layer (INL) and was shown to be down-regulated
during dark adaptation and up-regulated in light-adapted retina [303]. In various disease
models including the three photoreceptor-linked mouse models of RP (Opsin/, 307 and
rds), a human retinitis pigmentosa model, expression of the miR-183/96/182 cluster was
shown to be dramatically decreased [303], suggesting a correlation between decreased
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expression and retinal disease. Inhibition of miR-83/96/182 cluster have also been
shown to cause severe retinal degeneration in sponge (for the cluster) transgenic mice
[296, 303]. Despite their implication in retinal degeneration, role of miR 96/182/183 in
normal retinal development is not well understood.
The vertebrate retina is a part of the central nervous system and contains six
neurons including, rod photoreceptors, cone photoreceptors, amacrine cells (AC),
bipolar cells (BP), horizontal cells (HC), and ganglion cells (GC) and one glial cell
namely Müller glia. The rod and cone photoreceptors are highly specialized neurons,
divided into morphologically and functionally distinct compartments: a synaptic terminal,
an outer segment, an inner segment, and a cilium connecting the outer and inner
segments [304]. Outer segments (OS) are formed initially from the primary cilia and
contain an axoneme, which begins at the basal bodies, and passes through a transition
zone also called the connecting cilia and into the outer segment. The miR182/96/183
cluster has been shown to play a vital role in the maintenance of cone photoreceptor
outer segments [296]. Global analysis of the cluster knockout has shown to enrich for
genes involved in synaptogenesis, synaptic transmission and phototransduction [296]
but the systematic analysis to find the primary, secondary and tertiary effects of the
cluster knockout in the retinal development has not been done.
5.3.3 Results and discussion
5.3.3.1 Transcriptomics summary of the static comparison
RNA sequencing (RNAseq) data from three developmental time points, including
postnatal (P) 5, P11, P27 wild type (WT) and triple microRNA knockout (KO) retinae were
analyzed. Static comparison was performed where the wild type and knockout at a given
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time point were compared to each other (Fig 5.7A). The binning data showed that 14,544
genes were expressed in P5WT and P5KO comparison, 14,598 genes were expressed
in P11WT –P11KO comparison and 13,778 genes were expressed in P27- P27KO
comparison (Fig 5.7B-D). In P5WT-KO comparison, of the expressed genes, 13,643
genes were non-differentially represented (Non_DR), while 12 genes were over
represented in P5KO (OR_P5KO) and 1 only one gene was over-represented in P5WT
(OR_P5WT) (Fig 5.7B). 319 and 569 genes were present in the P5WT_only and
P5KO_only bins, respectively. In P11WT-KO comparion, of the expressed genes, 13,643
genes were non-differentially represented (Non_DR), while 9 genes were over
represented in P11WT (OR_P11WT) and 1 only one gene was over-represented in
P11KO (OR_P11KO). 331 and 614 genes were present in the P11WT_only and
P11KO_only bins, respectively (Fig 5.7C). In P27WT-KO comparison, of the expressed
genes, 13,133 genes were non-differentially represented (Non_DR), while 3 genes were
over represented in P27KO (OR_P27KO) and 8 genes was over-represented in P27WT
(OR_P27WT). 277 and 357 genes were present in the P27WT_only and P27KO_only
bins, respectively (Fig 5.7D).
Alternative splicing status: When the alternative splicing (AS) status of each bin was
interrogated in P5WT-KO comparison, 59 % of genes in Non_DR bin employs AS, while
38% of genes in P5WT_Only bin and 47% of genes in P5KO_Only bin employ AS. Similar
trend is seen in other two static comparisons as well (Fig 5.7B). In P11WT-KO analysis,
59 % of genes in Non_DR bin employs AS, while 36% of genes in P11WT_Only bin and
42% of genes in P11KO_Only bin employ AS (Fig. 5.7C). In P27WT-KO analysis, 58 %
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of genes in Non_DR bin employs AS, while 35% of genes in P27WT_Only bin and 41%
of genes in P27KO_Only bin employ AS (Fig. 5.7D).
Thus, genes in Non_DR showed greater degree of AS, which is pattern that has
consistently been shown in the other analyses of retinal developmental time points as
well. It further emphasizes the importance of regulation of AS at the isoform level, when
the at the gene level, the expression is not changed very much.
5.3.3.2 Transcriptomics summary of the temporal comparison
Temporal comparison was performed where the developmental time points
were compared as the course of development progressed separately in WT and KO. In
this strategy, P0 wild type data, which was used to compare the P21 Nrl WT and KO data,
was used to compare with P5WT and P5KO to understand the changes that could have
manifested in the P5KO retina. Also, P5 was compared to P11 and P11 was then
compared to P27 (Fig 5.8A).
The binning data of P0WT – P5WT comparison showed that 15,055 genes were
expressed in P5WT and P5KO comparison (Fig 5.8B). Out of 15,055 genes, 10,814
genes were present in Non_DR bin, 307 genes in OR_P0WT bin, while 1081 and 2854
genes were present in P0WT_Only and P5WT_Only bins, respectively (Fig 5.8B). In
P0WT-P5KO comparison, the number of genes in Non_DR bin were 10,886 out of 15,118
genes that were expressed (Fig 5.8C). There were 316, 1000, and 2916 genes in
OR_P0WT, P0WT_Only and P5KO_Only bins, respectively (Fig 5.8C). There was a slight
increase in the number of expressed genes in the P0WT-P5KO comparison, which was
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reflected in P5KO_only bin and Non_DR bins. But, there was no gene over represented
in P5WT or KO compared to P0WT.
In P5WT-P11WT comparison, 14,546 genes were expressed, out of which 13,402
genes were present in Non_DR bin (Fig 5.8D). 7 and 10 genes were present in OR_P5WT
and OR_P11WT bins, while 571 and 556 genes were present in P5WT_only and
P11WT_only bins (Fig 5.8D). In the KO comparison between P5 and P11, 14,849 genes
were expressed, out of which 13,526 genes were present in Non_DR bin (Fig 5.8E). 6
and 4 genes were present in OR_P5KO and OR_P11KO bins, while 731 and 582 genes
were present in P5KO_only and P11KO_only bins (Fig 5.8E).
In P11WT-P27WT comparison, 14,586 genes were expressed, out of which
12,804 genes were present in Non_DR bin (Fig 5.8F). 9 and 6 genes were present in
OR_P11WT and OR_P27WT bins, while 1165 and 602 genes were present in
P11WT_only and P27WT_only bins (Fig 5.8F). In the KO comparison between P11 and
P27, 14,614 genes were expressed, out of which 13,144 genes were present in Non_DR
bin (Fig 5.8G). 8 and 2 genes were present in OR_P11KO and OR_P27KO bins, while
1113 and 347 genes were present in P11KO_only and P27KO_only bins (Fig 5.8G).
Alternative splicing status: When the alternative splicing (AS) status of each bin was
interrogated in P0WT-P5WT and P0WT-P5KO comparisons, genes in Non_DR bin
showed the highest degree of AS with 64% of genes with multiple isoforms (Fig 5.8B,C).
Similar pattern was observed in other comparisons where Non_DR bin had about 59% of
its genes with multiple isoforms and exhibited the higher degree of AS compared to other
bins (Fig 5.8D-G). Genes in the “Only” bins were predominantly ones with only one
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isoform, therefore no AS event. Overall about 51 – 80% of genes in only bins in all the
temporal comparisons had single isoforms (Fig 5.8D-G).
5.3.3.3 DAVID analysis of static and temporal comparison
Once the bins were obtained, next step was to analyze the functions enriched by
transcriptionally co-segregated genes present in each bin. DAVID analysis was
performed on each bin belonging to every pairwise comparison in static and temporal
analysis. Many unique GOterms emerged in the temporal analysis but not as many
enriched in the static analysis.
Static Comparison: In static analysis, in P5WT-KO comparison, only bin that enriched
for functions was P5KO_Only. There were 7 functional GOterm enrichments and all
functions

were

mostly

associated

with

the

synaptic

transmission

including

neurotransmitter receptor activity, ion channel activity, GABA receptor activity, and
synapse (Fig 5.9). It has been shown that in the tri microRNA knockout, beta waves by
electro retinogram were flat, suggesting that there could be deficits in the synaptic
transmission (unpublished data from Dr. Dong). In P11WT – KO analysis, there were two
enrichments for P11WT_only and P11KO_Only bins, which mainly enriched for musclerelated functions. There were a few functions relating to cellular maintenance including
translation and cellular matrix were enriched in P27WT-KO comparison (Fig 5.9).
Temporal comparison: DAVID analysis of temporal comparison yielded many more
functional enrichments compared to static comparison. Interestingly, P5KO_Only bin in
P0-P5KO comparison yielded muscle related functions and synapse related functions,
suggesting that these molecular programs could be affected much as early as P5 (Fig
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5.9). By leveraging the data to P0WT, the aberrance in the normal development was
extracted.
P5WT-P11 WT comparison had many interesting functional enrichments. Mainly, genes
belonging to P5WT_only bin enriched for ‘cell fate commitment’, which is the case in the
developing mouse retina round P5, when many cells including amacrine cells, cone cells,
bipolar cells begin to differentiate. Genes in both P11WT_Only and P11KO_only bins,
enriched for ‘GABA receptor activity’ function and interestingly, there were different
number of genes underlying them. This function was seen in at P5 in static analysis, while
in temporal analysis, it appears much later. In the comparison of P11WT-P27WT, there
were a few functional enrichments relating to immune system by genes in P11WT_Only,
which could be due to the development of glial cells and DAVID analysis could have
related glial-associated genes with immune response (Fig 5.9).
5.3.3.4 Covariance and coefficient correlation analysis results
Covariance and correlation coefficient is used to describe linear relationships
between two variables, in this case two developmental time points. Correlation and
covariance describe how one time point behaves with respect to another. Therefore,
when a developmental time point is compared to itself, it has the highest correlation, which
is given as 1. This correlation could be positive or negative or neutral. Closer a time point
in the gene expression changes to that of another time point, stronger the correlation is
and would be closer to 1. When the genes behave in a totally opposite manner between
two points, the correlation becomes negative. Usually, the value of sample correlation
coefficient, r, ranges from 0 – 0.2, it is considered a very weak or negligible correlation,
while 0.2 – 0.4 is considered weak, 0.4 – 0.7 is considered moderate, 0.7-0.9 is strong
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and 0.9 -1 is very strong correlation. This correlation gives a sense of how a
developmental time point behaves, in terms of overall gene pattern changes in every bin
or by a particular function. Here, we used genes enriching for the function ‘GABA receptor
activity’ in P11WT_Only bin to see how this time point behaves in relation to other time
points both in the WT and in KO (Fig 5.10).
The covariance results showed that when a time point is compared itself, the
covariance was 1. When P0WT was compared all other time points including P5WT &
KO, P11WT & KO, P27WT &KO, r value was in the range of 0.2 – 0.5, where it was least
correlated with P27 (r = 0.2) and most correlated with P5 (r = 0.59) (Fig 5.10). Next, when
P5 was compared in a similar manner, it had highest correlation to the KO counterpart (r
= 0.96), closely followed by P11 (r=0.9), then followed by P27 (r = 0.7) and strangely least
correlated with P0 (r = 0.59) (Fig 5.10). This trend explains the course of development,
where a given time point is closer to the next developmental time point compared to the
previous time point. P5KO followed a similar pattern in that it was the closest to P5WT
(Fig 5.10). P11WT was almost equally closely related to both P5 and P11 WT and KO at
about 0.87 – 0.9 r vale. The interesting observation was in P11KO, where it showed a
higher correlation with P27WT (r = 0.97) compared to its own WT counterpart (r = 0.92)
(Fig 5.10). This suggests that P11KO might have the gene expression patterns similar to
that in P27WT, thereby indicating a developmental shift in the KO, where the patterns
observed by P27 in normal development might happen sooner around P11 in the KO (Fig
5.10). However, this result has to be vetted through more covariance analyses for other
functional enrichments to see if this pattern truly emerges.
5.3.4 Future directions
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Currently, I am employing this strategy to find the correlation of genes enriching
for various functions in each bin to check if the pattern of P11KO and P27WT correlation
is consistent, which if the case, can help in the understanding of retinal development in
the absence of this triple microRNA cluster as a whole and might suggest re-wiring of the
networks in the P11KO to mimic the gene regulatory networks at P27 in the wild type
retina.
5.3.5 Materials and methods
Binning strategy
Binning strategy employed in this analysis is same as that described in section 5.2.5
under ‘Binning strategy’.
Functional annotation analysis
DAVID analysis to extract functional enrichments was done in the same way as described
in section 5.2.5 under ‘Functional annotation analysis’.
Covariance and correlation coefficient analysis
Covariance and correlation coefficiency is a function of Microsoft excel, which helps in
determining the correlation between two variables. The sample correlation coefficient (r)
gives the strength of correlation.
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Figures:
Figure 5.1

Fig 5.1 Binning strategy for RNA-Seq data: Binning protocol shown here is for two
theoretical samples, A and B. Schematic on the top shows the different steps in the
binning protocol and the outcomes are shown as bar graphs underneath (purple boxes).
In the bar graph FPKM units are shown on the y-axis and the gene is represented as a
bar in green (sample A) and orange (sample B). Colored lines within the bar represent
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the constituent isoforms (Yellow boxes). The dashed line represents the threshold (1
FPKM) of gene expression.
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Figure 5.2

Fig 5.2 Validation of high-resolution transcriptome by RNA-Seq A-D. Expression of
genes with established expression kinetics including (A) Fgf15, Sfrp2, Atoh7, Irx4, (B)
Fabp7, Gngt2, Nr2e3, Nrl, Rho, Pax6, (C) Malat1, Xist, Tsix, Neat1, (D) Hist2h2bb,
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Hist2h2aa2, Hist1h4k and Hist1h4f shown as bar graph with FPKM in y-axis (log scale
for A-C) between E16CE (blue), P0CE (red), and P0NE (black). E - J. Combined
E16CE-P0CE and P0CE-P0NE high-resolution transcription kinetics, E16CE_Only (E),
OR_E16CE (F), Non_DR (G), OR_P0CE (H), P0CE_Only (I) and No_Ex (J).
OR_E16CE - Over represented in E16CE; OR_P0CE – Over represented in P0CE;
Non_DR – Non-differentially represented.
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Figure 5.3

Fig 5.3 Custom bioinformatics pipeline revealed transition in biological
processes: A. E16CE-P0CE comparison is shown with its bins as boxes that were
used to extract gene list for DAVID analysis and the GOterms for functions enriched by
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these lists were curated (Detailed list of GOterms in Additional file 2: Table S1.1, S1.2).
This process is represented by the roman number I. B. An example to show the output
of Part I, where OR_P0CE bin was chosen from E16CE-P0CE comparison. The genes
that enriched for a function in each bin in A were then subjected to pipeline shown in C
(II), which starts with gene list entry to GeneMANIA followed by (arrow going up)
identification of new partners. (Right) Output of the pipeline in C (II), where the primary
gene list (17 genes) that enriched for “Visual Perception” function is shown in the first
column. The three iterations of the pipeline in part II are denoted as 1X, 2X and 3X. D
(III). Genes in the final list were assigned to their bins in E16CE-P0CE and P0CE-P0NE
comparisons. E. Output for D (III) with rows showing distribution of genes in bins from
E16CE–P0CE comparison and the columns reflecting genes in bins from P0CE-P0NE
comparison.
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Figure 5.4

Fig 5.4 Custom microarray revealed isoform/gene expression coherence and
validated RNA-Seq. A -C. Shown here is a centroid view of K-means clusters of
isoform-specific probes across retinal development (Clusters given in Additional file 4:

161

Table S3). The y-axis shows arbitrary units (-3 to 3) of expression and the
developmental time is shown on top and bottom. D – F. Selected GOterms enriched by
DAVID analysis for genes in clusters A-C.
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Figure 5.5

Fig 5.5 Temporal comparison of P21-Nrl-WT and P21-Nrl-KO to P0
Shown is an example of common and unique GOterms identified in the P21_only bin in
both P0 vs. P21-Nrl-WT (P21WT_Only) and P0 vs. P21-Nrl-KO (P21KO_Only)
comparisons and the genes underlying them. Left common function (visual perception);
Right Unique to P0 vs. P21-Nrl-KO (regulation of blood pressure) (Detailed list of
GOterms in Additional file 2: Table S1.3, S1.4).
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Figure 5.6

Fig 5.6 RNA-Seq revealed progression of biological programs across normal and
aberrant retinal development. A. Schematized representation of kinetics of the
molecular programs identified by RNA-Seq (E16CE-P0CE- P0NE) is represented with
different colors and the shapes represent the gene expression kinetics. B. Extension of
our temporal analysis strategy to P21-Nrl-WT and P21-Nrl-KO by comparing them to P0
(P0CE +P0NE) revealed molecular programs in normal development (P21-Nrl-WT) and
unique programs in aberrant development (P21-Nrl-KO). C. Schematic representation of
a cell at P0, where the cytoplasm and the nucleus are temporally synchronized and the
cell with dotted line shows that the nuclear transcriptome is shifted forward temporally
compared to that of the cytoplasm
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Figure 5.7
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Fig 5.7. Transcriptomics summary of static comparison: A. Strategy employed in
the static comparison where wild type and knock out are compared. B – D.
Transcriptome summary of the comparison between P5WT-P5KO (B), P11WT-P11KO
(C), P27WT-P27KO (D). The white box represents all genes examined for this study.
The venn diagram within it represents the different bins. Alternative splicing status of
each bin is shown as a pie chart.
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Figure 5.8
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Fig 5.8. Transcriptomics summary of temporal comparison: A. Strategy employed
in the temporal comparison where developmental time points are compared to each
other as the development progresses. B – G. Transcriptome summary of the
comparison between P0WT-P5WT (B), P0WT-P5KO (C), P5WT-P11WT (D), P5KOP11KO (E), P11WT-P27WT (F) and P11KO-P27KO (G). The white box represents all
genes examined for this study. The venn diagram within it represents the different bins.
Alternative splicing status of each bin is shown as a pie chart.
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Figure 5.9

Fig 5.9. DAVID analysis output of Static and Temporal comparisons. Table shows
the two comparisons – Static and temporal comparisons with the pairwise comparisons
and Goterm functional enrichments of genes belonging to their respective bins.
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Figure 5.10

Fig 5.10 Covariance analysis of genes enriching for GABA A receptor activity.
Covariance and correlation analysis of genes enriching for ‘GABA A receptor activity’
across different time points both in the wild type and miR182/96/183 knock out retinae.
Cells in ‘red’ indicate the highest correlation between those time points. While cells in
‘blue’ indicate weaker correlation.
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Chapter 6: Conclusion and Future Directions
In Chapter 3, it was shown that Sfrs10 was expressed in differentiating retinal
neurons and are maintained in the adult retina. Its expression implies the usage of RNA
processing including AS by retinal neurons during terminal differentiation. The extent to
which AS is employed during neuronal differentiation and function is not well understood
and our data on the expression of Sfrs10 suggests that it might play a crucial role. Indeed,
neuronal specific-knockout of Sfrs10 has shown perinatal lethality due to massive
apoptosis in ventricular regions in the cortex. Thus, a retina specific-knockout of Sfrs10
will be a valuable tool in helping us understand the role of Sfrs10 and its downstream
targets in the developing retina. Additionally, using the inducible cre, Sfrs10 can be
ablated at various stages of development to check if Sfrs10 is required for the
maintenance of retinal neurons post-differentiation. The expression of Sfrs10 specifically
in the red/green cone photoreceptors during the postnatal retinal development suggested
Sfrs10-regulated alternative splicing in that subset of cone photoreceptors. Currently
there are no clear nuclear markers for red/green cone photoreceptors. Thus, Sfrs10 can
serve as a valuable marker for these cone cells.
The upregulation of SFRS10 in AMD retinae suggests that it might be required for
AS of a subset of genes involved in hypoxic stress response. For instance, a gene might
normally be expressed but under stress conditions, it might undergo AS shift and the
isoform responding to stress is regulated by SFRS10. It could be that there is an
increased demand for the isoform regulated by Sfrs10 under hypoxic stress. By identifying
the targets of Sfrs10 in the AMD could pave way for the therapeutic intervention of the
disease progression. It was shown that Sfrs10, indeed, plays an anti-apoptotic role by
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regulating the alternative splicing of Bcl2 in colon cancer. It was also shown that Sfrs10
competes with miR-204 to bind to Bcl2. Thus, the same pathway could be activated under
hypoxic stress to exhibit a protective role. A mouse model for retinal degeneration such
as rd1 (where rod photoreceptors die as early as P13) could be employed to check if, by
knocking down miR-204 or by over expressing Sfrs10, rod photoreceptors survive longer
in this disease model.
In Chapter 4, it was shown that Citron kinase was expressed in a specific subset
of retinal progenitor cells and its expression diminishes postnatally. Loss of CitK shows
the absence of Islet1 specific subset of bipolar cells. This suggests that CitK might be
present in those progenitor cells that would eventually give rise to Islet1+ bipolar cells
postnatally. This observation corroborates the ‘competence’ model where it was shown
that a retinal progenitor cell, once determined to become a bipolar cell, cannot make
embryonically born neurons even when placed in the embryonic environment. By
employing conditional knockout mice for Citron Kinase crossed with inducible Chx10-cre
mice, we can study the role of Citron kinase in the bipolar cells postnatally and if Citron
N has a role to play in the terminal differentiation of these cells. Another question that still
remains unanswered is the other factor that compensates for the loss of CitK in the
knockout till E14 after which the massive apoptosis of retinal progenitor cells begin. Since
there are other members of the ROCK/ROK family present, it would be interesting to
knockdown each one at a time, to see if these are playing the role of the compensatory
factor for CitK loss. Further, the role of Citron N has not been studied in the retina and if
we could specifically knockdown the kinase domain of CitK, the role of Citron N could be
investigated.
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Two novel isoforms of CitK were identified, where one lacked the exon 9 while
another had intron 13 retention. The former isoform would result in a protein, which lacks
the kinase domain and the latter would have an altered SMC domain, suggesting its
influence on the nuclear activity of CitK, which has been reported in Drosophila. Thus,
investigating the role of these isoforms separately can provide more information on
diverse roles of CitK in retinal progenitor cells. For this, isoform specific short hairpin RNA
(shRNA)s have been engineered. Using RNA interference technique, these shRNAs will
be introduced into the dividing progenitor cells using P0 invivo retinal electroporation.
Post- electroporation, retinae can be harvested at various time points and
immunohistochemistry analysis on these tissue will be performed. This will allow us to
identify the isoform-specific aspects of the phenotype and could possibly highlight both
the nuclear and cytoplasmic role of Citron Kinase, attributing each role to a specific
isoform.
In Chapter 5, global analyses of transcriptome changes and how alternative
splicing informs retinal development was discussed. It was shown that genes, which did
not change in their transcriptional levels, had the highest level of alternative splicing at
the isoform level. RNAseq data obtained from fractionated retinae revealed that the
nuclear transcriptome was temporally ahead of cytoplasmic transcriptome, in that nucleus
was preparing for the next molecular event while executing the current program. A
customized bioinformatics pipeline was devised to extract the biological meaning from
large datasets. This strategy was also compared to other methodologies routinely
employed by other biologists. The application of this pipeline is diverse, in that, it could
be used to investigate transition in molecular programs across tissue types and cell
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states, including investigations of disease progression. This pipeline was also employed
to understand the progression of uterine cancer, where RNAseq data from tumor samples
from five different regions as well as from different stages of cancer. The goal here is to
identify the chronology in which each of the tumor developed and whether or not the
tumors developed at later stages were formed de novo or from metastasized cells. By
identifying tumor-specific molecular signatures and finding the underpinning biological
programs, the relationship between each tumor with respect to that biological function
begin to emerge, thereby allowing us to determine the similarities and differences
between the tumors.
Another analysis that employed this pipeline was investigating the role of a
microRNA cluster knockout in the retinal development. Since the cluster, miR 182-92183, is known to play a role in photoreceptor and bipolar cell maintenance, one would
predict that the absence would lead to pathways involved in photoreceptor
function/maintenance going aberrant. To test whether or not, we can identify these
molecular signatures early in the development, RNAseq data from various stages of
retinal development is obtained from the knockout and wildtype counterpart. Additionally,
downstream targets of this miRNA cluster is known, which would help us to leverage the
changes we observe in the bins obtained through our analysis. Currently, this work is in
progress, where we employed the automated upstream and downstream bioinformatics
pipeline to extract all the pathways enriched by each bin in a pairwise comparison along
with the whole gamut of genes involved in each of the pathway. We are also employing
the nodal analysis where, for example, P5WT is compared to P11KO RNAseq data and
this comparison along with P5WT-P11WT comparison. The rationale here is that by
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comparing these two pairwise comparisons, we can detect the divergence in the normal
pathway as it precipitates. This way, primary, secondary and tertiary effects of the miRNA
cluster KO can be established.
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Appendix 1:
1. Steps to run the bioinformatics pipeline
Analyses from RNAseq data involve mapping the reads obtained from sequencing onto
the reference genome or transcript libraries or exon-exon junction libraries or
combinations of these. The gene expression level is then estimated from unique reads.
Biological meaning can be extracted by comparing the expression levels of genes
between samples.
The pipeline that was employed by us to extract biological information from big data
(RNAseq) used a customized bioinformatics pipeline which organized information into
separate bins. The genes in these bins were grouped based on their transcriptional
kinetics across two samples. Then genes belonging to each bin were analyzed using
DAVID to understand the functions enriched by them. Additionally, other potential
partners to these genes involved in a pathway were also identified using another tool
called GeneMANIA.
Following sections describe step-wise procedure to execute the bioinformatics pipeline
mentioned above. It begins with accessing the remote server to execute the scripts. This
is followed by the main scripts employed in our pipeline and the tools employed in those
scripts such as Bowtie for read mapping, IsoEM for estimating the isoform frequency of
genes from mapped reads, and GFOLD and Fisher’s exact test for making differential
expression calls.
1.1. Server Access
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To access the remote server, accounts have to be created by Dr. Ion Mandoiu of
Computer Science and Engineering department. Once they are created, the user has to
download two software namely, WinSCP and PuTTY. While WinSCP is the client server
that saves all the directories, scripts and the output of the script execution, PuTTY is the
user interface. The platform used is Linux; hence the commands are given in Linux
language. Once these two softwares are downloaded, the user can logon to WinSCP
using their username and the password provided by Dr. Mandoiu. Once logged in, the
user can change his/her password by giving the command “passwd”.
Default server given is cnv1 and so the host is cnv1.engr.uconn.edu. The default port is
22. After the password change, the user could see their home directory as the default
start screen in WinSCP. All directories, fastq files and scripts for running the pipeline are
stored in “data1” directory in the “root” directory. When the user wants to switch to that
directory, command line “cd” followed by the path to that directory should be given. To
login in PuTTY, the user should use the same password (Note: no characters will appear
when the user types his/her password. Once they hit enter, cnv1% will appear. The screen
in PuTTY will always have the header, “cnv1%”. If that shows up, the user can continue
typing their command line. For example, to change the directory to data1 from home
directory, the user can type
Cnv1%

cd /data1

If the user wants to create directory under their name in data1, the command line is,
Cnv1% mkdir Krishna

This will create a directory named “Krishna” under data1 directory.
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Likewise, new directories can be created. The user has to be careful in knowing where
they currently are as creating directories elsewhere could be confusing later. To make
sure they are in the correct location, the user can type the command “pwd”. This will show
the current location. Then they can change directory using “cd” followed by the path of
the location they want the new directory created.
1.2. Common command lines
Some of the commonly used command lines are as follows:
1. To check the current location of the user: pwd
2. To create new directory: mkdir <a name>
3. To copy the contents of a directory: cp –recursive <pathname> <destination path
name>
4. To create short links (short cuts for directories): ln –s <path name>
shortcutname.same extension as the original file.
5. To unzip or zip files: gunzip or gzip followed by the path name.
6. To check if the script is running: ps x
7. To abort a running script: kill followed by the ID (it will show up when the user uses
ps x command).
8. To find a particular character in the output: grep followed by that character (it could
be a gene name or word)
9. To save the log file for a script: /pathname of the script >& output name.log & (This
enables the script to run even when the user terminates the session in WinSCP).
10. To concatenate two data: cat filename1.extension filename2.same extension >
newname.same extension.
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1.3. Building index files:
For comparing the RNAseq data, a reference file or an index file must be first built. It has
to be done for each species. In case of mouse, separate index files were built for C57/BL6
and CD1 strain of mice. CD1 reference was used in the E16CE, P0CE, P0NE comparison,
while the former was used in the Nrl wildtype (WT) and knockout (KO) and microRNA WT
and KO RNAseq data analysis. To build the index file, one needs two reference files. First
one is the FASTA file, which contains the genome information for the species under
investigation. It can be obtained from UCSC genome browser (https://genome.ucsc.edu/).
For mouse, version Mus musculus 10 (mm10) was used. This reference genome is that
of the C57/BL6 strain. The second file that is required is the gene transfer file (GTF),
which contains information about gene structure such as gene name, start and end
positions,

frame,

and

strand.

This file

is

obtained from

Ensembl

browser

(www.ensembl.org), where the mouse file (version 68) was used to generate the index
file. The downloaded file contains the isoform IDs, but not the gene IDs, which are needed
for generating the index file.
Script used:
#!/bin/tcsh
set
set
set
set

genome=/import1/UCSC/mm10/mm10.fa;
GTF=/import1/GTF/mm10Ensembl68wGeneNames.gtf;
isoSequences=/import1/bowtie_index/mm10/mm10Ens68_polyA200_randOrder.fa;
Ens_index=/import1/bowtie_index/mm10/mm10Ens68_polyA200_randOrder.fa;

The highlighted fields in “green” are species-specific. Here shown is that of mouse.
These fields have to be changed when working with different species.
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Prior to executing the above mentioned script, the “CreateGTFWithGeneIDs” script
must be executed, which queries the Ensembl transcript IDs to a clusterFile containing
both transcript and gene IDs, generating a new GTF file that contains the gene IDs. When
executing this script, the file names of the downloaded GTF, the clusterFile with geneIDs
and transcriptIDs, and the output GTF must be provided as inputs one, two, and three,
respectively. The output files will be created at the location of the user when they enter
the command to execute the script. Therefore, the user should enter the intended
destination directory before executing the script. This is done by entering the change
directory command, cd, followed by the destination path/directory. Following is the
‘createGTFWithGeneIDs’ script:
GTF=$1
clusterFile=$2
outputGTF=$3
rm -f tmp.GTF sortedClusterFile.txt tmp.txt
awk '{print substr($12,2,length($12)-3), $0}' $GTF | sort -k 1,1 > tmp.GTF
sort -k 1,1 $clusterFile > sortedClusterFile.txt
join sortedClusterFile.txt tmp.GTF > tmp.txt
awk '{print $3 "\t" $4 "\t" $5 "\t" $6 "\t" $7 "\t" $8 "\t" $9 "\t" $10 "\t" $11,
"\42" $2 "\42;", $13, $14}' tmp.txt > $outputGTF

CD1 reference genome:
Single nucleotide variations due to the strain difference between C57/BL6 and CD1 are
first accounted for and reads are mapped to the newly created reference genome.
1.4. Input files:
The input files for the analysis are the FASTQ files. They are unmapped raw reads
obtained from the RNAseq run. Nowadays, reads are obtained as paired-end reads (~
120 bp per end). Therefore, each sample contains two FASTQ files for each end. The
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user then sometimes unzips the files followed by creating a short link for these files in
their directory in the root directory.
1.5: Read mapping: Bowtie
Reads are mapped using the read aligner, Bowtie, which efficiently aligns short reads
(~35bp). Burrows-Wheeler index is used by Bowtie to index the genome. The output is
usually obtained in the sequence alignment/map (SAM) format. Bowtie forms the basis
for other algorithms such as TopHat, Cufflinks, Crossbow and Myrna. Input for Bowtie
include an index file and fastq files (raw reads). These fastq files can be single or pairedend reads.
The alignments that are reported by Bowtie are randomized to avoid “mapping bias”,
which is defined as the spurious holes that cause the aligner not to report a particular
class of good alignments. These alignments cannot have more than “N” mismatches,
where N= 0 – 3 in the first “L” bases, where L ≥ 5. The first L bases are called the “seed”.
Also, the sum of the Phred quality values may not exceed “E” (default is 40).
Required Inputs: (Bowtie, IsoEM command lines along with these inputs are a part of
Run-analysis.sh script)
set genome=/import1/genome/mm10/mm10.fa;
set knownGeneGTF=/import1/GTF/mm10Ensembl68wGeneNames.gtf;
set index=/import1/bowtie_index/mm10/mm10Ens68_polyA200_randOrder.fa;
set isoSamFile=mm10_Ens68_coordinates;
set genomeSamFile=mm10_Ens68_in_genome_coordinates;
#set geneClusters=/import1/GTF/mm10Ens68_TransID_GeneName.txt;
set isoEM_Dir=/home/sahar/isoem-clip-polyA/bin;
set fastqDir=/data1/krishna/nrlko/data

Bowtie command:
bowtie --chunkmbs 512 -k 20 -l 30 -n 3 -p 16 -e 250 --sam --sam-nohead \
$index ${fastqDir}/${condition}-${replicate}.fastq \
${condition}-${replicate}-$isoSamFile.sam
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1.6: IsoEM
Isoform expectation-maximization (IsoEM) algorithm is employed to infer the frequency
of isoform occurrence for a gene from the mapped reads. The algorithm uses information
on the standard deviation, distribution of insert sizes, which are generated during the
sequencing library preparation. It uses base quality scores, strand and read pairing
information. IsoEM maps the reads to the known isoforms using output from Bowtie by
converting read alignments to genome coordinates. This in turn is combined to obtain
isoforms for each read, which then use “line sweep” technique to detect the compatibility
between reads and isoforms, during which reads are grouped based on their isoform
compatibility. Next, when reads match multiple isoforms, IsoEM simultaneously estimates
the frequencies as well as iteratively performs the following two steps until they converge:


E-step: Expected number of reads, n (j) is computed from isoform (j) based on
computed weight (w) assuming that the frequency of the isoform, f (j) is correct.



M-step: For each isoform, f (j) is set and read coverage is normalized based on the
E-step.

Script used:
set option="--directional";
set average=320;
set std=60;
isoem -a --directional -G $knownGeneGTF P0-all-sort.sam -polyA 200
mv ${condition}-${replicate}-$genomeSamFile.iso_estimates ${condition}${replicate}.iso_estimates
mv ${condition}${replicate}-$genomeSamFile.gene_estimates ${condition}${replicate}.gene_estimates

1.7: Making the differential expression (DE) calls:
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Once the reads are mapped and the isoform frequency is estimated in Fragment
Per Kilobase per Million mapped reads (FPKM) units, the threshold for gene expression
is set. In case of retina, based on the known expression kinetics of genes, the threshold
was set to 1. Therefore, when a gene (whose FPKM is calculated based on the sum of
its constituent isoforms) is considered expressed (FPKM ≥ 1), differential expression (DE)
calls had to be made. To make DE calls, two independent algorithms were employed
namely, GFOLD and Fisher’s exact test. The overall script that is executed is “analysispipeline script” which is as follows:
#!/bin/sh
sample1=$1
sample2=$2
#1
../bin/run-all-methods $sample1 $sample2
#2
../bin/getGFOLDIsoDEIntersection ${sample1}_${sample2} # no second parameter
for isoform
../bin/getGFOLDIsoDEIntersection ${sample1}_${sample2} gene
##3
../bin/ExpressedNotExpressedAnalysis ${sample1}_${sample2}
#
##4, 5, 6, and 7
../bin/DivideOnlyGroupsToOneAndMultipleIsoforms ${sample1}_${sample2}
../bin/GetDIEGenes ${sample1}_${sample2}
../bin/MergeFiles ${sample1} ${sample2} ${sample1}_${sample2}
## 7
../bin/LabelGeneSubgroupsInAllPartitionsFiles ${sample1}_${sample2}
#8
../bin/GetStats
#clean up
#rm -f *List
#rm -f *.tmp

This script encompasses the following eight scripts:
i.

Run-all-methods

#!/bin/bash
geneGTF=/import1/GTF/mm10Ensembl68wGeneNames.gtf
isoDE=/home/sahar/code/FishersTest/isode
isoGTF=/import1/GTF/mm10Ensembl68.gtf
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sample1=$1
sample2=$2
echo "in run-all-methods"
echo $sample1
echo $sample2
# The number of mapped reads in million is taken from the bowtie log.
Eventaully needs to be computed from the sam file for automation
#get the number of aligned reads
count1=`awk '{if ($3 != "*") print $1}' ${sample1}mm10_Ens68_in_genome_coordinates.sam | sort --parallel 6 | uniq | wc -l`
count1InMillion=$(( count1/1000000 ))
count2=`awk '{if ($3 != "*") print $1}' ${sample2}mm10_Ens68_in_genome_coordinates.sam | sort --parallel 6 | uniq | wc -l`
count2InMillion=$(( count2/1000000 ))
../bin/runFisher $sample1 $sample2 $count1InMillion $count2InMillion
../bin/runGFOLD ${sample1}-mm10_Ens68_in_genome_coordinates ${sample2}mm10_Ens68_in_genome_coordinates $geneGTF gfold.geneout
../bin/runGFOLD ${sample1}-mm10_Ens68_in_genome_coordinates ${sample2}mm10_Ens68_in_genome_coordinates $isoGTF gfold.out
echo "end run-all-methods"

This in turn contains two other scripts including (1) runGFOLD and (2) runFisher
GFOLD:
Generalized fold change algorithm is based on the Bayesian posterior probability
distribution, which is used to estimate the relative difference in the gene expression. It is
also employed for the isoform level analysis of differential expression. This method is
preferred over methods that give raw fold change for estimating the differential expression
of gene in terms of p-value.
Script used: runGFOLD
#!/bin/sh
sample1=$1
sample2=$2
GTF=$3
output=$4
echo "runGfold"
gfold count -ann $GTF -tag ${sample1}.sam -o ${sample1}.${output}.read_cnt
gfold count -ann $GTF -tag ${sample2}.sam -o ${sample2}.${output}.read_cnt
gfold diff -sc 0.01 -s1 ${sample1}.${output} -s2 ${sample2}.${output} -suf
.read_cnt -o $output
echo "end runGfold"
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If the fold change needs to be changed, “format GFOLD” script has the parameter that
needs to be changed.
formatGFOLDfiles script:
#!/bin/bash
gfoldFile=$1
FCThreshold=$2
rm -f ${gfoldFile}.${FCThreshold}.isoDEFormat
awk -v FCt=$FCThreshold '{FC=2^$4; if (FC < 1 && FC > 0) FC=(1/FC); if
($5>$6) Dir=1; else Dir=2; if (FC >= FCt && $2!=0) diff="DE"; else
diff="nonDE"; if ($1 != "#") print $1, $5, $6, $2, Dir, FC, diff}' $gfoldFile
> ${gfoldFile}.${FCThreshold}.isoDEFormat

The field in “red” needs to be changed to “2” for the script to consider the input fold change
along with the change mentioned in the ‘getGFOLDsioDEintersection’ file.
Fisher’s exact test:
Fisher’s exact test is another algorithm used in the estimation of differential expression of
genes between tow samples. This algorithm calculates the probability score (P-value) and
it gives an exact measure of the deviation from the null hypothesis compared to G-test or
Chi-square test, when the sample size is small.
Script used: runFisher
#!/bin/sh
Fisher=/home/sahar/code/FishersTest/isode
echo "in runIsoDE"
sample1=$1
sample2=$2
NumberOfMappeReadsinMillion1=$3
NumberOfMappeReadsinMillion2=$4
pair=${sample1}_${sample2}
echo $pair
rm -f ${pair}*.iso_estimates
rm -f ${pair}*.gene_estimates
rm -f ${pair}.DE
rm -f ${pair}_wgeneName.DE
rm -f ${pair}.geneDE
key-merge ${sample1}.iso_estimates ${sample2}.iso_estimates
${pair}.iso_estimates
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>

awk '{if ($2 < 1) fpkm1 = 0; else fpkm1 = $2; if ($3 < 1) fpkm2 = 0; else
fpkm2 = $3; if (fpkm1 != 0 && fpkm2 != 0) print $1 "\t" fpkm1 "\t" fpkm2}'
${pair}.iso_estimates > ${pair}Tab.iso_estimates
key-merge ${sample1}.gene_estimates ${sample2}.gene_estimates >
${pair}.gene_estimates
awk '{if ($2 < 1) fpkm1 = 0; else fpkm1 = $2; if ($3 < 1) fpkm2 = 0; else
fpkm2 = $3; if (fpkm1 != 0 && fpkm2 != 0) print $1 "\t" fpkm1 "\t" fpkm2}'
${pair}.gene_estimates > ${pair}Tab.gene_estimates
$Fisher ${pair}Tab.iso_estimates $NumberOfMappeReadsinMillion1
$NumberOfMappeReadsinMillion2 2 0.01 housekeeping ENSMUST00000147954 >
${pair}.DE
$Fisher ${pair}Tab.gene_estimates $NumberOfMappeReadsinMillion1
$NumberOfMappeReadsinMillion2 2 0.01 housekeeping Gapdh > ${pair}.geneDE
#
$Fisher ${pair}Tab.iso_estimates $NumberOfMappeReadsinMillion1
$NumberOfMappeReadsinMillion2 2 0.01 total > ${pair}.DE
#
$Fisher ${pair}Tab.gene_estimates $NumberOfMappeReadsinMillion1
$NumberOfMappeReadsinMillion2 2 0.01 total > ${pair}.geneDE
echo "end run IsoDE"

The number in “red” is the specified fold change. This number can be changed based
on the fold change for each set of data. This change has to accompany the fold change
in formatGFOLD script for the change to take effect. The field highlighted in “green” is
the transcript ID of mouse Gapdh gene. When different species data is analyzed, this
field should be changed to the species-specific Gapdh isoform that is expressed in the
data.

ii.

getGFOLDisoDEintersection

This is the intersection of GFOLD and Fisher test results to select for genes with p-value
0.01 and fold change ≥ 2.
#!/bin/sh
pair=$1
subset=$2 # gene if for gene DE and nothing (do not supply parameter) if
isoform DE
echo "In getGFOLDIsoDEIntersection"
echo $pair $subset
../bin/formatGFoldFiles gfold.${subset}out 1 # 1 will not eliminate
DE calls based on fold change of GFOLD; it will be done on the intersection
with isoDE; so it would be based on isoem FPKMs
rm -f ${pair}.${subset}DE.IdFpkm1Fpkm2DirDE
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awk '{print $1, $2, $3, $5, $7}' ${pair}.${subset}DE >
${pair}.${subset}DE.IdFpkm1Fpkm2DirDE
rm -f gfold.${subset}out.IDDirDE
awk '{print $1, $5, $7}' gfold.${subset}out.1.isoDEFormat >
gfold.${subset}out.IDDirDE
rm -f keymerge.tmp
key-merge ${pair}.${subset}DE.IdFpkm1Fpkm2DirDE
gfold.${subset}out.IDDirDE > keymerge.tmp
rm -f ${pair}.${subset}DE.IdFpkm1Fpkm2DirDEGFoldDirDE
awk '{if (NF == 7) print $0}' keymerge.tmp >
${pair}.${subset}DE.IdFpkm1Fpkm2DirDEGFoldDirDE # eliminate lines with no
IsoED output; isoDE with run only on genes expressed on both samples (FPKM >
0.1)
rm -f ${pair}.${subset}IsoDEGFOLDOverExpIn1List
awk '{if ($4 == $6 && $5 == "DE" && $7 == "DE" && $2 > $3) print $1,
$2, $3, "1", ($2/$3), "DE"}' ${pair}.${subset}DE.IdFpkm1Fpkm2DirDEGFoldDirDE
> ${pair}.${subset}IsoDEGFOLDOverExpIn1List
rm -f ${pair}.${subset}IsoDEGFOLDOverExpIn2List
awk '{if ($4 == $6 && $5 == "DE" && $7 == "DE" && $3 > $2) print $1,
$2, $3, "2", ($3/$2), "DE"}' ${pair}.${subset}DE.IdFpkm1Fpkm2DirDEGFoldDirDE
> ${pair}.${subset}IsoDEGFOLDOverExpIn2List
rm -f ${pair}.${subset}IsoDEGFOLDNonDEList
awk '{if ($4 != $6 || $5 != "DE" || $7 != "DE") print $1, $2, $3,
"nonDE"}' ${pair}.${subset}DE.IdFpkm1Fpkm2DirDEGFoldDirDE >
${pair}.${subset}IsoDEGFOLDNonDEList
if [ "$subset" != "gene" ]
then
rm -f ${pair}_wgeneID.${subset}IsoDEGFOLDOverExpIn1List
key-merge ../mm10Ens68TransID_GeneName.txt
${pair}.${subset}IsoDEGFOLDOverExpIn1List | awk '{if (NF == 7) print $0}' >
${pair}_wgeneID.${subset}IsoDEGFOLDOverExpIn1List
rm -f ${pair}_wgeneID.${subset}IsoDEGFOLDOverExpIn2List
key-merge ../mm10Ens68TransID_GeneName.txt
${pair}.${subset}IsoDEGFOLDOverExpIn2List | awk '{if (NF == 7) print $0}' >
${pair}_wgeneID.${subset}IsoDEGFOLDOverExpIn2List
rm -f ${pair}_wgeneID.${subset}IsoDEGFOLDNonDEList
key-merge ../mm10Ens68TransID_GeneName.txt
${pair}.${subset}IsoDEGFOLDNonDEList | awk '{if (NF == 5) print $0}' >
${pair}_wgeneID.${subset}IsoDEGFOLDNonDEList
else
rm -f ${pair}.${subset}IsoDEGFOLD*List.GeneIDs
awk '{print $1}' ${pair}.${subset}IsoDEGFOLDOverExpIn1List >
${pair}.${subset}IsoDEGFOLDOverExpIn1List.GeneIDs
awk '{print $1}' ${pair}.${subset}IsoDEGFOLDOverExpIn2List >
${pair}.${subset}IsoDEGFOLDOverExpIn2List.GeneIDs
awk '{print $1}' ${pair}.${subset}IsoDEGFOLDNonDEList >
${pair}.${subset}IsoDEGFOLDNonDEList.GeneIDs
fi
echo "End getGFOLDIsoDEIntersection

The field in “red” has to be changed to the desired fold change along with the changes
in ‘formatGFOLDfiles’ and ‘runFisher’ scripts for the new fold change to be included in
the anaylsis. This script works directionally, i.e., a gene that comes out of GFOLD as
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“differentially expressed”, then is checked for its p-value (whether it is 0.01) in the output
of runFisher script. Only those genes that have passed this becomes “DE genes”. If a
gene is “DE” by GFOLD but does not pass the set p-value in Fisher, the gene does not
pass the DE test.
iii.

ExpressedNotExpressedAnalysis

This script uses threshold = 1 to determine whether a gene is expressed (FPKM≥1) or
not (FPKM <1).
iv.

DivideOnlyGroupsToOneAndMultipleIsoforms

This script further sub-divides the “Only” group of genes into single isoform or multiple
isoform.
v.

GetDIEGenes

vi.

MergeFiles

It merges the output of the above mentioned scripts.
vii.

LabelGeneSubgroupsInAllPartitionsFiles

This assigns the label to each gene by merging the output of the above scripts.
viii.

GetStats

This gives the final number of genes in each category (bin) and in the sub-category
along with the number of mapped reads and number of not expressed genes.
1.8: Binning:
Once the genes are categorized based on their FPKM units and their differential
expression, they are subjected to DAVID analysis to identify the functional enrichments
of those genes.
2. Downstream analysis of the binned data
205

2.1: Finding the functional enrichment through DAVID analysis.
The Database for Annotation, Visualization and Integrated Discovery (DAVID) is
an algorithm to provide functional enrichments for a given set of genes. Additionally, it
provides other major biological functions related to the gene list as well as find other
functionally similar genes in the species genome not listed in the query. Protein domain
and motifs information along with gene-disease association are also provided by DAVID.
It is one of the most sought big data mining tool to investigate the biological meaning from
RNAseq data. DAVID mines the available literature and gene ontology studies to give
functional enrichments for the genes. Usually a gene list that has an underlying common
feature such as transcriptional kinetics could enrich for more meaningful functions
compared to a random list of genes. For example, most up- or down- regulated set of
genes between two samples have been shown to be involved in specific interesting
biological processes compared to genes that are not changing between the two. The
functions enriched by DAVID could be either validated from apriori knowledge or by
performing wet lab experiments. Also, the size of the gene list is an important factor in
determining the function with higher statistical significance. Therefore, a larger gene list
can have a statistically significant enrichment.
The advantages of DAVID includes its flexibility to use different species
background for analyses. Besides giving the functional enrichment with statistical
significance, DAVID also provides annotation categories, protein-protein interaction,
protein functional domains, disease association, bio-pathways, sequence feature,
homology, and gene tissue expression etc.
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Following are the steps to identify the functional enrichments of genes belonging to
different bins:
1. Highlight “Upload” tab.
2. Paste the gene list in the white space under “A. Paste a list”.
3. Choose “Ensembl _Gene _ID” in the drop down box under “Step 2: Select
Identifier”.
4. Choose “Gene list” under “Step 3: List type”. Hit “Submit list”.
5. Click “Submit to conversion tool” which will be next to the drop down box in
option 1.
6. Another tab would open up. Click on “red arrow” next to “official _gene _symbol”
under “convert all” under “Summary of Ambiguous gene IDs”.
7. Click “Submit converted list to DAVID as a gene list”. Give a name to the list
instead of “new_converted_list”.
8. Go to the neighbouring tab that was already open but now the “list” tab would
be highlighted.
9. Choose “Mus musculus” species and click on “Select species”. If any other
species is selected (You can find it by looking at the current background) other
than Mus musculus, go to “Background” tab and choose “Mus musculus” from
it and click “Use”.
10. Click “Functional Annotation clustering”.
11. Repeat the step above again with selecting the species, and clicking on
“Functional Annotation Clustering” again.

207

12. Another window would open. Click on “Download file”. Save the text file under
the same name you gave earlier.
2.2: Finding the potential interactors of genes involved in a pathway through
GeneMANIA
GeneMANIA is an algorithm that finds genes related to a set of input genes by
functional association. GeneMANIA mines data from literature regarding genetic
interactions, pathways, co-expression, protein domain similarity, protein-DNA, proteinprotein, genetic interactions, gene and protein expression data, phenotypic screening
profiles, and co-localization studies. Sometimes, orthologous studies are also used to
define a partner to a gene in a complex or a pathway. The first input set of genes are
“bait” as they define the rest of the potential partners.
GeneMANIA works best with the maximum input number of 50 genes and make
gene function predictions on the basis of gene ontology annotation patterns. Network
generated is accompanied by the data source such as PubMed or BioGRID, Pfam etc.
Co-expression data usually is collected from Gene Expression Omnibus (GEO) from a
publication. Physical interaction data is mainly associated with protein-protein interaction
studies from primary literature and databases such as BioGRID and Pathwaycommons.
In genetic interaction data, two genes are functionally associated if perturbation of one
gene affects the other gene. Also, two genes are linked if they share a protein domain,
which is obtained from InterPro, SMART and Pfam. Co-localization is another way of
linking two genes when they are shown to be present in the same tissue and the same
location or gene products present at the same cellular location. Connection between two
genes also come from pathway data where they are shown to participate in the same
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reaction within a pathway (data collected fromReactome, bioCyc, Pathwaycommons).
Predicted connections are usually associated with orthology.
Following are the steps involved in identifying the network in GeneMANIA:
1. Input the list of genes, which is considered the “bait”.
2. Select the species.
3. The input list is shown in black balls while the new potential interactors as ones in
grey balls.
4. Save the network and the list of genes.
The scripts for the above mentioned customized bioinformatics pipeline were written by
Dr. Sahar AlSeesi under the guidance of Dr. Ion Mandoiu.
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Supplementary Information for Chapter 5
Supplementary figures – Additional file 1
Figure S1
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Figure S1 (Related to Materials and Methods): Read position mismatch analysis.
A – C. Reads obtained from deep RNA sequencing for E16CE (A), P0CE (B) and P0NE
(C) were subjected to mismatch analysis by HardMerge alignment. Shown in x-axis is
the read position (1 – 101) and shown in y-axis is the percentage of reads with
mismatch.
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Figure S2

Figure S2 (Related to Fig. 5.2): Transcriptome summary for E16CE-P0CE & P0CEP0NE comparison: A & B. Transcriptome summary of the comparison between
E16CE-P0CE and P0CE-P0NE, respectively. The white box represents all genes
examined for this study. The venn diagram within it represents the different bins. C.
Alternative splicing (AS) status of “expressed in both” groups (OR_E16CE, Non_DR,
OR_P0CE, and OR_P0NE) in E16CE-P0CE and P0CE-P0NE comparisons.
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Figure S3

Figure S3 (Related to Fig. 5.4): Downstream analysis of genes belonging to the
OR_P0NE bin enriching for the GOterm "Synapse": A. Output of the downstream
gene annotation analysis pipeline parts II and III for OR_P0NE category which enriched
for synapse. B. Genes resulted from the DAVID analysis for the GOterm “synapse”
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were further sub-divided into presynaptic or postsynaptic along with the time point of
their transcription initiation. Up (↑) and down (↓) arrows indicate upregulation or
downregulation of transcription at that time point.
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Figure S4

Figure S4 (Related to Fig. 5.5): Transcriptome summary for static & temporal
comparison: A. Transcriptome summary of the comparison between P21-Nrl-WT and
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P21-Nrl-KO (Static comparison). The white box represents all genes examined for this
study. The venn diagram within it represents the different bins. B & C. Transcriptome
summary of the comparison between P0 vs. P21-Nrl-WT and P0 vs. P21-Nrl-KO,
respectively (Temporal comparison). The white box represents all genes examined for
this study. The venn diagram within it represents the different bins.
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Supplementary tables
Legends:
Additional file 2: Table S1: Output of Binning in E16CE – P0CE and P0CE –P0NE
comparisons: Custom bioinformatic pipeline and binning of E16CE - P0CE and P0CEP0NE comparisons at the gene level (S1.1, S1.3) and isoform level (S1.2, S1.4) as
discussed in the strategy in Fig. 1C.
Additional file 3: Table S2: DAVID analysis output for temporal comparisons:
DAVID output for genes belonging to bins in E16CE-P0CE comparison (S2.1), P0CEP0NE comparison (S2.2), P0 vs. P21-Nrl-WT comparison (S2.3) and P0 vs. P21-Nrl-KO
comparison (S2.4).
Additional file 4: Table S3: Clusters obtained in the microarray analysis: Clusters
generated through K-means clustering in Genesis for the microarray.
Additional file 5: Table S4: Output of Binning in P0 – P21WT and P0 – P21KO
comparisons: Custom bioinformatics pipeline and binning of P0 (P0CE+P0NE) vs.
P21WT-rep1, P0 vs. P21WT-rep2 and P0 vs. P21-WT-rep3 comparisons (S4.1) and P0
(P0CE+P0NE) vs. P21KO-rep1, P0 vs. P21KO-rep2 and P0 vs. P21-KO-rep3
comparisons (S4.2).
Additional file 6: Table S5: DE based analysis results for static and temporal
comparisons: DE based analyses for static (P21WT vs. P21KO) (S5.1) and temporal
(P0 vs. P21WT and P0 vs. P21KO) comparisons (S5.2, S5.3).
Additional file 7 – Table S6: DAVID analysis output of DE based analyses for
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static and temporal comparisons: Results of DAVID analysis based on DE genes for
P0 vs. P21WT (S6.1), P0 vs. P21KO (S6.2), and P21WT vs. P21KO (S6.3)
comparisons.
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